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ABSTRACT
Clarification of the angio-architecture and haemodynamic effects of cerebral 
arteriovenous malformations (AVMs) using non-invasive imaging may advance our 
knowledge and understanding of their natural history, resulting in improvements in 
the management of patients with these lesions.
The aims of the work in this dissertation was to investigate the 
haemodynamic effects of AVMs and to determine whether newer non-invasive 
imaging techniques allow an accurate enough assessment of the angio-architecture of 
AVMs to be able to replace conventional digital subtraction angiography (DSA) in 
some clinical situations. The hypotheses were:
1. Non-invasive structural imaging techniques, such as CT angiography (CTA) 
and MR angiography (MRA), provide adequate structural and volumetric 
information to replace the more invasive technique of DSA.
2. MR perfusion imaging is able to demonstrate the alteration of cerebral 
haemodynamics by AVMs.
6 Rapid frame rate DSA (RFRDSA) provides useful quantitative data on the
blood flow within cerebral AVMs.
In this work CT and MR angiography (CTA and MRA) were compared with 
conventional digital subtraction angiography (DSA). Twenty patients were 
examined with CTA and ten with MRA. Both techniques were able to detect most 
of the important angio-architectural features, but were not as accurate as DSA as 
decision-making tools, in particular because temporal resolution and nidus definition 
were poor. The use of gadolinium enhancement during MRA improved the 
visualisation of both nidus and draining veins.
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The nidal volume of ten AVMs was calculated from DSA and three magnetic 
resonance (MR) sequences. With biplanar DSA, an ellipsoid volume was calculated 
using orthogonal projections. MR images showed potential but were difficult to 
interpret due to varied appearances of flowing blood and, on gadolinium-enhanced 
MRA, the enhancement of abnormal brain.
The cerebral haemodynamics of fifteen patients with AVMs were examined 
with contrast bolus tracking. This semi-quantitative technique was able to 
demonstrate consistent differences in cerebral blood flow and volume, mean transit 
time and time to minimum signal intensity in brain distant from the AVM. Changes 
in the perinidal regions were dominated by the presence of draining veins.
A vascular phantom was calibrated to allow calculation of flow rates from 
rapid frame rate DSA. The technique for quantifying flow was assessed in five 
patients and compared with values measured by transcranial doppler. It was not 
possible to calculate accurately flow and velocity for AVM feeding vessels.
These imaging modalities allowed improved appreciation of the structure and 
haemodynamic effects of cerebral AVMs but further development is needed before 
they will be of use as reliable clinical tools.
Key Words: cerebral arteriovenous malformation, CT angiography,
MR angiography, rapid frame rate DSA, contrast bolus tracking.
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PARTI
INTRODUCTION
Chapter 1
AIMS OF THE WORK IN THIS DISSERTATION
The current management of patients with arteriovenous malformations 
(AVMs) is often unsatisfactory. One important reason for this is that their natural 
history and effect on cerebral haemodynamics are poorly understood. In addition, 
there is often a requirement for repeated cerebral angiography. These procedures 
are invasive, have associated risks, in particular that of stroke, and currently require 
inpatient admission. In a pathology that most commonly affects young adults, this 
has major implications for the patients, their families and society as a whole. 
Clarification of haemodynamic effects and advances in non-invasive imaging 
techniques may not only improve our knowledge and understanding of the natural 
history of AVMs, but may also allow advances in their management.
1.1 Hypothesis
The aims of the work in this dissertation was to investigate the 
haemodynamic effects of AVMs and to determine whether newer non-invasive 
imaging techniques allow an accurate enough assessment of the angio-architecture of 
AVMs to be able to replace conventional digital subtraction angiography (DSA) in 
some clinical situations. The hypotheses were:
1. Non-invasive structural imaging techniques, such as CT angiography (CTA) 
and MR angiography (MRA), provide adequate structural and volumetric 
information to replace the more invasive technique of DSA.
2. MR perfusion imaging is able to demonstrate the alteration of cerebral 
haemodynamics by AVMs.
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3. Rapid frame rate DSA (RFRDSA) provides useful quantitative data on the 
blood flow within cerebral AVMs.
1.2 Non-invasive structural imaging
The non-invasive structural imaging studies began with a prospective 
comparison of both CTA and MRA with DSA in patients with cerebral AVMs. The 
third study compared nidus volume measurements, traditionally determined from 
DSA, with those estimated from three different magnetic resonance (MR) sequences. 
This is of particular importance in those patients treated by stereotactic radiosurgery.
1.3 Perfusion imaging
The effects of AVMs on local cerebral perfusion and blood flow were 
investigated using bolus-tracking technique. Bolus tracking exploits the T2* 
shortening effects of gadolinium.
1.4 Haemodynamic imaging
The use of RFRDSA at 30 frames sec'1 was first validated using a vascular 
phantom. This technique was then used in a small group of patients to determine 
the accuracy of flow and velocity measured using RFRDSA and compared with 
those found on transcranial doppler (TCD).
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Chapter 2
INTRODUCTION
2.1 The clinical significance of arteriovenous malformations
Cerebral vascular malformations (CVMs) are inborn errors of vascular 
morphogenesis, resulting in the formation of abnormal arterial, venous or capillary 
channels with or without a shunt. CVMs may be classified into several types on the 
basis of their angiographic and MR image characteristics (Yasargil, 1987; 
Valavanis, 1996). The primary differentiating feature in CVMs is the presence or 
absence of shunting within the lesion. Shunting occurs only when a direct 
communication exists between arterial and venous channels. Angiographically, 
shunting is characterised by early opacification of draining veins, resulting in 
decreased arteriovenous transit time. Various degrees of dilatation of the involved 
arteries and veins may be seen because of increased flow through these low 
resistance channels (Dembo, 1982). These arteriovenous communications are of 
two types: fistulous and plexiform. In the fistulous type, an arterial channel empties 
directly into a venous channel. AVMs make up the plexiform type, where one or 
several arterial channels feed a vascular conglomerate of multiple arteriovenous 
communications from which one or multiple venous channels emerge as draining 
veins. The plexiform vascular conglomerate associated with arteriovenous shunting 
is called the nidus and may contain one or more direct arteriovenous fistulae, with 
tangled arteries, venous sinusoid spaces and veins communicating directly without 
an interposed capillary network (Stein and Wolpert, 1980). Oxygenated blood is 
shunted directly into the venous system.
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AVMs were first recognised by ancient Egyptians in 1500 BC, but it was in 
1863 that Virchow (Virchow, 1863) first described the pathological appearances of 
an intracranial AVM. The first clinical diagnosis has been attributed to Steinheil in 
1895 (Steinheil, 1895). Early attempts at operative intervention were unsuccessful, 
however their diagnosis and treatment was revolutionised by the introduction of 
cerebral angiography by Moniz in 1927 (Moniz, 1934).
CVMs without evidence of arteriovenous shunting arise from postarteriolar 
vascular channels and involve either capillaries or veins. This group is made up of 
capillary telangiectasia, developmental venous anomalies and cavernous 
malformations.
2.1.1 Epidemiology
Large autopsy studies have shown a prevalence of AVMs of 0.14 - 0.5%, 
making them seven to ten times less common than intracranial aneurysms (Perret 
andNishioka, 1966b; Wilkins, 1985; Stein and Kader, 1992). There is an expected 
annual incidence of one brain AVM per 100 000 population, of which only 0.006% 
are multiple (Perret and Nishioka, 1966b; Stein and Wolpert, 1980). Gender 
distribution is almost equal, although there may be a slight male preponderance, with 
no genetic predisposition (Perret and Nishioka, 1966b; Michelson, 1979; Parkinson 
and Bachers, 1980; Crawford, 1986b; Ondra, 1990).
2.1.2 Presentation
Most individuals develop symptoms prior to the age of 40 years with a mean 
age at presentation of 33.7 years (Perret and Nishioka, 1966b; Michelson, 1979; 
Parkinson and Bachers, 1980; Dembo, 1982; Luessenhop and Rosa, 1984; 
Crawford, 1986b; Ondra, 1990; Stein and Kader, 1992). This is in contrast to 
intracranial aneurysms when only a quarter of patients present by the age of 40 
(Perret and Nishioka, 1966b). Fifteen percent of patients however will remain 
asymptomatic (Brown, 1996). In the first two decades, particularly during period of
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brain growth, many lesions show progressive growth and haemodynamic changes 
with increasing deleterious effects (Luessenhop and Rosa, 1984).
2.1.2.1 Haemorrhage
Sixty to 70% of individuals with AVMs present with haemorrhage at a peak 
age of 25 - 40 years (Perret and Nishioka, 1966b; Drake, 1979; Crawford, 1986a; 
Ondra, 1990; Guterman, 1993; Heros, 1993; Tuijman, 1995; Brown, 1996). 
These figures may under-represent the true incidence of haemorrhage as clinically 
silent haemorrhage is diagnosed at surgery in as many as 10% of patients when 
haemosiderin staining is seen surrounding the lesion (Stein and Wolpert, 1980). It 
has been postulated that episodes of acute headache, seizures or other acute 
neurological symptoms may also represent haemorrhage.
Rupture of AVMs is responsible for 10% of all intracranial haemorrhages 
and is, after aneurysmal subarachnoid haemorrhage (SAH), the second most frequent 
cause of an intracerebral bleed from a vascular abnormality (Pott, 1992). 
Haemorrhage is largely intraparenchymal, although extension into the ventricular 
system and associated SAH are both common. Of haemorrhages caused by AVMs 
30% are SAH, 23% parenchymal, 16% intraventricular haemorrhage (IVH) and 31% 
combined (Hartmann, 1998).
The mean annual risk of haemorrhage is 2 - 4%, with an associated combined 
annual mortality and morbidity of 2.7% (Wilkins, 1985; Brown, 1988; Itoyama, 
1989; Ondra, 1990; Stein and Kader, 1992; Pollock, 1996a). Brown et al. (Brown, 
1988) observed that annual haemorrhage rates actually appear to increase over time 
from 1.3% risk in the first year after diagnosis to 2.2% risk at 15 years, whilst others 
have found that the risk remains constant or even diminishes with time, regardless of 
presenting symptom (Itoyama, 1989; Ondra, 1990). The mean time from 
presentation in any form to haemorrhage is 7.7 years (Ondra, 1990).
Most studies have shown that the risk of repeated haemorrhage increases to 
6% in the first year after the initial bleed, thereafter returning to the pre-haemorrhage
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risk (Graf, 1983; Wilkins, 1985; Itoyama, 1989). There is an overall rebleed rate 
of 23 - 35% at a mean of 3.6 years after the presenting haemorrhage (Perret and 
Nishioka, 1966b; Itoyama, 1989; Brown, 1996; Pollock, 1996a).
2.7.2.2 Seizures
Seizures are the second most common presenting symptom. Twenty to 30% 
of individuals present initially with seizures, however by the time the diagnosis has 
been made, as many as half will have had fits (Perret and Nishioka, 1966b; 
Crawford, 1986a; Crawford, 1986b; Itoyama, 1989; Ondra, 1990; Stein and 
Kader, 1992; Tuijman, 1995; Brown, 1996). The younger the patient at diagnosis 
the more likely they are to develop epilepsy: patients aged 10 - 19 years have an 
82% 20 year risk, whilst those aged 50 have a less than 2% 20 year risk of 
developing seizures (Crawford, 1986b).
Seizures are a common presenting symptom, particularly if the lesion 
involves the cortical surface. For this reason, it is commonly large AVMs that cause 
epilepsy as they are more likely to involve cortex (Crawford, 1986b). Other risk 
factors for developing seizures include involvement of the temporal lobe, previous 
haemorrhage and previous intracranial surgery (Crawford, 1986b). Frontal AVMs 
most commonly present with generalised seizures, whilst the majority of parietal 
AVMs present with focal motor seizures (45%) (Perret and Nishioka, 1966b). 
Posterior fossa and basal ganglia lesions rarely cause epilepsy (Crawford, 1986b). 
Seizures may be a sign of acute haemorrhage or epileptogenic effect of parenchymal 
iron deposits.
With treatment of the lesion, improved seizure control can be achieved 
although many still require anticonvulsants. Control of seizures tends to be better 
following surgery, but useful improvement can be seen with embolisation (complete 
or partial) (Michelson, 1979). The longer the duration of symptoms prior to 
treatment, the less likely is improvement after AVM obliteration.
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2.1.2.3 Neurological deficit
Non-haemorrhagic focal neurological symptoms in AVM patients are 
infrequent and appear to be dependent upon the location of the AVM. Most 
commonly it is lesions within the middle cerebral artery (MCA) distribution that 
cause neurological deficit. Large basal ganglia lesions may present with slowly 
progressive dementia, hemiparesis or visual field defect, whilst occasionally 
brainstem AVMs produce motor or sensory deficit with or without cranial nerve 
involvement. Symptoms may be permanent, transient or progressive (Michelson, 
1979). Non-progressive focal neurological deficit is seen in 7.2% of individuals 
(stable 4.6%, reversible 2.6%) whilst progressive deficit is seen in only 1.3% 
(Crawford, 1986a; Crawford, 1986b; Mast, 1995).
The cause of neurological deficit remains uncertain: recurrent haemorrhages, 
multiple microinfarcts, decreased perfusion because of arterial stenoses, venous 
hypertension, or ‘steal’ have all been proposed as possible aetiological mechanisms.
2.1.2.4 Other presenting symptoms
Patients with AVMs often complain of headaches although, as a primary 
symptom, they are unusual. Pain tends to be well localised, unilateral and throbbing 
and is often difficult to distinguish from other types of vascular headache (Dembo, 
1982). Headache occurs more frequently in AVMs that have a significant dural or 
pial component and despite treatment of the lesion it often persists (Stein and Kader, 
1992; Valavanis, 1996). Cranial bruits are present in 25% of cases and are again 
especially common with dural AVMs.
Patients may rarely present with raised intracranial pressure, or more 
commonly, symptoms of localised mass effect such as trigeminal neuralgia. 
Paediatric patients with large AVMs or vein of Galen aneurysms can present with 
obstructive hydrocephalus or, if there is significant shunting thorough the lesion, 
cardiac failure.
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2.1.3 Natural history
Knowledge of the natural history of a disease process is a prerequisite for 
evaluating the influence of any treatment modality on the course of that disease. 
This is especially true when the risks of therapy may be profound. Recently it has 
become difficult to identify large groups of untreated patients with AVMs in which 
to study natural history because of the availability of various treatments. In 
attempting to elucidate the natural history of AVMs, it is clear that there is a 
tendency to include patients with more complex lesions in the analyses of untreated 
patients because the more straightforward lesions are more likely to have been 
treated.
In their prospective study, Ondra et al. (Ondra, 1990) found the annual rate 
of mortality was 1% and that of severe morbidity 1.7%, these rates being constant 
over the course of the study. Eighty-five percent of the patients who bled, 
corresponding to 34% of the patient population of the study, either died or suffered 
severe morbidity during the 24 years of the study. Other studies have had similar 
findings (Michelson, 1979; Brown, 1988). Each haemorrhage has an associated 10 
- 13% mortality and 30% serious morbidity (Perret and Nishioka, 1966b; Graf, 
1983; Heros, 1993). There is a higher incidence of neurological deficits with an 
intracerebral haemorrhage (ICH) (90.2%) than SAH (56.8%) and the younger the 
patient, the better the prognosis (Graf, 1983; Itoyama, 1989).
Several authors have demonstrated a worsening mortality and morbidity with 
repeat haemorrhages (Wilkins, 1985; Brown, 1996; Hartmann, 1998). In one 
study, the 30 day mortality after the first haemorrhage was 17.6%, but increased 
dramatically after the second haemorrhage to 50% (Brown, 1996). Overall 
mortality from the first haemorrhage is 10%, 13% from the second haemorrhage and 
20% from subsequent haemorrhages (Wilkins, 1985). Other studies have found no 
correlation between the number of haemorrhages and outcome although agree that 
prognosis is worse in those who have bled when compared with those who have not 
(Itoyama, 1989).
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Death from all causes in patients with AVMs is 29% at 20 years and 18% at 
10 years, of which 15% are directly attributable to the AVM (Michelson, 1979; 
Crawford, 1986a). The risk of death does not appear to be dependent on the mode 
of presentation, size or depth of the AVM, although patients with parietal lobe 
AVMs have a lower risk of death at 20 years (Crawford, 1986a; Ondra, 1990). Of 
those who do not die in the first two decades following presentation, 33% will have 
had no further symptoms, 22% will be in a fair condition and 29% will be disabled 
(Michelson, 1979).
2.2 Pathological Considerations
2.2.1 Pathogenesis
AVMs are presumed to be congenital in origin. This is supported by the 
following observations: there is no growth by neoplasia; there is generally no history 
of trauma, stroke, or other potential cause of a vascular fistula; they cannot be 
produced experimentally; they rarely become symptomatic after the sixth decade of 
life; they appear to develop by displacing the maturing brain to its margins and 
preserving neurological function (Stein and Kader, 1992). That AVMs occur in 
association with genetic disorders, for example Sturge-Weber, Wybum-Mason, 
ataxia telangiectasia and Osler-Weber-Rendu syndromes has also been used as 
evidence that they are developmental lesions.
The pathogenesis of AVMs is generally attributed to maldevelopment of the 
cerebral vascular system during the 40 to 80 mm length stage of human 
embryogenesis, when there is division of vessels into primitive arteries, capillaries 
and veins (Stein and Wolpert, 1980; Dembo, 1982; Mullan, 1996). However, the 
underlying anomaly ultimately responsible for the vascular malformation still
t hremains a matter of controversy. Between the 7 week and the end of the first 
trimester, the primitive penetrating vessels of the brain exist as an anastomotic
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plexus that undergoes a continuous remodelling process characterised by the 
addition and elimination of vascular connections. In 1928, Dandy (Dandy, 1928) 
postulated that retention of primordial arteriovenous connections from the fetal 
intracranial vasculature could result in the development of AVMs. Subsequent 
theories of the causes of AVMs have focused on the persistence of an arteriovenous 
connection from the fetal intracranial vasculature with the failed development of an 
intervening capillary network. It has been suggested that a primary maldevelopment 
of primordial capillaries could result in the disturbed formation of local arteries and 
veins and that such a dysplastic vascular plexus could account for the spectrum of 
lesions encountered. Yasargil (Yasargil, 1987) suggests that persistence of the 
embryonal plexus will lead to a pure plexiform type containing vessels without 
direct arteriovenous fistulae. A gradual but incomplete destruction of the embryonal 
plexus will result in a mixed type of malformation, composed of both plexiform 
connections and direct arteriovenous fistulae; gradual but complete destruction of the 
plexiform parts will ultimately result in a pure direct arteriovenous fistula
Alternatively, some have postulated that the primary abnormality lies within 
a disturbed venous drainage system, particularly in view of the venous abnormalities 
often associated with AVMs (Yasargil, 1987; Mullan, 1996; Nussbaum, 1998). 
AVMs frequently incorporate evidence of an early failure in venous maturation, such 
as absence of middle cerebral vein (MCV) or a recognisable connection between it 
and the cavernous sinus or an AVM exit channel running in an abnormal direction to 
that found in adult morphology. This suggests that AVMs are already in place 
before the MCV connects to the cavernous sinus immediately after birth. On closer 
examination, persistence of a well-recognised earlier venous pathway can often be 
demonstrated (Mullan, 1996). However, should an arteriovenous fistulous 
communication take place, the increased flow through the venous side would 
prohibit the venous regression, which normally occurs as more definitive channels 
take over.
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On the arterial side, the multitude and lack of functional architecture of 
arteries terminating within the AVM might suggest that they belong to a relatively 
primitive penetrating vessel. However, these could appear much later under the 
influence of an appropriate vasogenic hormone (Mullan, 1996). Interestingly, at a 
microscopic level, veins of AVMs tend to retain their embryonic character, whilst 
arteries appear to undergo normal developmental maturation (Deshpande and 
Vidyasagar, 1980; Nussbaum, 1998).
There is evidence that up to a half of these lesions increase in size with time, 
with increasing enlargement and tortuosity of feeding arteries and draining veins 
(Drake, 1979; Michelson, 1979; Stein and Wolpert, 1980; Crowell, 1985). This 
tendency to enlarge is dependent upon the age at which the initial diagnosis was 
made: the younger the patient at the time of angiography, the more marked the 
growth. With enlargement, they often progress from a low flow to high flow 
lesions. It may be that haemodynamic disturbances such as venous outflow 
obstruction open previous arteriovenous connections, causing a pulse synchronous 
expansion of abnormal feeding vessels or a gradual dilatation of vessels by 
haemodynamic stresses (Wakabayashi, 1991; Nussbaum, 1998). Other hypotheses 
include a local increase in angiogenic factors due to chronically raised intraluminal 
pressure or indirectly from decreased tissue perfusion with resultant tissue hypoxia 
(Nussbaum, 1998). Alternatively, haemorrhage from venous overload may be the 
stimulus for angiogenesis (Nussbaum, 1998).
2.2.2 Elements of an AVM
2.2.2.1 Nidus
The nidus represents the area of arteriovenous shunting within the AVM, and 
although often difficult to identify precisely, is probably best regarded as that part of 
the AVM which is interposed between the recognisable feeding arteries and larger 
terminal draining veins. The nidus of the AVM is composed of a conglomerate of
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vascular loops, whose precise origin remains a source of controversy. Some feel 
they represent abnormal vascular channels, others that they are embryonic veins or 
normal veins arterialised by high blood flow and pressure.
Microscopically, vascular channels range from well-differentiated arteries 
and veins to thick-walled, hyalinised channels. In the arteries, the normal 
lamination of elastica and muscularis is altered with segmental dilatation (Crowell, 
1985). They show medial hypertrophy, endothelial thickening with hyaline change 
and thrombosis and secondary degeneration with fibrosis and atheroma may occur 
(Stein and Wolpert, 1980). These changes may be caused by mechanical stresses 
induced by long-standing high flow and may cause an increased risk of stagnation 
and retrograde thrombosis of former arterial feeders with treatment of the AVM (al- 
Rodhan, 1993). Calcification of vessels is present in a significant number of lesions 
and may be prominent (McCormick, 1966; Michelson, 1979; Dembo, 1982). The 
veins usually have thickened collagenous walls and appear arterialised yet the 
increased cellularity in their walls depends on proliferation of fibroblasts, not of 
smooth muscle cells. The abnormal dilated feeding arteries, draining veins and 
angiomatous nidus are often located primarily in white matter.
AVMs can broadly be divided into two main categories: those with a single 
nidus (with all the vascular channels somehow interrelated) and those with more 
than one nidus in which there are adjacent but individually separated components of 
the malformation. Most AVMs exhibit a defined compact nidus with clearly 
discernible boundaries and identifiable arterial inlet and venous outlet. In fewer 
than 10% of cases, the nidus appears as a diffuse, irregular vascular area without 
clear delineation of the arterial entry zone or the venous exit zone. The nidus may 
be composed of a single or multiple vascular compartments, where a compartment is 
defined as an intranidal vascular unit, characterised by one or more feeding arteries, 
arteriovenous shunting and a unique draining vein. These compartments within the 
AVM nidus are not rigid well-defined anatomical units but haemodynamic units that 
may communicate.
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Degeneration of parenchyma around and within the malformation is almost 
constant, with no intervening brain tissue usually being found between vascular 
loops of the malformation except in cases of a loosely arranged AVM nidus 
(McCormick, 1966). Any cerebral tissue remaining in the interstices is generally 
gliotic and considered non-functional, with haemosiderin pigmentation and foci of 
calcification (Stein and Wolpert, 1980; Kalimo, 1997). This has also been 
confirmed using functional MRI (Schlosser, 1997).
2.22.2 Arterial feeders
Recognition of the type, number and associated angioarchitectural features of 
feeding arteries is very important in understanding the structure of the AVM and for 
planning treatment.
Cerebral arteries may be related to a malformation in one of three ways: as a 
terminal feeding artery, a transit (partially participating) feeding artery or as an 
artery ‘en-passage’ (non-participating) non-feeding artery.
Terminal feeding arteries may arise as far proximal as the anterior, middle 
and posterior cerebral arteries or as far distal as the fourth or fifth branching of these 
vessels. This type of feeder ends directly in the nidus but, before doing so, gives off 
branches to normal brain. They may be markedly dilated and tortuous, but often 
decrease in calibre following treatment of the AVM. Embolisation performed 
through a terminal feeder is safe, provided the catheter tip is positioned within the 
distal segment of the artery. The risk of ischaemic complications associated with 
embolisation relates to brain parenchyma proximal to the AVM. Such 
complications are caused by reflux of the embolic agent into more proximal 
segments and inadvertent occlusion of normal branches.
Transit arteries with participation are usually enlarged and seem to enter the 
malformation. They give off side branches, which feed the AVM but then continue 
on to supply normal brain beyond. These must be traced to the point where the 
branches enter the malformation before definitive ligation or embolisation is
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undertaken. Arteries ‘en passage’ are not enlarged but are running in the vicinity of 
the AVM and often appear to be part of the lesion.
2.22.3 Venous drainage
Draining veins are usually divided into superficial groups, which drain into 
the sagittal, sphenoparietal, cavernous, transverse and sigmoid sinuses, and deep 
groups which pass to the subependymal collecting system and subsequently into the 
internal cerebral veins, basal vein of Rosenthal, internal occipital vein, into the vein 
of Galen and hence into the straight sinus and torcular or petrosal sinuses.
In most cases drainage seems to follow the expected cortical or subcortical 
vein in the area, but at times unusual routes of drainage are noted, reflecting either 
pre-existing embryonic channels or perhaps normal small transcerebral venous 
systems. Unexpected venous drainage most probably represents a secondary event 
following thrombosis of the anatomically expected draining vein and therefore 
corresponds to the development of venous collateral circulation, which distributes 
the increased venous pressure from the AVM into normal veins. Extensive venous 
collateralisation decreases the risk of rupture and prevents the development of 
neurological symptoms. Depending on the location of the AVM, collateral 
rerouting may occur by way of ipsilateral, contralateral or transcerebral veins.
Failure of the venous collateral circulation to compensate for the venous 
hypertension results in the formation of a focal venous ectasia or varix proximally 
and the development of acute or progressive, transient or permanent clinical 
symptoms. Such venous ectasias or varices are vulnerable to rupture and their 
angiographic demonstration indicates an increased risk of haemorrhage.
2.22.4 Sinuses
Sinuses may also be altered by the presence of an AVM, particularly large 
high flow lesions. Flow directions may be abnormal owing to increased pressure of 
the arterial input of the AVM being reflected in the venous drainage, or to
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anomalous construction of the sinuses themselves. There may be agenesis or 
obliteration of the sigmoid, transverse, straight and even sagittal sinuses. With sinus 
obliteration (in cases of callosal, parathalamic, occipital or cerebellar AVMs) 
embryonic connections, which normally involute, may persist. For example, there 
is frequently a communication between the vein of Galen and the superior sagittal 
sinus (SSS) when the straight sinus is occluded.
Vinuela et al. (Vinuela, 1985) found angiographic evidence of major venous 
wall irregularities or stenoses of the galenic system in 14 cases and occlusion of the 
deep venous system in seven cases of a total of 53 patients with AVMs. Numerous 
venous collaterals through medullary and cortical regional veins were noted and 
there was a late drainage through the basal vein of Rosenthal in all cases. They 
suggested that the abnormal haemodynamic patterns produced by the drainage from 
AVMs into the vein of Galen and straight sinus might lead to a high incidence of 
venous occlusion and stenosis. This might, in turn, lead to the higher than expected 
incidence of intracranial haemorrhage in deep-seated AVMs, which tend to have 
such drainage patterns. Yasargil encountered frequent anomalies of the sinuses 
including agenesis and stenosis or occlusion, particularly of the straight, transverse 
and sigmoid sinuses (Yasargil, 1987). This was mostly observed with large parietal, 
occipital and posterior fossa AVMs, as well as in AVMs with a significant fistulous 
component. If the normal dural sinuses were absent, the veins often coursed 
towards primitive embryonic channels and even out to the skull and scalp. As with 
any high-pressure intracranial fistula, flow may be reversed in the veins and reflux 
back through the sinuses. Impaired venous outlets in such cases often resulted in a 
reflux into the internal cerebral vein as well as reversal and redistribution of venous 
flow.
2.2.3 Association of aneurysm and AVM
The overall incidence of arterial aneurysms associated with AVMs has been 
reported as between 10 and 20%, 75% of which are on major feeding arteries
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(Michelson, 1979; Miyasaka, 1982; Crawford, 1986a; Brown, 1988; Lasjaunias, 
1988; Duong, 1998; Hartmann, 1998). In those presenting with haemorrhage, the 
incidence of associated aneurysms increases to as much as 58% (Perret and 
Nishioka, 1966b; Lasjaunias, 1988; Tuijman, 1995). Their prevalence increases 
with age and they are found in 8% of individuals with AVMs aged less than 25 
years, 24% of those aged 25 - 50 years and in 37% of those aged greater than 50 
years (Miyasaka, 1982; Lasjaunias, 1988).
Three hypotheses exist to explain the high occurrence of aneurysms in 
association with AVMs: firstly, that the development of the aneurysm is secondary 
to increased blood flow to AVM; secondly, that both aneurysm and AVM are 
congenital blood vessel abnormalities that develop simultaneously; thirdly, that their 
existence is merely co-incidental (Wilkins, 1985). Miyasaka et a l (Miyasaka, 
1982) reviewed the angiograms of 132 consecutive patients with AVMs and found 
43 aneurysms in 22 patients (16.7%). They found that aneurysms were more likely 
to occur in those patients with larger AVMs. They suggested that as the prevalence 
of AVMs in a large autopsied series of patients with cerebral aneurysms was not 
significantly higher than in a control group without aneurysms, that the same 
developmental defect was unlikely to be responsible for both lesions. Similarly the 
theory of coincidental association was thought to be unlikely. The distribution of 
aneurysms and infundibula on major feeding vessels to the AVMs, remote from the 
Circle of Willis, was such that they concluded that haemodynamic changes in the 
arteries supplying the malformation must have had some role in the aetiology of 
concurrent aneurysms.
Aneurysms associated with AVMs fall into three broad categories: those 
found on the enlarged arterial feeders, but in locations in which aneurysms are often 
found to arise spontaneously (proximal, related) (35 - 57%); those occurring on 
feeding vessels in the vicinity of an AVM but at locations in which it is unusual to 
find aneurysms arising in the absence of an AVM (distal, related) (20%); and finally 
those which arise at locations seemingly unrelated to the AVM (unrelated) (24 -
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43%) (Perret and Nishioka, 1966b; Lasjaunias, 1988). Distal related aneurysms 
may be extranidal or intranidal.
Management of combined lesions can be difficult. Most authors suggest 
treatment of the symptomatic lesion first with up to two thirds of aneurysms showing 
regression with obliteration of the AVM, rendering further treatment unnecessary 
(Lasjaunias, 1988; Cunha e Sa, 1992; Stein and Kader, 1992). Aneurysms, which 
do not regress, may be treated as any other unruptured aneurysm after excision of the 
AVM. When bleeding occurs in the setting of an associated aneurysm and AVM, it 
is usually the aneurysm that has ruptured, although the site of extravasated blood on 
CT remains the most accurate way of confirming the source of bleeding prior to 
treatment (Drake, 1979; Crowell, 1985). Lasjaunias et al. suggest that the presence 
of aneurysms indicates the most high flow feeders and therefore allows targeted 
endovascular treatment (Lasjaunias, 1988).
Aneurysms often have a thinner and weaker wall than other arterial elements 
of the AVM. As they are exposed to nearly the same arterial pressures as the 
arterial components of the AVM, they represent the most likely site of rupture 
following intra-arterial pressure rises, particularly if sudden. Following 
embolisation of a nidus compartment, a sudden increase in intraarterial pressure 
involving the non-occluded vessels supplying the remaining AVM may occur, 
predisposing unprotected aneurysms to rupture. Therefore, embolisation of AVMs 
should be first performed through feeding arteries either carrying proximal related 
aneurysms or supplying compartments containing extra or intranidal aneurysms. In 
addition, venous hypertension, which occurs with stenosis or obstruction of the 
venous drainage may lead to aneurysmal rupture.
36
2.3 Classification of AVMs
As ever more sophisticated means of studying AVMs have developed, 
systems of classification have diversified from the early descriptive terms based 
purely on morphological observation.
2.3.1 Topographical analysis
Topographic location of an AVM can be classified by combining information 
obtained from DSA with that from structural imaging in the form of MRI or CT 
(Berenstein and Lasjaunias, 1992). A summary of this classification is seen in 
Table 2.1.
Table 2.1: Topography of intracranial AVMs
Cortical
arteries
Perforating
arteries
Choroidal
arteries
Deep
veins
Superficial
veins
Cortical + - - - +
Cortico-subcortical + - - - £ +
Cortico-ventricular + +  * +  * + +
Cortico-callosal + - +  * + +
Deep-seated +  § + - + +  t
Choroid plexus - +  * + +
from Berenstein (Berenstein and Lasjaunias, 1992)
$ Can be recruited via transcerebral veins 
§ Insular and cerebellar
* Subependymal arterial anastomosis or branches can be seen
Cortical AVMs are exclusively fed by cortical arteries and drain into 
superficial veins. Cortico-subcortical lesions recruit cortical arteries and drain into 
superficial veins but may also drain into the deep venous system if the transcerebral 
venous system is patent. In both cortical and cortico-subcortical lesions, some 
regions of the cortex drain to deeply located veins that should not be considered as a
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part of the true deep venous system. Such vessels include the medial veins of the 
temporal lobe and the basal vein, the veins of the cerebellar vermis, and the 
precentral vein.
Cortico-ventricular lesions correspond to the classical pyramidal shaped 
malformation, reaching the ventricular wall at their apex. Feeding arteries are both 
perforating and cortical. Draining veins are also deeply and superficially located. 
Cortico-callosal lesions belong to the cortico-ventricular group as they have the same 
venous characteristics, however they do not recruit perforating arteries, but are 
supplied by the cortical arterial network and choroidal arteries.
Deep-seated lesions can be located supra- or infratentorially in the depth of 
the brain. Their niduses involve the deep nuclei and the long fibre tracts with their 
arterial and venous connections. They recruit exclusively perforating arteries and 
drain into the deep venous system. They may use transcerebral veins if patent, 
either as a direct venous outlet or as a collateral pathway.
Choroid plexus AVMs are fed primarily by choroidal arteries and 
subependymal arterial feeders arising from the Circle of Willis. Drainage is via 
ventricular veins, with occasional recruitment of transcerebral veins when patent.
This form of classification is similar to that described by Yasargil who 
categorised AVMs according to their anatomical location (Yasargil, 1987).
2.3.2 Spetzler classification
Spetzler and Martin (Spetzler and Martin, 1986) proposed a grading system 
for AVMs in 1986 on the basis that, in making a recommendation for treatment of a 
patient with an AVM, it was important to estimate the risk of surgery for that patient. 
A simple, broadly applicable grading system designed to predict the risk of 
morbidity and mortality associated with surgical treatment of a specific AVM was 
proposed. The lesion is graded on size, pattern of venous drainage and eloquence of 
adjacent parenchyma with a total of six grades (Table 2.2). Points for each of these 
features are added together to give the grade of the AVM from grade I to V. They
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also included a grade VI for those extremely large diffuse AVMs involving critical 
structures. These lesions were felt to fall into a separate ‘inoperable’ category. 
Retrospective application of the grading scheme to their series of surgically excised 
AVMs demonstrated its correlation with the incidence of post-operative neurological 
complications.
Table 2.2: Determination of AVM Spetzler grade
Graded Feature Points Assigned
Size of AVM
small (< 3cm) 1
medium (3-6cm) 2
large (> 6cm) 3
Eloquence of adjacent brain
non-eloquent 0
eloquent 1
Pattern of venous drainage
superficial only 0
deep 1
from Spetzler (Spetzler and Martin, 1986)
2.4 Haemodynamics
2.4.1 Cerebral blood flow
Normal cerebral blood flow (CBF) ranges from 36 to 82 ml lOOg*1 min*1 in 
normal subjects, 80% is distributed to the cerebral cortex and 20% to the white 
matter. This represents a cerebral perfusion volume of approximately 750 ml min'1, 
equivalent to 15% of the resting cardiac output. The brain accounts for about 20%
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of the body’s total oxygen consumption. CBF values of greater than 170 ml lOOg'1 
min'1 have been found in patients with cerebral AVMs (Deutsch, 1983).
Regardless of the fluid flowing through a vessel, the smaller the calibre and 
greater the length, the greater the resistance to flow. Flow is inversely related to 
resistance and directly proportional to the pressure gradient along the vessel. 
Vessels in parallel will have less resistance than vessels in series; an AVM must be 
considered as a combination of these.
Blood vessels are able to distend and contract, which can greatly affect the 
volume and rate of blood flow through them. As these vessels are not rigid, they 
require a certain amount of pressure within them to remain patent. In arterioles and 
larger vessels, the pressure required for distension is also highly dependent upon 
muscular tone. As veins contain a smaller amount of muscular and elastic tissue, 
they are more readily distensible but tend to collapse when intraluminal pressure is 
low. The expansibility of veins allows them to hold a large capacity of blood.
2.4.1.1 Neuronal Control
The cerebral vasculature has a rich extrinsic innervation from the autonomic 
nervous system, but this supply is to pial vessels only. The extrinsic sympathetic 
supply is derived from the superior cervical ganglion. The parasympathetic fibres 
(which originate in the brainstem nuclei) travel via the facial nerve through the 
sphenopalatine ganglion and thence to the perivascular neural plexus. Despite its 
extensive input, the functional significance of extrinsic autonomic regulation of CBF 
remains unclear. The cerebral vasculature also receives input from the intrinsic 
neural regulatory systems originating in the brainstem. Experimental electrical 
stimulation of these areas results in a significant increase in CBF.
2.4.1.2 Chemical mediators
The precise chemical mechanisms by which vascular smooth muscle tone is 
determined remain unknown. Modulators of cerebral vascular tone are thought to
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include the vasodilators acetylcholine, adenosine, calcitonin gene-related peptide, 
vasoactive intestinal peptide, substance P and nitric oxide and the vasoconstrictors 
neuropeptide Y and endothelin 1.
2.4.2 Regulation of cerebral blood flow
CBF is normally tightly controlled by two major mechanisms: autoregulation 
and chemoregulation/metabolic coupling. It is also affected by a variety of other 
mediators, in particular arterial partial pressure of carbon dioxide.
2.4.2.1 Autoregulation
Autoregulation is the process by which CBF remains at a relatively constant 
level despite variations in cerebral perfusion pressure (CPP), where :
CPP = systemic arterial blood pressure - intracranial pressure
Vascular tone in resistance vessels is determined by transmural pressure, an 
increase in which produces vasoconstriction and a reduction in flow, and vice versa. 
Blood flow to the brain can be constantly maintained between a systemic arterial 
blood pressure of approximately 50 to 180mmHg. Resistance vessels are maximally 
vasodilated at a CPP of 40mmHg; vasoconstriction is maximal at a CPP of 
180mmHg. Beyond these limits, CBF changes in direct proportion to the systemic 
blood pressure.
2.4.2.2 Chemoregulation/metabolic coupling o f cerebral blood flow
Local CBF is determined by cerebral metabolism. The oxygen consumption 
of human brain (cerebral metabolic rate for oxygen, CMRO2) is usually fairly stable, 
in the range 3.0 -  3.8 ml lOOg'1 min'1. The coupling of cerebral metabolism with 
CBF is referred to as chemoregulation/metabolic coupling. Brain CMRO2 is 
significantly influenced by temperature with a 5% reduction in CMRO2 with every 
1°C drop in temperature.
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2A.2.3 Effects o f Carbon Dioxide
Hypercapnia increases cerebrovascular resistance, which in turn decreases 
CBF and cerebral vascular volume; hypocapnia has the opposite effect. This CBF 
response is mediated by changes in extracellular hydrogen ion concentration.
2.4.3 Flow Dynamics within AVMs
A more thorough knowledge of basic circulatory mechanisms and their 
control within AVMs and the surrounding parenchyma is essential if their treatment 
is to become more effective and safer. Haemodynamics in draining veins appears to 
play a particularly important role in the stability of AVMs and it is therefore 
important to establish the range of values of normal cerebral vein velocities and the 
range of flow velocities of draining veins of AVMs; knowledge of both could, for 
example, provide points of reference that may help determine the elimination of 
arteriovenous shunting and the restoration of normal haemodynamics in the cerebral 
venous system as endpoints for endovascular intervention.
However, detailed and accurate haemodynamic characterisation of an AVM 
nidus is currently not possible in practice because of the usual angioarchitectural 
complexity of cerebral AVMs (particularly in those referred for embolisation), the 
fragile nature and small size of vessels within the nidus that renders them 
inaccessible to safe microcatheterisation and the limitations of current imaging 
modalities that are unable to clearly resolve individual vascular components of the 
nidus. Therefore, in assessing the haemodynamic consequences of the presence of 
an AVM, the acquisition of flow and pressure information from AVM arterial 
feeders and draining veins is a feasible alternative to haemodynamic data obtained 
directly from the nidus of the AVM (Murayama, 1998).
2.4.3.1 Feeding artery and draining vein pressures
Most studies demonstrate a reduction in feeding artery pressure (FAP) to 40 
-  50% of systemic arterial pressure (Nomes and Grip, 1980; Handa, 1993; Kader
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and Young, 1996). It appears that the intra-arterial pressure decreases with distance 
along the arterial tree, although pressure drops are particularly exaggerated at major 
branch points. The fall in pressure is proportional to the number and length (greater 
than 8cm from the Circle of Willis in particular) of feeding arteries (Nomes and 
Grip, 1980). This may be in part related to the AVM size, since FAP is inversely 
proportional to AVM size (Spetzler, 1992).
The magnitude of flow through a fistula is inversely proportional to the 
resistance across it. Therefore, FAP should be lower in large high-flow lesions. By 
measuring blood velocity in arterial feeders, TCD may provide an estimation of flow 
thorough an AVM. TCD velocities in the parent vessels of feeding arteries to the 
AVM have been found to correlate with lesion size (Fleischer, 1993; Kader, 1994). 
In addition, Fleischer et al. (Fleischer, 1993) confirmed a significant inverse 
correlation between FAP and parent vessel peak velocity.
The pressure within draining veins, however, is increased compared with 
normal cerebral veins (Nomes and Grip, 1980; Young, 1994). FAP and superficial 
draining vein pressure (DVP) appear to have a parallel relationship, in that higher 
arterial pressure is associated with higher venous pressure (Young, 1994). This 
suggests that the nidus allows some transmission of arterial pressure to the draining 
vein. Contrary to this however, is the observation that increases in systemic 
pressure do not influence DVP (Young, 1994; Kader and Young, 1996). It may be 
that the nidus does not behave simply as a passive conduit for pressure transmission, 
but that there is a pressure buffering effect by the feeding arteries (Kader and Young, 
1996). In addition the transnidal pressure drop or net CPP gradient is inversely 
correlated with AVM size (Young, 1994).
2.4.3.2 ‘Steal'phenomenon
Shunting of blood through an AVM is exclusively pressure-dependent, in 
contrast to flow through normal vasculature of the central nervous system in which 
flow is autoregulated. If an AVM causes a ‘sump’ effect on the surrounding
43
cerebral tissue, there is no physiological mechanism that enables redistribution of 
flow. As a consequence, the perfusion pressure to the surrounding brain is reduced 
with an associated decrease in relative CBF (rCBF) (Deruty, 1996). It has been 
suggested that this may be responsible for certain neurological deficits, defined as 
‘steal’. This concept is the subject of considerable controversy.
There have been reports of angiographic evidence of ‘steal’ with poor filling 
of adjacent vessels (Norlen, 1949; Feindel, 1971; Leblanc and Little, 1990; 
Sorimachi, 1995). Removal of the AVM allows normal filling of these vessels on 
angiography. There also appears to be poor activity demonstrated by functional 
MRI immediately adjacent to the AVM. It has been suggested that this gives weight 
to the argument proposing that ‘steal’ exists and that blood is being diverted away 
from normal tissue by a sump effect of the AVM (Beltramello, 1996). Okabe et a l 
(Okabe, 1983) studied rCBF before and after AVM excision, comparing the classical 
method of scintillation detection of radioactive xenon with stable xenon CT. 
Compared with age-matched controls, rCBF values in patients were significantly 
reduced in areas adjacent to the AVM in both grey and white matter. Hemispheric 
flows were also significantly reduced compared to normal controls for grey matter 
throughout, with a significantly reduced rCBF in the ipsilateral hemisphere 
compared with the contralateral hemisphere. These differences were not seen in 
white matter. After successful surgical removal of the AVM, mean rCBF returned 
to normal in both grey and white matter and areas adjacent to the AVM and the 
contralateral hemisphere. Okabe’s finding that the grey matter was subject to the 
greatest degree of vascular ‘steal’ might be expected, as grey matter receives a 
greater proportion of blood than does white matter.
Cerebral autoregulation maintains CBF relatively constant over a wide range 
of perfusion pressures and above the threshold for ischaemia. The lower limit of 
autoregulation in humans is normally approximately 50mmHg (Kader and Young, 
1996). However, more than half of all AVM patients have a distal pressure of less 
than 40mmHg, significantly below the lower limit of autoregulation (Kader and
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Young, 1996). Even increasing systemic mean arterial pressure by 25mmHg with 
phenylephrine fails to increase CBF in these hypotensive vascular territories (Young, 
1994; Kader and Young, 1996). This suggests that chronic hypotension does not 
necessarily result in impaired autoregulation or vasomotor paralysis with loss of 
ability to vasoconstrict in order to prevent acute increases in perfusion pressure. 
Instead it appears to adaptively displace the lower limit of autoregulation in affected 
vascular territories by a shift of the autoregulatory curve to the left. In other words, 
the pressure at which the resistance vessels of the brain become maximally dilated 
and therefore CBF begins to change in a passive fashion with increases in arterial 
pressure is reset to a lower level (Hacein-Bey, 1995; Kader and Young, 1996). 
This is supported by the fact that, although perfusion deficits can appear after 
vasodilatation, secondary to hypercapnia obtained by acetazolamide administration, 
it appears to occur at a much lower pressure than is commonly thought to be the 
lower limit of autoregulation (Hacein-Bey, 1995). The mechanism by which this 
occurs is not known. AVMs may therefore induce cerebral hypotension, most 
probably related to high bulk flow through the conductance vessels that supply the 
low resistance AVM nidus. However, these hypotensive areas often seem to have 
normal vasoreactivity and are able to function normally with CBF reset to a slightly 
lower level (Takeuchi, 1987; Kader and Young, 1996).
There are numerous reports of deficits or CBF reductions which are partially 
or completely resolved with AVM obliteration, although there have been no studies 
which relate alterations of CBF to specific vascular patterns or pressure changes 
(Leblanc and Little, 1990; Tanaka, 1993). It would be expected that a severely 
hypotensive arterial territory should have a compensatory increase in cerebral blood 
volume (CBV) compared to normal. Although global CBV does appear to be 
elevated, there is no evidence of a large regional change in CBV corresponding to a 
decrease in arterial pressure, (Tyler, 1989; Fink, 1992; Kader and Young, 1996). 
Previous positron emission tomography (PET) and single photon emission CT 
(SPECT) studies have demonstrated that there is no such increase in CBV in the
45
regions surrounding the AVM (Takeuchi, 1987; Fink, 1992). In addition, there is 
no compensatory increase in oxygen or glucose extraction fraction, implying that 
CBF in the perinidal regions of the AVM, although low, is far above any critical 
level (Fink, 1992). Kader (Kader and Young, 1996) suggested that rather than 
demonstrating ‘steal’, these changes may represent nothing more than the gliotic 
area often seen around the AVM nidus.
Another possible cause for this coupled reduction in CBF and CBV is a 
phenomenon similar to the functional disruption in areas remote from strokes termed 
‘diaschisis’, a transient event in which a reduction of rCBF is seen in uninvolved 
areas distant from an acute stroke (Homan, 1986; Tyler, 1989; Meyer, 1991; 
Tanaka, 1993; Kader and Young, 1996; Yamada, 1999). Patterns of distant 
diaschisis in the thalamus, brainstem and contralateral cerebellum have been seen in 
AVM patients (Homan, 1986; Tyler, 1989; Tanaka, 1993). This suggests some 
remote anatomical or functional neural derangement unrelated to the haemodynamic 
effects of the arteriovenous shunt. Although the mechanism and significance of 
diaschisis remain controversial, it is thought that, following acute localised lesions of 
the central nervous system (arising from any cause), there is a loss of afferent and 
efferent axons in one area, causing cell body loss or decreased cell body activity in 
remote cortical or subcortical regions owing to loss of association fibres between the 
two areas (Tarr, 1990; Meyer, 1991). MRI studies suggest that the neuronal mass 
within the hypotensive area may be reduced (Tanaka, 1993) and Iizuka et al. (Iizuka, 
1990) described widespread neuronal degeneration in the thalamus by retrograde 
degeneration after MCA occlusion in a rat model.
Other possible explanations for focal neurological symptoms previously 
attributed to ‘steal’ include focal seizures, previous haemorrhage, venous 
hypertension or mass effect, with only a minority being due to haemodynamic failure 
as result of arterial hypotension. Some authors suggest that all of these mechanisms 
may have a role to play in the neurological symptoms and haemodynamic alterations
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associated with AVMs, but that in individual patients, one particular mechanism may 
predominate (Tarr, 1990).
2.4.4 Haemodynamic changes associated with treatment
Changes associated with treatment can be monitored and can be useful in 
assessing progress in the obliteration of the fistula. Post-operatively, there is an 
increase in arterial pressure in feeders with an increase in stump pressure of 
approximately 50% on pre-occlusive levels with an associated drop in venous 
pressure (Nomes and Grip, 1980; Hassler and Steinmetz, 1987; Handa, 1993). The 
ratio of systemic arterial blood pressure to FAP increases by about 20% to 
approximately 60 -  70% of normal systemic arterial pressure, this ratio normally 
being 90% (Handa, 1993). This results in an acute rise in the arteriovenous 
pressure gradient and normalisation of perfusion pressure (Nomes and Grip, 1980; 
Kader and Young, 1996; Murayama, 1998).
Transvenous assessment of flow velocity may be more useful than 
transarterial assessment of pressure in the haemodynamic evaluation of 
arteriovenous shunting during embolisation. Convergence of peak systolic and end- 
diastolic draining vein velocities to differences below 10 cm sec'1 are associated with 
complete embolisation. This is unlike the changes observed in FAP after 
embolisation in which the pressure rises are parallel to the pressure values measured 
before embolisation (Murayama, 1998).
2.4.4.1 Normal perfusion pressure breakthrough
Complications, including both oedema and haemorrhage, may follow the 
eradication of an AVM. This occurs rarely in 2 -  4% of individuals and is most 
commonly seen in large high-flow AVMs with numerous large calibre feeding 
arteries (Spetzler, 1978; Morgan, 1993; Kader and Young, 1996; Young, 1996). 
The normal perfusion pressure breakthrough theory was proposed by Spetzler 
(Spetzler, 1978) in 1978 to account for and describe the onset of acute cerebral
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swelling and haemorrhage following excision of large AVMs. Spetzler suggested 
that, in the presence of a large AVM, the nidus offers no resistance, resulting in 
intracranial steal and relative ischaemia of the surrounding hemisphere. This leads 
to vasomotor paralysis and loss of autoregulation in the surrounding vessels, which 
remain maximally dilated. After occlusion, flow is redirected to the surrounding 
hemisphere as it returns to normal perfusion pressure. Nomes et al. (Nomes and 
Grip, 1980) demonstrated an immediate rise in stump pressure in arterial feeders 
following a test occlusion. By correcting for a decrease in venous pressure 
following occlusion, the rise in the CBF of surrounding parenchyma becomes even 
more dramatic. Unable to autoregulate, the paralysed vessels do not constrict in 
response to the increased perfusion pressure and oedema and haemorrhage result. 
Barnett et al. (Barnett, 1987) found that the two patients in their series who 
developed normal perfusion pressure breakthrough following surgery had low local 
cortical blood flow and disturbed carbon dioxide reactivity before AVM excision 
with a marked increase in local cortical blood flow after excision. Batjer et al. 
(Batjer, 1988) also confirmed that these complications were seen most commonly in 
patients who had a significantly depressed hemispheric CBF before treatment which 
increased dramatically following embolisation compared with the unaffected group. 
Nomes et al. (Nomes and Grip, 1980) noted that, in their experience, this 
complication was seen most commonly in those AVMs with long feeders, greater 
than 8cm when measured from the Circle of Willis. They demonstrated that these 
long feeding vessels had a greater pressure drop from systemic arterial blood 
pressure to the intravascular pressure measured immediately proximal to the AVM, 
with associated higher velocities. They sought to explain this by suggesting that 
these vessels gave rise to more branches prior to termination within the 
malformation, which would, by necessity, be maximally dilated to divert blood 
tending to pass preferentially into the lower resistance AVM. In order to prevent 
these dramatic changes in cerebral haemodynamics with AVM obliteration, Spetzler
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recommended staging treatment with two or more procedures involving partial 
embolisation or resection.
Whilst there is general agreement that resection, in particular, of high-flow 
AVMs can be associated with intra- and postoperative complications of oedema and 
haemorrhage, the underlying mechanisms remain disputed. Hassler et al (Hassler 
and Steinmetz, 1987) demonstrated normal vasomotor responses to changes in 
arterial partial pressure of carbon dioxide in all brain-supplying arteries immediately 
following AVM removal, suggesting that these vessels show preserved 
autoregulation. It was only the terminal feeding arteries and branches of transit 
arteries that directly supplied the AVM that showed an impaired response to hyper- 
and hypocapnia. Alternative hypotheses have therefore been proposed. Some 
suggest that perioperative hypoperfusion could lead to microinfarcts, with resultant 
oedema and haemorrhage post-operatively when the systemic blood pressure is 
returned to more normal levels (Morgan and Sundt, 1989). Alternatively, 
spontaneous thrombosis or inadvertent surgical ligation of a major draining vein 
distally may lead to occlusive hyperaemia (Wilson and Hieshima, 1993). The 
sudden drop of DVP to almost zero following excision of the AVM is likely to 
predispose to an increased risk of thrombotic occlusion. On the arterial side of the 
system, some authors have hypothesised that retrograde thrombosis of feeding 
vessels may have the same effect, supported by the fact that postoperative 
angiograms in affected individuals show stagnant or very slow arterial flow (al- 
Rodhan, 1993). Miyasaka et al (Miyasaka, 1990) reported retrograde thrombosis of 
former feeders in five (6.6%) of 76 patients. The incidence increased to 14% when 
only medium-sized and large AVMs were considered.
Another mechanism that has been proposed is a derangement in the 
autonomic perivascular innervation, which can profoundly influence CBF and would 
be compatible with certain paradoxical CBF responses in AVM patients (Young, 
1996). Batjer et al (Batjer, 1988) argues that post-treatment hyperaemia is caused 
by a deranged vascular bed that actively participates in swelling. Local changes in
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peptidergic activity in adjacent circulatory regions may somehow affect distant beds 
by collateral innervation. Such a mechanism might explain why there is a global 
increase in CBF after many cases of AVM resection, which cannot be explained by 
local changes in perfusion pressure. A final explanation that may result in such 
complications is that resection of the AVM may have been incomplete and that post­
operative haemorrhage may be as a result of rupture of an underlying remnant.
2.5 Risk factors for haemorrhage
Prevention of spontaneous haemorrhage is the primary objective of AVM 
treatment, but the risks of treatment (especially for larger lesions) can be high. For 
this reason, identification of risk factors, particularly modifiable risk factors, is 
important in allowing a more targeted approach in cases where only partial treatment 
is possible. Many authors have hypothesised that there must exist a finite set of 
pathophysiological conditions, coupled with anatomic aberrations, that result in 
spontaneous ICH and that it ought to be possible to identify such factors (Kader, 
1994).
2.5.1 Patient factors
2.5.1.1 Gender
Male patients appear to be at greater risk of a haemorrhage in the first year 
after presentation whilst females are at a greater risk in the first 10 years. The 
average annual risk for females is 3-4%, whilst males average 2% per year. 
However, at 20 years following diagnosis, males and females are equally affected 
(Graf, 1983).
There is considerable disagreement as to whether pregnancy is a risk factor 
for haemorrhage. In one series, one in four female patients aged 20 -  29 years were 
pregnant at the time of presentation with haemorrhage, suggesting that pregnancy 
may be a risk factor (Crawford, 1986a). Other series have found that pregnancy is
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not a risk factor for haemorrhage, but most recommend that vaginal delivery should 
be avoided (Stein and Kader, 1992).
2.5.1.2 Age
The older the patient the greater the risk of haemorrhage (Graf, 1983; 
Crawford, 1986a). In those aged greater than 60 years, the nine year risk is 89% 
whilst in those aged 20-29 years, it is only 15% (Crawford, 1986a).
2.5.1.3 Presentation
In a series of 217 conservatively treated individuals (from a total population 
of 343 AVM patients), Crawford et al. (Crawford, 1986a) found that patients had a 
42% 20 year and 30% 10 year overall chance of developing haemorrhagic 
complications. There was a slight increase in the risk of haemorrhage in the first 
two years after diagnosis but this settled to 2% per year. This risk varied depending 
on symptoms at diagnosis. In individuals presenting initially with haemorrhage, the 
risk of a further haemorrhage was higher (51% 20 year risk, 36% 10 year risk) than 
in those who had not bled (33% 20 year risk, 17% 10 year risk). In those whose 
presenting complaint was epilepsy, the risk of haemorrhage at 20 years was 30% 
(22% at 10 years), whilst those presenting with a neurological deficit had only an 
8% risk of haemorrhage at 20 years (8% at 10 years). Of those AVMs found 
incidentally, no patient bled. Graf et al. (Graf, 1983) confirmed that patients 
presenting with convulsions were at a lower risk of haemorrhage of 30% at 10 years, 
whilst those not presenting with seizures had a 45% 10 year risk of haemorrhage.
2.5.2 AVM factors
2.5.2.1 Site o f AVM
Deep AVMs, such as basal ganglia and posterior fossa lesions, more 
commonly present with haemorrhage whilst superficial lesions more commonly 
present with epilepsy (Crawford, 1986a; Tuijman, 1995; Duong, 1998; Mansmann,
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2000). This may however not be independent of the fact that these deep lesions are 
often associated with deep venous drainage. Temporal or occipital lesions have a 
higher risk of presenting with haemorrhage (67% and 52% at 20 years and 36% and 
42% at 10 years respectively), whilst parietal AVMs are associated with a lower risk 
of subsequent haemorrhage (32% at 20 years and 23% at 10 years) (Crawford, 
1986a). Many deep lesions are non-cortical and are therefore perhaps unlikely to 
cause seizures, the second most common presenting symptom, making them more 
likely to present with haemorrhage.
2.5.22 Size o f AVM
Small AVMs more commonly present with haemorrhage whilst large AVMs 
more commonly present with epilepsy, although the risk of rehaemorrhage does not 
appear to be dependent upon size (Guidetti and Delitala, 1980; Graf, 1983; 
Crawford, 1986a; Albert, 1990; Spetzler, 1992; Kader, 1994; Duong, 1998; 
Mansmann, 2000). In their series of 110 patients, Albert et al. (Albert, 1990) found 
that of those patients presenting with haemorrhage, 12 had large AVMs, 45 had 
medium AVMs and 53 had small AVMs. In contrast, of the 40 patients whose 
presentation was non-haemorrhagic, only four had small AVMs. They pointed out 
however that this may not be independent of the fact that most small AVMs have a 
single draining vein.
An alternative explanation may exist for the fact that small AVMs present 
more commonly with haemorrhage than large AVMs. Small and large AVMs may 
have similar haemorrhage risks, but small AVMs may fail to become symptomatic in 
other ways, such as seizures or progressive neurological deficit, in the way that large 
AVMs do. However, if this were the case, it might be expected that large AVMs 
would come to medical attention at an earlier age than smaller AVMs, presenting 
with symptoms other than haemorrhage. Identical age at time of presentation in 
haemorrhage and non-haemorrhage groups supports the hypothesis that small AVMs 
do indeed have a higher risk of haemorrhage (Kader, 1994). Conversely, large and
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small AVMs may bleed at similar rates, but haemorrhages from large AVMs may be 
less likely to be clinically evident. The size of the haematoma does appear to be 
inversely related to the size of the AVM, thought to be due to the higher FAP and 
higher perfusion pressures seen in smaller AVMs (Spetzler, 1992; Duong, 1998). 
As many as 10% of individuals have evidence of previous clinically silent 
haemorrhage at the time of surgery, although this has not been specifically related to 
AVM size (Stein and Wolpert, 1980).
2.5.3 Angiographic features
2.5.3.1 AVM nidus
AVMs with a diffuse nidus morphology have been shown to be at increased 
risk of presenting with haemorrhage (Pollock, 1996a).
2.5.3.2 Arterial supply
Small AVMs are at a higher risk of bleeding than larger lesions and many 
have hypothesised that this may be because they have a higher pressure in their 
feeding arteries (Spetzler, 1992; Fleischer, 1993). Spetzler et al. (Spetzler, 1992) 
demonstrated an inverse relationship between FAP and AVM size, regardless of 
presentation. This difference in FAP is readily explained by a difference in the 
resistance to flow of small and large AVMs. They also found that the average 
difference between mean arterial blood pressure and FAP was 6.5 mmHg in those 
who did not present with haemorrhage, but 40 mmHg in those whose AVM had 
ruptured (Spetzler, 1992). This has been confirmed by other authors (Miyasaka, 
1993; Duong, 1998). Kader et al. measured mean FAP just proximal to the nidus 
with an intravascular microcatheter or intraoperatively by direct puncture using 26- 
gauge needle (Kader, 1994). Mean FAP was again found to be higher in patients 
with haemorrhage than those without, although was only weakly related to size of 
lesion. However it remains unclear whether the increase in FAP is an important
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factor in the pathophysiology of AVM haemorrhage or is the haemodynamic 
sequelae of the AVM rupture (Pollock, 1996a).
There is concern that FAP increases with reduction of AVM size by partial 
embolisation, thus increasing the risk of haemorrhage immediately following the 
procedure (Spetzler, 1992). Sorimachi et al. (Sorimachi, 1995) found that FAP did 
increase with gradual obliteration of nidus with an associated increased risk of peri- 
procedure haemorrhage, particularly in those with low FAP initially and in those 
with the greatest changes in FAP before and after embolisation. Their overall 
complication rate was 28% and as a result they advocated staged embolisation 
(Sorimachi, 1995). If the resistance to flow in a large AVM increases following 
embolisation, then the FAP in the remaining lesion will be elevated. Assuming that 
the risk of haemorrhage is related to FAP then the usefulness of partial embolisation 
as a sole treatment for AVMs needs careful scrutiny. The goal of treatment for 
AVMs should be complete obliteration (Spetzler, 1992).
The pattern and distribution of feeding arteries is also important. The feeding 
arteries with transient branches (brain-nutrifying branches distal to nidus) have a 
higher resistance than an artery terminating in an AVM, resulting in a significantly 
higher pressure in these vessels (Sorimachi, 1995). The pressure in feeders with 
terminal divided branches also tend to be lower than in those with single branches 
although the differences are not statistically significant (Sorimachi, 1995). 
Perforator feeding vessels and vertebro-basilar supply have also been found to be 
predictive of a haemorrhagic presentation (Tuijman, 1995).
2.5.3.3 Venous drainage
AVM haemorrhage is generally thought to be consistent with venous 
bleeding, and it is therefore not surprising that venous characteristics predominate 
amongst risk factors for AVM haemorrhage (Miyasaka, 1992). AVMs with deep 
venous drainage or a single draining vein are more likely to haemorrhage (Miyasaka, 
1992; Kader, 1994; Tuijman, 1995; Pollock, 1996a; Duong, 1998). Both of these
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factors may have a profound effect on AVM haemodynamics by promoting an 
increased pressure gradient across the vasculature of the nidus (Miyasaka, 1992; 
Miyasaka, 1993).
Young et al. (Young, 1994) examined AVM physiology and discovered that 
there was a direct relationship between FAP and DVP. Despite this, the transnidal 
pressure gradient was lower in large AVMs, possibly explaining the lower incidence 
of haemorrhage in large AVMs (Spetzler, 1992; Young, 1994). However, DVP 
alone was neither predictive of AVM haemorrhage nor related to the presence or 
otherwise of deep venous drainage. This was confirmed by Kader et al. (Kader, 
1994). Draining vein stenosis, occlusion and venous hypertension may also result in 
critical haemodynamic stresses that predispose to rupture of AVMs (Miyasaka, 
1992; Murayama, 1998; Mansmann, 2000). It has been suggested that turbulent 
flow and elevated pressure in the deep venous system may compound the problem 
by promoting enhanced platelet aggregation and thrombosis sufficient to cause AVM 
haemorrhage (Duong, 1998).
2.5.3.4 Associated aneurysms
Tuijman et al. (Tuijman, 1995) found that both intranidal and multiple 
aneurysms increased the risk of haemorrhage. This has been confirmed by other 
authors (Dion and Mathis, 1994). However other studies have found that the 
presence of aneurysms did not independently predict haemorrhagic complications 
(Duong, 1998; Mansmann, 2000). Arterial stenoses, angioectasia and arteriovenous 
fistulae however appear to be protective against haemorrhage (Mansmann, 2000).
2.5.3.5 Combined risk factors
The risk of haemorrhage can be quantified by drawing together several of the 
known predictive factors. Pollock et al. (Pollock, 1996a) suggested such a system. 
Low risk AVMs consist of those which have not previously bled and have more than 
one draining vein and a compact nidus. They found the annual risk of haemorrhage
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in this group of individuals to be 1.0%. An intermediate low risk group with an 
annual risk of 2.2% is made up of those with AVMs that again have not previously 
bled, but have a single draining vein, with or without a diffuse nidus. A third group 
of intermediate high risk (3.7%) consist of those individuals who have previously 
had an associated haemorrhage, have more than one draining vein and have a 
compact nidus. High risk individuals are those that have previously bled, have a 
single draining vein, with or without diffuse nidus morphology. Their annual risk of 
haemorrhage was 8.9%.
The management of AVM patients should be based not only on the morbidity 
of the proposed treatment but also on those factors that predispose individuals to 
either a low or high haemorrhagic risk. Such systems improve the accuracy of risk- 
benefit decisions regarding further management of these individuals.
2.6 Investigation
From a morphological point of view, neuroradiological studies should not 
only identify all feeding arteries and draining veins, but also evaluate the 
angioarchitecture and other characteristics of the nidus as well as the different 
manifestations of high flow angiopathy, the associated parenchymatous lesions or 
other incidental and clinically asymptomatic cerebral pathologies. From the 
haemodynamic point of view, flow velocities in the different vascular compartments 
and global modifications of the cerebral circulation should also be evaluated in 
detail.
2.6.1 Plain Xrays
Although not often used in the routine investigation of a suspected AVM, 
calcification can be seen on plain skull Xrays in up to 25% of affected individuals. 
Prominent tortuous vascular channels can also be sometimes identified.
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2.6.2 CT scan
CT scans are most commonly used in the clinical setting of acute 
haemorrhage, where the haematoma is readily identifiable. Most commonly this 
occurs in the brain parenchyma adjacent to the AVM, with SAH or IVH observed 
less frequently.
In the absence of haemorrhage, AVMs usually appear as patchy mixed- 
density lesions on non-contrasted scans. The low density areas may represent areas 
of infarction or encephalomalacia from previous haemorrhage, whilst high-density 
areas may be caused by areas of small recent haemorrhage or calcification. In some 
large AVMs the feeding arteries, draining veins or tightly packed nidus may be 
visible on non-contrast scans as slightly hyperdense structures. Almost all AVMs 
will exhibit marked enhancement following contrast injection (Figures 2.1a and b). 
The nidus and large serpentine afferent and efferent pedicles can often be seen, 
although small AVMs may be missed.
As a rule, draining veins have a larger diameter than feeding arteries. 
Furthermore, draining veins may exhibit varicose or aneurysmal dilatations. 
Superficial draining veins are located on the surface of the brain immediately 
beneath dura and appear as round enhancing nodules when seen in cross section, that 
can be traced on higher sections to join the SSS. In contrast, superficial arteries 
feeding the AVM may be followed in the depths of a sulcus. They have a 
curvilinear appearance and usually are of a smaller size than the veins. Based on 
these criteria, it is usually possible to predict, by CT, the main arteries supplying the 
AVM and the venous system(s) involved in its drainage.
2.6.3 Digital subtraction angiography
DSA is still the ‘gold standard’ method for evaluating the angioarchitecture 
and haemodynamics of AVMs, prior to the consideration of treatment. DSA has 
almost entirely replaced conventional angiography. The recent introduction of 
biplanar DSA equipment is a technological advancement permitting reduction of
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Figure 2.1: a) Pre- and b) post contrast CT scan of a left occipital AVM
radiation exposure, the amount of contrast material used and investigation time 
compared with monoplanar equipment. Iodinated non-ionic contrast materials are 
preferred because of their decreased neurotoxicity compared with ionic agents.
Evaluation of cerebral AVMs by selective angiography requires studies 
aimed at depicting both the AVM and the arterial and venous circulation of the brain 
(Figures 2.2a and b). Therefore four-vessel studies and additional external carotid 
studies are generally required depending on the location of the AVM. Complete 
angiographic evaluation usually involves two steps. Firstly the selective 
angiographic investigation of the AVM and cerebral vasculature and secondly, the 
superselective angiographic investigation of the AVM nidus.
Complete selective angiography of cerebral AVMs should provide the 
following information:
1. Arterial territory or territories involved in supplying the AVM
2. Individual feeding arteries
3. Assessment of changes secondary to high-flow angiopathy
a. isolated or multiple stenoses
b. arterial enlargement, ectatic vessels
c. flow-related aneurysms
4. Gross assessment of the nidus (shape, size, presence of arteriovenous fistulae, 
large ectasias, flow conditions)
5. Venous territory or territories involved in the AVM drainage
6. Individual draining veins
7. Venous high-flow angiopathy
a. dural sinus high-flow
b. venous thrombosis
c. venous enlargement, stenoses, varices
8. Venous drainage of the brain
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Figure 2.2: a) Arterial and b) venous phases of an AVM on DSA
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The low resistance AVM nidus means that by the time contrast is seen in 
normal brain capillaries it is already seen in the veins draining the AVM. Even 
using DSA, it can be difficult to see the arterial feeders at the fistulous site because 
of rapid recirculation of contrast material through the fistula, often exacerbated by 
wash-out by non-opacified blood (Konno, 1996). Alternatively, intranidal 
pathology such as aneurysms or direct arteriovenous fistulae, may remain 
undetected.
In certain situations, AVMs are not identified. This may mean that the 
AVM is occult, of slow flow or thrombosed. In the acute phase of parenchymal 
haemorrhage, the haematoma may compress the AVM nidus. Cerebral angiography 
performed early may therefore not demonstrate the entire AVM giving the incorrect 
impression of reduced flow through the AVM. Depending on the relative sizes of 
the haematoma and AVM, the nidus may be compressed by the haematoma in the 
early phase of haemorrhage and therefore undetectable by angiography. 
Exceptionally, nidus compression by an acute haematoma may lead to thrombosis 
and spontaneous obliteration of the AVM. Unless there is an indication for early 
surgical evacuation of the haematoma, cerebral angiography should be repeated, if 
not delayed until after haematoma resorption has taken place, to allow demonstration 
of the true size, extension and flow conditions of the AVM.
Angiography is not without complications. It is invasive and currently 
requires inpatient admission. In the Co-operative study from 1966, the complication 
rate was found to be 5.8% with an associated mortality of 0.82%. This risk was 
related to age and was found to be higher in those requiring a general anaesthetic for 
the procedure (Perret and Nishioka, 1966a). The accepted complication rate is 
currently 1-2% (Mani, 1978; Waugh and Sacharias, 1992). In a more recent study, 
Heiserman et a l (Heiserman, 1994) documented a 1% overall incidence of 
neurological deficit with a 0.5% incidence of permanent deficit following cerebral 
angiography. All complications occurred in patients presenting with a history of 
stroke, transient ischaemic attacks (TIAs) or carotid bruit, which they felt reflected
61
the difficulty of performing angiography in a population at risk of atherosclerotic 
changes. Patients suffering complications were older, had longer average procedure 
times and were given a greater volume of radiographic contrast than those 
unaffected. In a separate study, hyperintense lesions seen on diffusion-weighted 
MRI consistent with silent embolic events were seen in 23% (Bendszus, 1999). 
Risk factors included larger contrast medium volumes, longer fluoroscopy time, 
additional catheters and vessels more difficult to cannulate. Again, patients with 
vascular risk factors (including previous stroke, TIA, suspected vasculitis, 
intraparenchymal haemorrhage, excluding aneurysmal or AVM haemorrhage) had a 
44% risk of hyperintense lesions compared with 13% in those with no vascular risk 
factors (Bendszus, 1999).
2.6.4 Magnetic Resonance Imaging
MRI provides useful information regarding the location and topography of 
the AVM, presence or absence of haemorrhage and associated parenchymal changes 
such as oedema, ischaemia, gliosis, atrophy or mass effect. This information is 
essential for planning the angiographic work-up and correlative analysis of the 
angiographic information.
AVMs are identified as flow-voids visualised on either T1 or T2 weighted 
sequences, often with associated foci of encephalomalacia (Figure 2.3). MRI has 
been shown to be better at establishing the size of AVMs than CT or DSA 
(Noorbehesht, 1987). This is thought to be due to the difficulty in separating out 
draining veins on CT and DSA. The size on MR is smaller than that determined 
from angiographic films, the discrepancy increasing with increasing size of AVM. 
MRI appears more accurate in defining the AVM nidus with implications as far as 
radiosurgical planning is concerned, when it is important to identify nidus accurately 
allowing treatment of the nidus only and not normal surrounding brain, thus reducing 
associated morbidity (Noorbehesht, 1987).
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Figure 2.3: Axial T2 FSE image of a left occipital AVM with obvious flow voids
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MRI also has its uses in follow-up imaging after treatment: endovascular 
embolisation, surgery or stereotactic radiosurgery. Pollock et al. (Pollock, 1996b) 
analysed MR images performed 2 years following radiosurgical treatment for an 
AVM. Only those patients who had AVMs visible on pre-treatment MR imaging 
were studied. They found that MRI had a sensitivity of 80%, specificity of 100%, a 
negative predictive value of 84% and positive predictive value of 100% with respect 
to predicting patency of AVMs at 2 years following treatment. A few false 
negatives went on to total obliteration at 3 years; it was felt likely that flow was so 
slow that it was not appreciated on MR images at 2 years in these cases (Pollock, 
1996b). The authors advocated timing of DSA in relation to MRI changes in an 
effort to diminish the need for repeated DSA procedures (Pollock, 1996b). It is 
likely that, with routine use of MRI and MRA simultaneously, these figures could be 
improved upon still further.
2.6.4.1 MR Angiography
MRA is performed on a conventional MR scanner and does not normally 
require the injection of a contrast medium. If accurate, MRA offers several 
advantages over conventional angiography including its non-invasive nature and lack 
of need for contrast agents. There are in principle two different techniques of MRA: 
time of flight (TOF) and phase contrast (PC) angiography. In both techniques the 
contrast between blood vessel and stationary tissue is as a result of blood motion. 
Both are non-invasive, with a good safety profile and a spatial resolution that 
approaches that of DSA.
In 3D TOF MRA, a short TR, minimum TE, gradient recalled sequence (T1 
weighted), stationery tissue is saturated by a repetitive radiofrequency pulse and 
‘fresh spins’ from non-saturated in-flowing blood, which traverses the region of 
interest (ROI), give high signal. Substances that normally have very high T1 signal, 
such as fat or blood, may be incompletely saturated (T1 contamination artifact) and 
appear as high signal areas. This can interfere with the diagnostic interpretation
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either by mimicking or by obscuring vascular structures (Rieger, 1996; Harrison, 
1997).
The advantages of 3D TOF are excellent spatial resolution, a high sensitivity 
and specificity, efficient scan time yielding a favourable signal-to-noise ratio, 
reduced complex flow signal loss and clearly visible Tl-weighted anatomy. It is 
well suited to demonstrating high velocity flow in the major feeding vessels and the 
nidus of AVMs. Contrast enhancement with gadolinium can be used to further 
increase contrast resolution with overall improvement in the delineation of small 
vessels. With rapid radiofrequency pulsing, the blood signal approaches a steady 
state saturation and blood/static tissue contrast can diminish over time. This loss of 
vascular contrast from the saturation effect, together with loss of signal from 
structures with slow flow are the primary limitation of TOF sequences (Harrison, 
1997; Pemicone, 1997). Slower flow within compartments of the nidus and in 
draining veins may therefore remain undetected. In addition it has a limited 
acquisition volume, but the use of multiple overlapping thin slab acquisition can 
overcome this. 2D TOF acquisitions have a lower spatial resolution and are 
insensitive to complex flow, but are of more value in imaging larger lesions with 
slower flow.
Of the TOF techniques, 3D TOF angiography is used almost exclusively for 
the examination of intracranial vessels, whilst 2D TOF is more commonly used for 
neck vessels.
PC MRA is based on the detection of phase shifts generated by a flow- 
encoding gradient. The phase shift is proportional to the velocity of blood and 
indicates flow direction (Brant-Zawadzki and Heiserman, 1997). Care must be 
taken to chose an appropriate ‘velocity window* depending on the area studied. 
Typical velocity parameters are 15 cm sec-1 for dural sinuses and 50 -  60 cm sec'1 
for major cerebral arteries. This gives it a higher sensitivity to slower flow than 3D 
TOF, but it can be time-consuming, particularly if several sequences with different
65
velocity settings have to be performed to encompass the full velocity range of a 
vascular system.
PC sequences again can be either 2D or 3D but are generally less sensitive 
for small lesions than 3D TOF. Fast 2D PC assesses flow quickly, provides a 
projective view of the vasculature and allows determination of flow direction. 3D 
PC requires longer acquisition times, but a volumetric data set is acquired that is 
used to produce maximum intensity projections (MIPs). Background suppression 
in PC MRA, even in tissues with a short T l, is excellent. PC angiography often has 
advantages over 3D TOF sequences in high-flow large vascular lesions that are 
geometrically complicated. Especially with 3D PC, huge and complex volumes can 
be covered by one stack without risk of intravolume saturation and can therefore be 
useful in imaging large AVMs. However 3D PC MRA does require long 
acquisition times and can be degraded by eddy currents and susceptibility artifacts. 
Time-consuming 3D PC can be partially replaced by the much faster 2D technique 
without a substantial compromise in image quality in most cases. The 2D method 
can also provide a rapid semi-quantitative haemodynamic evaluation, consisting of 
several acquisitions of three or four single-slice images each of which has a different 
velocity-encoding velocity. Moreover the 2D PC technique is capable of providing 
direct quantification of both flow velocity and flow volume in principle arterial 
feeders and draining veins. All these features mean that a 2D PC study is often 
sufficient for the diagnosis and even the post-therapeutic follow-up of cerebral 
AVMs except when a 3D presentation is specifically required.
Contrast enhanced MRA (CEMRA) is a relatively new technique. 
Paramagnetic contrast agents strongly increase the MR signal due to enhanced T l 
shortening. With contrast, blood regains its longitudinal magnetisation more rapidly 
giving a stronger signal intensity and therefore improving the signal-to-noise ratio 
between blood vessels and background and eliminating flow artifacts. The contrast 
can be increased still further by subtracting pre-contrast from post-contrast images 
provided the patient does not move. In 2D acquisitions, patient motion artifacts
66
may render one or many of the sequentially collected slices uninterpretable. Signal- 
to-noise ratios are better during 3D acquisitions and therefore these artifacts can be 
compensated for as long as they are not too numerable and do not occur in central k 
space measurements. Shorter TR and TE and thinner slices are possible with 3D 
data sets, allowing large volumes to be acquired within several seconds. Sequential 
imaging permits measurement of arterial, capillary and venous bolus passage. The 
primary limitation of 3D CEMRA is the k space acquisition speed and thus the 
achievable image resolution during the limited first pass of contrast media. The 
availability of high performance gradient sets on clinical scanners now allows speed­
up to an extent where the fundamental signal-to-noise ratio limit becomes imminent. 
To maximise signal-to-noise ratio for a given spatial resolution, a contrast agent with 
maximal intravascular concentration should be chosen. Visualisation of vessels 
much less than 1 mm in diameter is now possible with a sufficient signal-to-noise 
ratio.
The advantage of MRI and MRA in combination is the ability to detect not 
only the nidus of the vascular malformation but also signs of past haemorrhage, 
which may influence management (Brant-Zawadzki and Heiserman, 1997). In 
addition, MRI is non-invasive, quicker, cheaper, more acceptable to patients and 
does not have the same potential for neurological complications (except in the 
presence of contra-indications to MRI scanning) compared with DSA (Pollock, 
1996b).
2 .7  C o n c lu s io n
Cerebral AVMs are congenital lesions with a prevalence of up to 0.5% in 
autopsy series. They are protean in their clinical manifestations, which include 
cerebral haemorrhage, epilepsy, progressive neurological deficit and headaches. 
Intracranial haemorrhage is the most common clinical presentation, seen in 60-70%
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of individuals. It is an important cause of stroke in young people, each bleed being 
associated with a 10% mortality and 30% morbidity.
Treatment of these lesions by endovascular embolisation, microsurgery or 
radiosurgery carries a small but substantial risk and being able to predict the 
haemorrhagic risk in the individual patient would enable better clinical decision 
making. There have been a number of studies assessing the risk of haemorrhage 
from an AVM but the results are contradictory. Many questions, such as the relative 
importance of the AVM size or type of venous drainage, remain unresolved. Factors 
favouring presentation with epilepsy and influencing its control are even less well 
researched. It seems clear that morphological analysis of these lesions alone is not 
sufficient and that haemodynamic factors may play an important role.
Intra-arterial catheter angiography remains the ‘gold standard’ investigation 
in patients with cerebral AVMs. DSA allows a detailed analysis of 
angioarchitecture of these lesions providing information about feeding arteries, nidus 
structure and draining veins. These results have an influence on the choice of 
treatment and prognosis of individual AVMs. However, DSA is an invasive 
procedure which requires inpatient care and carries a risk of neurological 
complications in 0.5 - 2%. Complete cure can usually only be achieved for small 
AVMs and patients with larger AVMs may have to undergo several staged 
procedures and follow-up DSAs with their associated risks.
The investigation and understanding of both the angioarchitecture and the 
haemodynamic effects of AVMs clearly requires much work. Associated 
improvements may allow advances in their management, with a reduction in overall 
patient morbidity and mortality.
68
PART 2 
STRUCTURAL IMAGING
Chapter 3
CT ANGIOGRAPHY 
3.1 Introduction
CTA is a form of spiral CT scanning. Spiral CT is achieved by continuously 
acquiring CT data while the patient is moved through the gantry. Rapid acquisition 
enables an entire vascular territory to be imaged within 30 - 60 sec. Initially used 
for imaging larger vessels such as the aorta, renal and hepatic arteries (Rubin, 1994; 
Costello and Gaa, 1995; Kanematsu, 1996; Wicky, 1998), CTA is being 
increasingly used in the investigation of intracranial vascular disease.
3.1.1 Basic principles
During CTA, thin section axial images are acquired during the injection of an 
iodinated contrast medium bolus, while simultaneous rotation of the CT Xray tube 
and movement of the scanning table takes place. Detailed demonstration of 
vascular anatomy depends on the intravascular iodine concentration, threshold 
selection and voxel size. Collimator width and table speed have important 
consequences on the quality of the CTA. The ratio of table speed to collimator 
width multiplied by the gantry rotation period is defined as scan pitch (typical range
1.0 -  2.0). An increase in pitch will increase the spiral length and therefore volume 
coverage but at the expense of spatial resolution. Collimator width selection 
strongly affects spatial resolution and signal-to-noise ratio. For intracranial CTA, 1 
mm collimation with submillimetre reconstruction intervals should be used (Rubin, 
1995).
CTA, using a 512 x 512 matrix with a field of view of 14 cm, has a spatial 
resolution of 0.5 mm (in plane), which is approximately ten times worse than that
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afforded by intra-arterial DSA (Rieger, 1996). This is primarily due to partial 
volume and noise effects. Furthermore, iodine concentration is considerably lower 
as it is given intravenously and peripherally. With a fixed threshold and voxel size 
in a 512 x 512 matrix, a decrease in iodine concentration results in an increase in 
partial volume effects, especially when the vascular luminal diameter becomes less 
that the section thickness (Rieger, 1996). If lumen diameters of less than 2 mm do 
not need to be visualised, CTA may be adequate. Resolution could be improved 
with introduction of higher heat capacity Xray tubes to allow for a higher current 
during spiral acquisition. As a result, the signal-to-noise ratio would improve, 
enabling collimation width reduction (Rubin, 1995). The recent introduction of 
multi-detector CT systems will improve volume coverage also leading to 
improvements in resolution (Rubin, 1999).
3.1.2 Post processing
Continuity of spiral CT data enables axial sections to be reconstructed on a 
computer workstation at any point along the spiral path and at arbitrary intervals. 
Thus overlapping sections can be generated that will result in smoother 3D 
renderings and diminished partial volume artifact, which leads to improved small 
vessel visualisation.
Threshold surface-shaded display (SSDs) renders volumes by generating 
images on the basis of a predefined threshold value. Contiguous pixels above the 
threshold are modelled as a single 3D structure by the computer. The computer then 
generates an imaginary source of illumination to depict surface reflections that are 
encoded in the image grey scale. SSDs can be made with multiple threshold levels 
and coloured displays can be used to enable segmentation of separate structures with 
varying attenuation (Figures 3.1 and 3.2). SSDs depict complex 3D relationships 
well, particularly in regions of overlapping structures, but much information 
regarding relative Xray attenuation is lost in the thresholding process.
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Figure 3.1: Segmented SSD image showing vessels (pink), embolisation material
(green) and ventriculo-peritoneal shunt (blue) using multiple 
threshold levels and a coloured display
Figure 3.2: Segmented SSD image showing vessels (pink) and bone (grey) using
multiple threshold levels and a coloured display
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MIPs are reconstructed automatically such that pixels with greatest 
attenuation values in a given direction are extracted to give a projection image. 
Attenuation values in the final reconstructed image more accurately reflect those in 
the axial images; thus calcium is easily distinguished from intraluminal contrast 
(Schwartz, 1994). The absence of a thresholding step ensures that no information is 
lost and subtle variations in attenuation can be appreciated.
A disadvantage of MIPs is that a single projection image does not encode 
depth relationships. This shortcoming is countered by the generation of multiple 
MIPs at view angles around an axis of rotation with resultant images viewed as a 
cine loop to enable appreciation of spatial relationships. Highly attenuating 
structures such as bone, metallic implants or intensely enhancing parenchyma can 
mask target anatomy on MIPs and some SSDs. Because the MIP selects only the 
brightest pixel along each direction, a high attenuation structure anywhere along that 
path will dominate and thus mask a structure of lesser attenuation. MIP 
representations of intracranial CTAs are particularly difficult to post-process 
compared with other regions of the vascular tree, as the highly attenuating skull 
hides the majority of vasculature. For the Circle of Willis and other central vessels 
it is relatively simple to define a sub-volume of the data within the skull, and to 
produce a MIP of just that volume. However, where the vessels of interest lie close 
to bony structures, this can become very difficult and time-consuming. Surface 
renderings have the property of occlusivity, less attenuating structure will be visible 
if its attenuation falls above the selected threshold and it lies closer to the ‘eye’ than 
a more attenuating structure (Figures 3.3a - c).
Post-processing is operator-dependant and can be time-consuming, 
particularly if manual segmentation is required. Valuable information can be lost by 
exclusion of relevant anatomical structures.
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Figure 3.3: a) MIP, b) left lateral SSD and c) right lateral SSD images of the same
AVM
b
c
The left and right SSD lateral projections are different because of the property of 
occlusivity, whilst the left and right lateral MIP projections are the same.
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3.1.3 Clinical applications
3.1.3.1 CTA o f intracranial aneurysms
The most common indication for intracranial CTA is currently in the 
delineation of aneurysms. The processed 3D model permits multiple projections of 
the lesion to be visualised, allowing assessment of the 3D anatomy of the 
aneurysmal complex and reproduction of the surgical approach. Young et al. 
(Young, 1999) demonstrated an overall sensitivity for detecting aneurysms on CTA 
of 96%, although this was better in larger aneurysms (97% if lesion > 3 mm, but 
87% if < 3 mm). Others have had similar findings (Schwartz, 1994). Visualisation 
of axial source images can be critical in the diagnosis of small or thrombosed 
aneurysms as they may fail to fill with intravascular contrast or be too small to be 
visualised on the 3D model (Young, 1999). CTA has also been used to demonstrate 
dissecting aneurysms (Lanzino, 1997).
CTA may be an alternative to DSA for early detection of aneurysms in 
patients with SAH. CTA can be performed immediately after conventional 
unenhanced CT has confirmed the diagnosis of SAH. Evaluation of the intracranial 
circulation can be undertaken non-invasively, giving the surgeon information 
regarding the site and configuration of any aneurysm present, which may prove 
invaluable should the patient require emergency evacuation of the haematoma. In 
addition, it can indicate whether endovascular treatment of the aneurysm might be 
possible prior to haematoma evacuation (Le Roux, 1993). Velthuis et al. (Velthuis, 
1997) demonstrated CTA to have a sensitivity 92% and specificity 100%, with 88% 
true positives and 35% false negatives. They found MIPs to be superior to SSDs, 
although cavernous sinus and internal carotid artery (ICA) lesions were particularly 
difficult to identify because of the proximity of the skull base.
Metal artifacts can severely degrade the CTA image quality, limiting its 
utility in post-operative situations. However, post-operative lesions have been 
assessed with CTA, which can be concurrently used to demonstrate vasospasm and
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patency of distal vessels (van Loon, 1997). Techniques to minimise the effects of 
beam-hardening artifact have been described where the AP digital scout image is 
used as a reference to tilt the patient's head. This allows projection of the aneurysm 
clip away from the remainder of the Circle of Willis on the axial slice and therefore 
reduces beam-hardening artifact in relevant areas (Brown, 1999; Young, 1999). 
Artifact can also be reduced by using very thin collimation (1mm) (Vieco, 1996). 
Some authors believe that in the post-operative situation beam-hardening artifact is 
always present, limiting image interpretation, such that CTA at present cannot 
replace DSA for evaluation of aneurysm clip placement (Vieco, 1996).
3.1.3.2 CTA o f intracranial AVMs
The use of CTA in delineating AVMs has been limited. Several small 
studies have been performed comparing DSA with CTA in patients with AVMs, 
where CTA has provided definitive information about site and size of the nidus 
(Gorzer, 1994; Rieger, 1996). In the study of Tanaka et al. (Tanaka, 1997), 12 
patients underwent CTA, MRA and DSA. They found that CTA demonstrated only 
50% of arteries but 78% of veins and concluded that this may have been due to 
suboptimal contrast enhancement and suggested that a shorter scanning time with an 
increased pitch and larger concentration of iodine may have improved the findings 
(Tanaka, 1997). However demonstration and measurement of the nidus was 
possible in all 12 patients. In AVMs with well-developed draining veins, dense 
opacification of these superimposed on the nidus may make identification of the 
nidus difficult by DSA. The 3D data set of the CTA can, however, be manipulated 
to allow adequate visualisation of the nidus without overlying veins. Tanaka et al. 
(Tanaka, 1997) concluded that the use of both MIP and SSD images improved 
visualisation of the relevant vasculature, but SSDs best delineated vessels and nidus. 
Aoki et al. (Aoki, 1998) reported similar findings and found that CTA provided 
precise anatomical information on niduses and draining veins, but could not 
demonstrate fine feeders. They suggested that CTA may therefore have a role in
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planning stereotactic radiosurgery where demonstration of the nidus is of utmost 
importance. Rieger et a l (Rieger, 1996) concluded that spiral CT seems to have the 
same potential as MRA for showing main feeding vessels, the angiomatous nidus 
and large draining veins, although these were not analysed quantitatively and were 
not compared with appearances on DSA.
In a single study of post-embolisation CTA in AVM, the remaining 
malformation was distinctly visualised since the hyperdense embolisation material 
could be erased by subtraction at the post-processing stage (Gorzer, 1994).
These studies show the potential uses of CTA in the delineation of AVMs, 
although systematic comparative studies of these newer techniques are still needed.
3.2 Methods
3.2.1 Patients
Patients were recruited from those seen by the neurovascular surgery or 
interventional neuroradiology services at The National Hospital for Neurology and 
Neurosurgery between February 1998 and January 1999. All patients were known 
to have AVMs and had undergone recent catheter angiography confirming the 
diagnosis. Those who were pregnant, had a history of allergy to iodine or were aged 
less than 16 years were excluded.
3.2.2 Imaging
CT scanning took place on a Somatom® Plus-4 scanner (Siemens Medical, 
Erlangen, Germany) at The National Hospital for Neurology and Neurosurgery. 
CTAs were acquired in spiral mode with a beam width 1 mm, table feed 2 mm (pitch 
2.0), rotation time 0.75 sec, 140 kV, 111 mA, using a 512 x 512 matrix with a field 
of view of 16 - 22 cm depending on the size of the patient’s head. A spiral length of 
68 or 112 mm was acquired, depending on the size of the AVM, with a scan time of
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27 or 43.5 sec respectively in a caudal to cranial direction. A reference slice was 
used to monitor a ROI in the cavernous sinus to detect the arrival of the contrast 
agent (1 mm beam width, 1.5 sec tube rotation, 140 kV, 111 mA, sample period 3.4 
sec), automatically triggering the CTA acquisition when a pre-determined threshold 
of 25 Hounsfield units (HU) was reached (Figure 3.5). A sample threshold graph is 
shown in Figure 3.4. A fixed volume of either 100 or 150 ml (depending on the 
spiral length) of iodinated contrast agent (Xenetix® 350, Guerbet Laboratories, 
Aulnay-sur-Bois, France), regardless of patient weight, was injected at a rate of 3 ml 
sec"1 using a power injector (AS 200-CT, Medex, Annecy, France). The total 
effective dose equivalent to the patient was estimated to be 0.72 mSv.
Figure 3.4 : A sample threshold graph of CTA acquisition showing average
Hounsfield unit values for ROI.
100
 Threshold
level
-50
Time (secs)
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Figure 3.5: Reference slice showing ROI over cavernous sinus to detect arrival of 
contrast bolus
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3.2.3 Processing
Both SSD and MIP images were generated for each patient and standardised 
views of the resulting CTAs were saved on film for review. All processing was 
carried out on a Sun® Ultra 5 workstation (Sun Microsystems, Berkley, USA) 
running Advantage Windows® (version 1.2) software (General Electric Medical 
Systems, Milwaukee, USA).
With this software, an 'object' is a 3D connected set of voxels whose HU 
values are within given thresholds, and objects can be selected for deletion or 
retention using a cursor. Up to four 'viewports' can be open, each working 
independently on the loaded volume. Images were reconstructed using an increment 
of 0.5 mm and 180 degree interpolation and collimation of 1 mm in all cases.
An initial 3D ‘model’ was built using thresholds of 0-1500 HU, which 
included all the contrast-enhanced vessels and bony tissues, as well as the head rest 
and immobilisation pads. The latter objects were deleted immediately. 
Segmentation of the bone from the model was achieved by applying a threshold of 
250-1500 HU and then selecting only the skull as the object of interest. This object 
was then ‘dilated’ with 2-4 iterations using the supplied dilation tool. Each iteration 
dilated the object using a 3x3x3 kernel, adding only voxels which were part of the 
original 3D model.
When generating a SSD, in a third viewport, the original model was re- 
thresholded to leave the vessels and to remove as much bone as possible, with 
typical thresholds of 80-350 HU. The dilated skull object was then subtracted from 
the vessels object, thus creating a clear separation between the intracranial contents 
and the soft tissues of the face and scalp. Finally, the main vessels could be 
separated from other unwanted tissues by selection with the cursor over the AVM. 
At this stage final adjustments to the thresholds were made to leave a clear 3D render 
of the vessels, including removal of small groups of voxels (‘floaters’) of less than 
25 mm3. The vessels object can also be merged with the undilated skull object, 
allowing appreciation of vascular anatomy in relation to bony structures.
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When generating MIPs, however, no further thresholding was required and 
the ‘dilated’ bony structures were simply removed. A MIP image was made from 
the remaining intracranial structures, all other subcutaneous soft tissue being lost by 
selection of the central structures as an ‘object’.
3.2.4 Image analysis
3D SSDs and MIPs of the CTAs were analysed independently by two 
neuroradiologists according to a pre-determined proforma; this was drawn up by the 
radiologists on the basis of their previous experience in analysing imaging of AVM 
patients.
CTAs were analysed for the following information:
1. Size (according to Spetzler classification (Spetzler and Martin, 1986))
2. Topographical classification (according to Berenstein and Lasjaunias
(Berenstein and Lasjaunias, 1992) as in section 1.3.1)
3. Arterial supply (anterior or posterior circulation or external carotid supply)
4. Number of arterial feeders (1, 2,3 or greater than 3)
5. Presence of aneurysms (on Circle of Willis, on feeding artery or intranidal)
6. Venous drainage (superficial, deep or both)
7. Number of draining veins (1,2, 3 or greater than 3)
8. Venous anatomy (the presence or otherwise of focal or diffuse varices, 
stenosis or thrombosis)
9. Nidus definition (good, average, poor)
10. Presence of calcification
11. Presence of angiogenesis
12. Presence of embolic material
13. Clinical goal of treatment
14. Morphological goal of treatment
15. Proposed treatment plan
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Some details of presentation and symptomatology were given to allow an 
informed decision regarding future management plans for the patients to be made. 
The images were stratified according to AVM size and then randomised, using a 
table of randomised numbers, to whether the SSD or MIPs were analysed first 
(Altman, 1991).
The CTAs were first assessed from film and any uncertainties that arose were 
resolved using the interactive model on the workstation. Having assessed the 
images independently, any disagreements between the two neuroradiologists were 
reviewed and a consensus opinion reached for use in comparison with DSA. These 
results were compared with those reached in a similar way by a third 
neuroradiologist reviewing the DS As.
3.2.5 Statistical analysis
Data were collated using Microsoft® Excel 98 and statistical analysis was 
performed using Stata™ 4.0 (Stata Corporation, Texas, USA), on an Apple 
Macintosh® iMac computer.
Kappa (k), as described by Altman (Altman, 1991), was used as a measure of 
agreement. Kappa values were generated in order to assess the interobserver 
variability for SSD and MIP images and to compare SSD and DSA and MIP and 
DSA consensus findings. Kappa has a maximum value of 1.00 and can be used to 
assess how close an agreement there is between groups. Conventionally accepted 
levels are shown in Table 3.1. Weighted kappa, a further refinement of this test, can 
be used in the setting of ordinal variables (for example, in this study, the number of 
arteries or veins) where there may be degrees of agreement.
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Table 3.1: Value of kappa and strength of agreement
Value of K Strength of agreement
<0.20 Poor
0 .21-0 .40 Fair
0 .41-0 .60 Moderate
0 .61-0 .80 Good
0.81 -1 .0 0 Very good
from Altman (Altman, 1991)
A worked example for the calculation of an unweighted kappa value on the 
basis of interobserver variability for pattern of venous drainage on SSD images is 
shown below (Table 3.2):
Table 3.2: Pattern of venous drainage on SSD images reported by two
radiologists
Radiologist A Superficial Deep
Radiologist B 
Superficial and Deep Total
Superficial 7 - 2 9
Deep - 1 1 2
Superficial and Deep 1 1 7 9
Total 8 2 10 20
The expected frequency in a cell, calculated on the assumption of the null 
hypothesis of no association, is the product of the totals of the relevant row and 
column divided by the total number of observations.
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The expected frequencies of agreement are therefore:
Superficial
Deep
Superficial and Deep 
Total
1 0 x 9 / 2 0  = 4.5
9 x 8 / 2 0  = 3.6
2 x 2 / 2 0  = 0.2
8.3
Total observed agreements 7 + 1+  7 = 15
K = ( 1 5 / 2 0 - 8 . 3 / 2 0 ) / ( I - 8 . 3 / 2 0 )  
= 0.57
3.3 Results
3.3.1 Patient baseline characteristics
Twenty patients, 11 male and nine female, known to have AVMs underwent 
CTA and DSA, separated by a median of one day, interquartile range 1 - 6 9  days. 
They had a median age of 42 years with an interquartile range of 35 -  46 years. 
Seven patients presented with seizures, six with haemorrhage (SAH, ICH or IVH), 
two with headaches and a homonymous hemianopia, two with a progressive 
neurological deficit, two with headaches alone and a single patient had an enlarging 
cosmetic deformity. Patient demographic data is summarised in Table 3.3.
3.3.2 CTA analysis
The radiologists’ findings are summarised in Appendix 2. On DSA, eight 
patients had small, five had medium-sized and seven had large AVMs. The 
anatomical locations were cortical in nine, cortico-ventricular in seven, cortico- 
callosal in two and deep-seated in two. Arterial supply was from the anterior
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Table 3.3 : Demographic data of all patients undergoing CTA
Gender Age Presentation
Site
AVM
Anatomy Size
*Time
interval
Prior treatment Planned treatment
1 F 35 Seizures Left temporal Cortical Small 70 None Embolisation
2 M 57 ICH Right frontal Cortical Small 1 None Stereotactic DXT
3 M 53 ICH
SAH
Left callosal Callosal Small 1 None Embolisation
4 M 44 Migraine
Hemianopia
Left parieto-occipital Cortico-ventricular Large 1 None Conservative
5 F 35 Migraine Right parietal Cortical Small 1 Embolisation Stereotactic DXT
6 M 56 Seizures Right
temporo-parietal
Cortical Medium 2 Embolisation Embolisation
7 M 21 Seizures Left frontal Cortico-ventricular Large 1 None Conservative
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Table 3.3 (continued) Demographic data of all patients undergoing CTA
Gender Age Presentation
Site
AVM
Anatomy Size
*Time
interval
Prior treatment Planned treatment
8 F 32 Haemorrhage Left callosal Cortico-callosal Small 1 Embolisation Conservative
9 M 43 Seizures Left temporal Cortical Medium 1 Embolisation Embolisation
10 F 46 Seizures Left fronto-parietal Cortico-ventricular Medium 1 None Conservative
11 M 41 Progressive
hemiparesis
Right fronto-parietal Cortico-ventricular Large 130 None Embolisation
12 M 48 Cosmetic Left
holo-hemispheric
Cortico-ventricular Large 1 None Conservative
13 F 36 SAH Left callosal Callosal Medium 1 Stereotactic DXT Embolisation
14 M 55 Seizures Right temporal Cortical Medium 1 Embolisation Conservative
Table 33 (continued) Demographic data of all patients undergoing CTA
Gender Age Presentation
Site
AVM
Anatomy Size
*Time
interval
Prior treatment Planned treatment
15 F 25 Progressive
hemiparesis
Left thalamic Deep Large 74 None Embolisation
16 F 40 SAH Right thalamic Deep Small 69 None Stereotactic DXT
17 M 38 Hemianopia
Headaches
Right
holo-hemispheric
Cortico-ventricular Large 91 None Conservative
18 M 46 Haemorrhage Left
temporo-parietal
Cortical Small 11 None Surgery
19 F 46 Headaches Right frontal Cortical Small 1 Embolisation Embolisation/ 
Stereotactic DXT
20 F 37 Seizures Left fronto-parietal Cortico-ventricular Large 2 None Embolisation
* time interval in days between CTA and DSA
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circulation alone in nine, anterior and posterior in six, anterior, posterior and external 
in four and anterior and external carotid supply in one case. Venous drainage was 
superficial in 10, deep in three and both in seven cases. Seven of the 20 patients had 
undergone partial treatment of their AVM prior to undergoing CTA, of whom six 
had undergone partial embolisation whilst the seventh had undergone stereotactic 
radiosurgery.
3.3.3 Kappa Values
The kappa values calculated for both interobserver variability and 
comparison of imaging techniques are shown in Table 3.4. Kappa values were 
similarly generated, using the results from the patients with small AVMs only.
3.4 Discussion
CTA is a quick, cheap and simple procedure to perform which does not have 
the attendant risks of catheter angiography. Unlike MRI, it can be performed in 
patients with ferromagnetic devices and is possible in claustrophobic patients as well 
as being less susceptible to movement artifact. It is relatively insensitive to 
turbulent or slow flow because the patent lumen enhances regardless. It does, 
however, use ionising radiation and has the potential risk of anaphylactic reactions to 
the iodinated contrast medium. Post-processing of the images is operator dependent 
and can be time-consuming, particularly when separating out osseous structures in 
lesions close to the base of skull or lying on the inner table of the skull. The 
presence of an acute haematoma also makes post-processing difficult as it is difficult 
to threshold out haematoma and iodinated contrast separately. Volume coverage of 
the CTA can be limited, due to the need to maintain adequate spatial resolution. 
This can sometimes pose a problem in large AVMs. CTA has poor temporal 
resolution, such that arterial and venous phases are seen together.
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Table 3.4: Kappa values for interobserver variability and comparison of imaging techniques for CTA images
Interobserver variability Comparison of imaging techniques 
for all AVMs
Comparison of imaging techniques 
for small AVMs only
SSD MDP SSD versus DSA MIP versus DSA SSD versus DSA MIP versus DSA
Size* 0.84 0.83 0.84 0.62 1.00 1.00
Nidal definition* 0.53 0.20 0.17 0.12 0.00 0.00
Anatomical classification 0.61 0.55 0.55 0.63 0.50 0.76
Arterial supply 0.64 0.61 0.53 0.51 0.00 0.00
Number of arterial feeders* 0.69 0.68 0.93 0.79 1.00 0.75
Venous drainage 0.57 0.75 1.00 0.75 1.00 0.77
Number of draining veins* 0.63 0.65 0.86 0.76 0.75 0.14
Aneurysm on feeding arteries - 0.00 0.00 0.00 - -
Aneurysm on Circle of Willis 1.00 0.77 0.77 0.77 1.00 1.00
Intranidal aneurysm 0.00 -0.14 0.35 0.35 1.00 1.00
Presence of focal varix 0.35 0.38 0.59 0.12 0.50 0.25
Table 3.4 (continued): Kappa values for interobserver variability and comparison of imaging techniques for CTA images
Interobserver variability Comparison of imaging techniques 
for all AVMs
Comparison of imaging techniques 
for small AVMs only
SSD MIP SSD versus DSA MIP versus DSA SSD versus DSA MIP versus DSA
Presence of diffuse varices 0.29 0.27 -0.17 0.53 -0.20 0.60
Presence of venous stenosis 0.00 -0.08 0.00 0.21 0.00 0.00
Presence of venous occlusion 0.00 0.00 0.32 0.46 - -
Presence of embolisation material 0.00 0.88 0.00 0.88 0.00 1.00
Presence of calcification 0.00 0.66 - 0.00 - 0.00
Presence of angiogenesis 0.05 0.74 0.53 0.60 - -
Clinical goal of treatment 0.64 0.61 0.59 0.58 0.00 0.00
Morphological goal of treatment 0.52 0.35 0.42 0.42 0.00 0.00
Mode of treatment -0.05 -0.04 0.13 0.06 0.00 -0.21
* weighted kappa values 
- spread of data insufficient to calculate kappa
CTA, however, has the advantage of producing a 3D volume. The 3D model 
processed permits multiple projections of the lesion to be visualised, allowing 
assessment of the 3D anatomy of the AVM complex (unavailable with catheter 
angiography) and it can be used to reproduce the surgical approach, with its unique 
capacity to display the relationship of vascular structures to bone. This can also be 
done retrospectively.
3.4.1 Interobserver variability
Both SSD and MIP images showed good agreement with regard to size, 
anatomical classification and identification of numbers of feeding arteries and 
draining veins and their origin / destination.
There was moderate agreement on nidal definition between the two 
radiologists on SSDs but extremely poor agreement on MIPs. This was a very 
subjective variable and it became clear that the two radiologists viewed nidus 
definition very differently. Another particular problem with nidus definition was 
the presence of overlying draining veins. The poor temporal resolution of CTA 
means that both arterial and venous phases of the angiogram are seen 
simultaneously, with overlying veins obscuring details of the nidus.
Specific arterial and venous features such as aneurysms, varices, venous 
stenosis and occlusion had low kappa values and therefore marked interobserver 
variability except in the case of aneurysms on the Circle of Willis (Figure 3.6). 
However kappa may not provide a good measure of agreement in situations with 
small numbers of patients and categories and poor spread across the cells. It may be 
better to examine the raw data in these situations (Appendix 2), where it can be seen 
that the two radiologists actually agreed in at least 70% of analyses.
There was very good agreement between observers as far as presence of 
embolisation material and calcification were concerned on MIP images (k was 0.88 
and 0.66 respectively). Both calcification and embolisation material can be easily 
appreciated on MIP images. Kappa values were 0.00 for the presence of
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Figure 3.6: DSA with corresponding SSD images of an anterior communicating
artery aneurysm and venous pouches associated with an AVM
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calcification and embolic material on SSDs, although observers agreed in 100% of 
cases. Review of the raw data revealed that neither observer was able to appreciate 
embolisation material or calcification on the SSD images. This is not surprising as 
the majority of information regarding relative Xray attenuation is lost in the 
thresholding process for SSDs. Examination of the axial source images during 
interactive viewing would allow visualisation of embolisation material, often with 
associated beam hardening artifact (Figures 3.7a - d). Calcification is often more 
subtle and of much smaller volume than embolisation material and therefore, in the 
case of SSDs, all axial source images or reformats must be viewed carefully to 
exclude the presence of calcification. This may involve many images and can 
therefore be a time-consuming process.
There was again good interobserver agreement in MIP images but poor 
agreement in SSD images for the presence of angiogenesis. Angiogenesis can also 
be subtle and is often found only within a tightly packed nidus.
SSDs have the property of occlusivity and any overlying structure, such as a 
large vein, can obscure the nidal structure from view. Appreciation of the nidus 
structure and identification of the presence of angiogenesis would again require 
careful evaluation of the axial source images and coronal or sagittal reformats with 
thin enough slices such that the fine intranidal structure is not lost.
Agreement was good for clinical goal of treatment on both SSD and MIP 
images, and moderate for morphological goal of treatment on SSD. However, 
agreement was poor between observers for morphological goal of treatment on MIPs 
and mode of treatment on both SSD and MIP images (k was 0.35, -0.05 and -0.04 
respectively). Examination of the raw data showed agreement between the 
reviewers of at least 75%. Certainly in the case of mode of treatment, this was 
partly related to the fact that this was a highly selected group of patients with at least 
50% undergoing embolisation.
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Figure 3.7: Embolisation material as seen on a) lateral DSA (black arrow), b) CT
axial source data, c) inferior MIP and d) inferior SSD images of the 
same patient.
SSD has the property of occlusivity and therefore the glue cannot be visualised. These CTA images 
also show how draining veins lying just deep to the inner table of the skull can be partially lost with 
post-processing (white arrows)
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3.4.2 Comparison of imaging techniques
3.42.1 CTA and DSA o f all AVMs
SSD and MIP demonstrated well the size, pattern of venous drainage and 
numbers of arterial feeders and draining veins. MIP appeared to be marginally 
better than SSD at identifying the anatomical type of AVM present (k 0.63 and 0.55 
respectively) but the raw data showed that both types of images agreed with DSA in 
75% of cases. They were both moderately good at identifying the origin of arterial 
feeders. One consistent difficulty with CTA and identification of the origin of 
arterial feeders was that any contribution from the external carotid was often 
removed with bone and therefore not appreciated by blinded observers. External 
carotid supply was present in five of the patients studied, but was not identified from 
any of the CTA (SSD or MIP) images. Nidal definition was extremely poorly 
demonstrated on both SSDs and MIPs (k 0.17 and 0.12 respectively) when compared 
to DSA. Observers commented that this was often as a result of overlying draining 
veins (Figures 3.8a -  c).
Kappa values for abnormal arterial and venous structures were in the main 
very poor for CTA images compared with DSA, with four exceptions: aneurysms 
arising from the Circle of Willis (k 0.77 in both SSDs and MIPs); the presence of 
focal varices on SSDs (k 0.59); and on MIPs, the demonstration of diffuse varices (k 
0.53) and venous occlusion (k 0.46). However, in all cases of abnormal arterial 
anatomy and the presence of venous occlusion on SSDs, there was agreement 
between CTA and DSA in at least 75% of cases. MIPs were again particularly good 
at demonstrating the presence of embolisation material (k 0.88). In SSDs, as 
previously mentioned, embolic material cannot be seen on the SSDs images 
themselves, resulting in poor agreement between SSDs and DSA (k 0.00). Presence 
of calcification showed no agreement between SSD and MIP images and DSA. 
This is due to the fact that DSA images were subtracted images and therefore 
calcification was not seen. In this situation, it is likely that the MIP images in
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Figure 3.8: a) Arterial and b) venous phases of an AVM on DSA with a
corresponding c) MIP image
The combination of both arterial and venous phases on CTA images can prevent accurate analysis of 
the nidal structure which is frequently obscured by large draining veins
96
particular would demonstrate calcification well if compared to unsubtracted DSA 
films. Angiogenesis was moderately well demonstrated on CTA images with kappa 
values of 0.53 and 0.60 (SSD and MIP respectively).
Clinical and morphological goals of treatment from CTA agreed moderately 
well with DSA, but mode of treatment had kappa values of only 0.13 and 0.06 (SSD 
and MIP respectively). This was a highly selected group of patients, nearly half of 
whom underwent partial embolisation as their initial treatment. In addition, the 
neuroradiologists evaluating the CTAs were given only limited information about 
the patients to make a decision regarding treatment options, whilst the 
neuroradiologists evaluating the DSAs knew the patients well. Knowledge of 
symptomatology, as well as AVM anatomy, was clearly important in making an 
informed decision about the most appropriate form of treatment in these situations. 
If these CTAs had been evaluated prospectively by the neurovascular team that 
includes both interventional neuroradiologists and neurosurgeons, it is likely that 
decision-making using CTA would be improved.
3A.2.2 CTA and DSA o f small AVMs
The observers of the CTAs felt that analysis of small AVMs was much easier 
than that of large complicated lesions (Figures 3.9a and b). For this reason, the 
eight small AVMs were re-analysed separately. Analysis of the kappa values in this 
group was particularly difficult because of the small numbers involved.
There was very good agreement between DSA and SSD and MIP images of 
small AVMs in size, number of arterial feeders and venous drainage. MIP images 
showed better agreement with DSA, compared with SSD, with respect to anatomical 
classification (k 0.76 and 0.50 respectively). Kappa values for the origin of arterial 
supply showed poor agreement between CTA images and DSA, however analysis of 
raw data showed agreement in over 60%. SSD was considerably better at 
identifying draining veins than MIP, when compared to DSA with respectively 
kappa values of 0.75 and 0.14. In an effort to reduce the radiation dose given to
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Figure 3.9: MIP images of a) large and b) small sized AVMs
a
Analysis of the smaller lesion is clearly more straight-forward than that of the larger 
lesion
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patients, the CTA volume acquired varied according to the size of the AVM. In 
some small cortical lesions lying close to the top of the skull this meant that the 
Circle of Willis was not included in the scanned volume. Observers of the CTAs 
found that this made distinction of arteries from veins more difficult and may have 
had some bearing on identification of the origin of arterial supply (both SSD and 
MIP) and numbers of draining veins on MIPs. Agreement on nidal definition was 
poor with kappa values of 0.00 in both cases, but evaluation of the raw data 
suggested that SSD showed better agreement than MIPs with DSA with agreement 
in 75% and 50% of cases respectively.
There was very good agreement between CTA images and DSA when 
identifying the presence or otherwise of arterial aneurysms. This was not reflected 
in the kappa values for aneurysms lying on the feeding arteries. There was perfect 
agreement between imaging modalities in this situation, but as there were no 
aneurysms identified, there was poor spread across the kappa frequency table and, as 
a result, too few categories to be able to calculate kappa.
This situation was also seen in identifying the presence of venous occlusion 
and angiogenesis. Although the kappa values for the presence of calcification was 
0.00 using MIPs, there was agreement in 75% of cases. There was no agreement 
between SSD images and DSA in detecting calcification. There was, however, 
perfect agreement in the identification of embolic material between MIPs with DSA 
(k 1.00), but poor agreement between SSDs and DSA (k 0.00).
Identification of abnormal venous anatomy had generally poor kappa values, 
except SSDs identifying the presence of a focal varix (k 0.50) and MIPs 
demonstrating diffuse varices (k 0.60). Again, review of the raw results data 
showed there was perfect agreement of both SSDs and MIPs with DSA in the 
identification of venous occlusion.
Poor kappa values were seen between both CTA images and DSA for 
treatment options, reflecting the highly selected group and that the vast majority of 
these patients can be cured with obliteration of the nidus. Clinical goal and
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morphological goals show kappa values of 0.00, but there was agreement in seven of 
the eight cases. This was not the case for mode of treatment kappa values (SSD and 
MIP, K 0.00 and -0.21 respectively), where there was poor agreement between 
reviewers.
3.5 Conclusion
During evaluation of the CTAs, it became clear that observers’ interpretation 
of certain characteristics was very different. Many features were objective, such as 
the number of feeders, site and presence or otherwise of aneurysms. Other features 
however, such as nidus definition and the distinction between focal and diffuse 
varices, were much more subjective. This was partly due to observer experience 
and therefore some of the kappa values have to be interpreted with this in mind.
The use of kappa as a measure of agreement does have limitations. Small 
numbers of observations with poor spread can result in there being too few 
categories to be able to calculate kappa. The analysis of a highly selected group of 
individuals will also mean poor scatter across the kappa frequency table. Both of 
these situations can lead to poor kappa values, and examination of the raw data may 
be of greater use in interpreting the level of agreement between observers. This was 
seen in several of the observations made in this study, in particular, the identification 
of aneurysms on feeding arteries and venous stenoses and occlusion and also in the 
comparison of imaging techniques when only small AVMs were considered. This 
was a limitation of the study. The methodology of the study could be improved by 
imaging a larger number of patients whose AVMs were managed by a wider variety 
of treatments.
CTA correctly identified main arterial feeders, associated arterial aneurysms, 
venous drainage patterns and venous varices in most cases, but was poor at 
identifying external carotid supply to the AVM. Small draining veins, particularly 
lying on the inner table of the skull, were also occasionally difficult to identify
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Figure 3.10: Coronal reformat from axial source data allowing appreciation of 
intranidal structure and features
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because they were frequently subtracted out with the ‘bone’ object. These problems 
could be rectified by modifying the post-processing protocol. In addition, observers 
of the CTAs found that in cases where the Circle of Willis had not been included in 
the imaged volume, distinction of arteries from veins and the identification of the 
origin of arterial supply were more difficult. The Circle of Willis should therefore 
always be included in the imaged volume. This often requires use of the larger of 
the two CTA acquisition protocols, allowing larger z-axis coverage and therefore 
easier and improved orientation and identification of feeding arteries for 
interpretation of the images. Although CTA was able to detect most important 
angio-architectural features in AVMs, it was not as accurate as DSA for making 
decisions regarding future management of patients, particularly because both 
temporal resolution and nidus definition were poor.
SSD CTAs were slightly superior to MIPs in most AVMs, particularly in 
those with a cortical location and superficial venous drainage. In addition, bone 
could be shown in SSDs as a separate differently-coloured object if required.
Isolated small feeding vessels were not always detected with CTA. This was 
more problematic on SSD than MIP images because of thresholding effects.
MIPs are easier and quicker to post-process. MIPs were better than SSDs at 
demonstrating intranidal glue or calcification but did not allow appreciation of bony 
relationships as bone was subtracted out during post-processing. However, access 
to the raw data axial slices prevented this from being a problem.
Interpretation of both SSD and MIP images was aided by the availability of 
the source data (Figure 3.10). SSD images in particular did not allow full 
appreciation of the internal structure of tightly packed niduses which prevented the 
observer from appreciating, for example, the presence of embolisation material or 
calcification. These features, however, are evident from source data. In reality, 
source data is always available for analysis and CTAs are not viewed in isolation, 
allowing appreciation of particular details from the source data alone, even if it is not 
identified on the CTA images themselves.
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Chapter 4
MR ANGIOGRAPHY
4.1 Introduction
DSA is invasive and has associated risks, in particular that of stroke. MRA 
is a non-invasive vascular imaging method which in some situations has replaced 
DSA and has now become part of clinical routine (Pollock, 1996c). Carotid artery 
stenosis, for example, can be demonstrated on MRA, most commonly using a 2D 
TOF sequence. Avoidance of DSA in these patients is of great advantage as many 
have vascular risk factors and are therefore at greater risk of complications when 
undergoing DSA.
MRA can be performed using either 2D TOF, 3D TOF or PC sequences. 
TOF sequences are based on the inflow of magnetised blood into a saturated 
stationary tissue, whilst phase-contrast imaging uses a bipolar pulse sequence to 
detect shifts in the phase caused by blood flowing through a magnetic gradient. In 
all techniques, contrast between blood vessel and stationary tissue is as a result of 
blood motion. All of these methods can detect laminar flow above a certain 
velocity, but turbulent or slow flow or in-plane flow may remain undetected. In 
addition, associated T1 contamination artifact, caused by blood or fat, appears as 
high signal areas and can obscure vascular detail. In AVMs, these can be highly 
relevant issues, with poor demonstration of the complex angioarchitecture of the 
lesion or the slow-flowing draining veins, particularly in the context of acute 
haemorrhage.
The use of gadolinium-based contrast medium has been advocated to 
minimise some of these disadvantages. Gadolinium shortens the T1 relaxation time 
of blood, which increases intravascular signal, making it less dependent on laminar
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flow and improving the signal-to-noise ratio. The resulting short T1 of blood 
permits sequences with very short TRs and thus short acquisition times. MRA 
images are therefore based on short T1 rather than flow-related enhancement and 
saturation effect problems are avoided (Pemicone, 1997). This has the potential for 
better visualisation of slow flow or flow running in the imaging plane (Parker, 1998). 
Intracranial contrast-enhanced MRA has, to date, mostly used a modified TOF 
sequence.
Few studies have prospectively assessed the accuracy and resolution of MRA 
in the assessment of AVM angioarchitecture when compared with DSA. Tanaka et 
a l (Tanaka, 1997) analysed the results of 12 unenhanced 3D TOF sequences with 
those acquired from both CTA and DSA. MRA detected 73% of arteries but only 
32% of veins due to saturation effects. Huston et al. (Huston, 1991) performed a 
similar study comparing 3D TOF and PC MRA. Fifty two percent of arteries and 
11% of veins were identified on 3D TOF sequences, whilst 44% of arteries and 54% 
of veins were identified on the PC MRA sequences.
Dynamic contrast-enhanced MRA uses a rapid sequence acquisition 
(gradient-echo slices) during the injection of a gadolinium bolus. This method is 
increasingly used for the investigation of the carotid artery but its application to the 
intracranial circulation has been limited (Bongartz, 1997). This is mainly because 
the rapid acquisition does not allow coverage of a large area. By investigating the 
use of contrast-enhanced MRA in small AVMs, large area coverage was not 
necessary.
4.2 Methods
4.2.1 Patients
Patients were recruited from those seen by the neurovascular surgery or 
interventional neuroradiology services at The National Hospital for Neurology and
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Neurosurgery between March 1999 and January 2000. All patients were known to 
have AVMs measuring less than 3 cm in one dimension and had undergone recent 
catheter angiography. To allow adequate temporal and spatial resolution on the 
contrast-enhanced gradient-echo sequences, only 12 slices at a maximum thickness 
of 2.5 mm were acquired. This necessitated restriction of the size of AVM that 
could be imaged. Patients with the usual contra-indications to MRI scanning were 
excluded.
4.2.2 Imaging
Scanning took place on a 1.5T Signa® scanner (General Electric Medical 
systems®, Milwaukee, USA) at the Multiple Sclerosis NMR Research Group, 
Institute of Neurology. All patients underwent 3D TOF pre and post contrast and 
dynamic contrast-enhanced gradient-echo sequences.
4.2.2.1 3D TOF sequences
The 3D SPGR-TOF sequence was acquired axially with TR 52 msec, TE 6.9 
msec, flip angle 30°, bandwidth 32kHz, 24 cm field of view, 0.9 mm slice thickness, 
64 slices and 512 x 192 matrix. Acquisition took 8:03 min. This sequence was 
performed before and after administration of a 15 ml bolus of gadolinium-based 
contrast medium, Dotarem® (Guerbet Laboratories, Aulnay-sur-Bois, France), 
irrespective of body weight. Only one contrast bolus per patient was required for 
the study, the second 3D TOF sequence being performed after the dynamic contrast- 
enhanced gradient-echo sequence described below.
4.2.2.2 Contrast-enhanced gradient-echo sequences
A 3D SPGR sequence was acquired with scan parameters TR minimum, TE 
minimum, flip angle 30°, bandwidth 32kHz, 22cm field of view, slice thickness 1.5 -  
3.0mm (depending on size of AVM), 12 slices per slab and 256 x 128 matrix. Each 
sequence took 13 sec. This sequence was performed 3 times in quick succession to 
allow subtraction of the second and third acquisitions from the first baseline
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acquisition in an effort to produce 3D angiographic representation of arterial and 
venous phases separately. A 15 ml hand-bolus of gadolinium-based contrast 
medium, Dotarem® (Guerbet Laboratories, Aulnay-sur-Bois, France), was given 
over 5 - 7 sec at 3 sec into the first acquisition.
4.2.3 Post processing
All processing was carried out on a Sun® Ultra 5 workstation (Sun 
Microsystems, Berkley, USA) running Advantage Windows® (version 3.1) software 
(General Electric Medical Systems, Milwaukee, USA).
Pre- and post-contrast 3D TOF images were produced in the usual way and 
standardised views of the resulting MRAs were saved on film for review.
The first gradient-echo acquisition, prior to contrast bolus arrival, was used 
as a baseline and subtracted from the second acquisition in order to demonstrate the 
arterial phase of the angiogram. The second was then subtracted from the third 
acquisition in order to demonstrate the venous phase of the angiogram. As above, 
standardised views of the resulting MRAs were saved on film for review
4.2.4 Image analysis
Image analysis was performed as described in section 3.2.4. All pre-contrast 
TOF images were reviewed in one sitting, followed by the contrast-enhanced 
gradient-echo sequences at a second viewing and finally the post-contrast TOF 
images at a third sitting.
4.2.5 Statistical analysis
Data were collated using Microsoft® Excel 98 and statistical analysis was 
performed using Stata™ 4.0 (Stata corporation, Texas, USA) as described in section 
3.2.5.
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4.3 Results
4.3.1 Patient baseline characteristics
Ten patients, three male and seven female, known to have AVMs measuring 
less than 3cm in at least one dimension underwent MRA and DSA, separated by a 
median of 61 days, interquartile range 4 - 1 6 7  days. They had a median age of 40 
years with an interquartile range of 23 - 48 years. Four patients presented with 
seizures, five with haemorrhage (SAH, ICH or IVH) and one was asymptomatic, 
having been identified following DSA for investigation of a remote haemorrhage. 
Patient demographic data is summarised in Table 4.1.
4.3.2 MRA analysis
The radiologists* findings are summarised in Appendix 3. From DSA, the 
anatomical locations were cortical in nine and deep-seated in one. Arterial supply 
was from the anterior circulation alone in four, posterior circulation in four and 
anterior and posterior in two. Venous drainage was superficial in eight and deep in 
two. Six of the 10 patients had undergone partial treatment of their AVM prior to 
undergoing MRA, five had undergone partial embolisation whilst the sixth had 
undergone both partial embolisation and stereotactic radiosurgery.
4.3.3 Kappa values
4.3.3.1 Pre- and post-contrast 3D TOF
The kappa values calculated for both interobserver variability and 
comparison of imaging techniques are shown in Table 4.2.
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Table 4.1: Demographic data of all patients undergoing pre- and post-contrast 3D TOF and contrast-enhanced gradient-echo MRA
Patient Gender Age Presentation 
Number Site
AVM
Anatomy Size
Time Prior 
interval* treatment
Planned
treatment
1 F 27 Seizures Right parietal Cortical Small 1 Embolisation Stereotactic DXT
2 M 18 ICH Right parietal Cortical Medium 36 None Embolisation
3 F 61 Seizures Right fronto­
parietal
Cortical Medium 1 Embolisation Conservative
4 F 49 Asymptomatic Left ambient 
cistern
Cortical Small 269 None Conservative
5 F 40 SAH Right thalamic Deep Small 421 None Stereotactic DXT
6 F 41 Seizures Left temporal Cortical Small 60 Embolisation Conservative
7 F 32 IVH Left temporal Cortical Medium 63 Embolisation / 
Stereotactic DXT
Conservative
8 F 48 SAH Left occipital Cortical Large 69 Embolisation Embolisation
9 M 55 Seizures Right temporal Cortical Medium 266 Embolisation Conservative
10 M 19 IVH Left cerebellar Cortical Small 8 None Embolisation
* time interval in days between MRA and DSA
Table 4.2: Kappa values for interobserver variability and comparison of imaging techniques for MRA images
Interobserver variability Comparison of imaging techniques for all AVMs
Pre contrast 
TOF
CEMRA Post contrast 
TOF
Pre contrast TOF 
versus DSA
CEMRA versus 
DSA
Post contrast 
TOF versus DSA
Size* 0.74 1.00 1.00 0.68 0.63 0.72
Nidal definition* 0.75 0.78 0.76 0.18 0.57 0.55
Anatomical classification 0.30 0.53 0.83 0.43 0.41 0.59
Arterial supply 0.36 0.40 0.69 0.19 0.00 0.69
Number of arterial feeders* 0.76 0.60 0.71 0.68 0.43 0.81
Venous drainage 0.31 0.39 0.17 -0.02 0.58 0.57
Number of draining veins* 0.60 0.74 0.53 0.12 0.64 0.77
Aneurysm on feeding arteries 0.43 1.00 0.00 -0.07 -0.07 0.00
Aneurysm on Circle of Willis 0.62 1.00 0.00 0.00 0.00 0.00
Intranidal aneurysm 0.71 1.00 0.00 -0.22 -0.08 -0.18
Presence of focal varix 0.67 0.17 -0.19 0.08 0.25 0.09
Table 4.2 (continued): Kappa values for interobserver variability and comparison of imaging techniques for MRA images
________Interobserver variability_____________ Comparison of imaging techniques for all AVMs
Pie contrast CEMRA Post contrast Pie contrast TOF CEMRA versus Post contrast 
TOF TOF versus DSA DSA TOF versus DSA
Presence of diffuse varices 0.67 0.55 0.52 -0.01 0.39 0.52
Presence of venous stenosis 0.67 0.41 0.00 -0.14 0.19 -0.43
Presence of venous occlusion 0.67 0.30 0.00 0.00 0.00 0.00
Clinical goal of treatment 0.31 0.74 0.57 0.15 0.41 0.12
Morphological goal of treatment 0.31 0.62 0.67 0.18 0.15 0.10
Mode of treatment 0.32 0.62 0.43 0.17 -0.25 -0.19
* weighted kappa values
4.3.3.2 ‘Arterial’ phase contrast-enhanced gradient-echo MRAs
Although designed to show only the arterial phase of the angiogram, these 
images showed both arterial and venous phases due to the rapid arteriovenous 
shunting present in AVMs. The kappa values calculated for both interobserver 
variability and comparison of imaging techniques are shown in Table 4.2.
4.3.3.3 ‘Venous’ phase contrast-enhanced gradient-echo MRAs
Subtracting the second acquisition images (actually showing both arterial and 
venous phases) from the third set of images left very little vasculature evident. As a 
result, all of these images were uninterpretable.
4.4 Discussion
MRI is non-invasive with a good safety profile. There are contra-indications 
to MR scanning which most importantly include those patients with ferromagnetic 
devices or implants. Although most intracranial implants now used are MR 
compatible, this has not always been the case.
3D TOF has a high spatial resolution. However, in high-flow vascular 
lesions, which are often geometrically complicated, 3D TOF does have 
disadvantages. 3D TOF sequences are less sensitive to turbulent or slow flow,
which has particular implications in patients with AVMs. The use of gadolinium 
can contribute to an increase in contrast resolution with overall improvement in 
delineation of small vessels.
CEMRA, using a paramagnetic contrast agent, results in enhanced T1 
shortening and therefore a more favourable signal-to-noise ratio, limiting signal loss. 
Stationary spins of the background tissue are saturated giving minimal signal whilst 
the unsaturated spins of moving blood giving a bright signal. Signal intensity 
increases with increasing blood velocity and TR and decreasing slice thickness. 
Blood regains its longitudinal magnetisation more rapidly giving stronger signal 
intensity and therefore increasing the difference in signal intensity between blood
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vessels and the surrounding background tissue. Contrast can be increased still 
further by subtracting pre- from post-contrast images provided the patient does not 
move between sequences. Exclusive arterial enhancement can theoretically be 
achieved by imaging first pass of the contrast bolus only. Venous contrast passage 
can also be imaged with only one intravenous bolus of contrast. The primary 
limitation of 3D CEMRA is the k space acquisition speed and thus the achievable 
image resolution during the time limited first pass of contrast media. This was a 
problem seen in the patients imaged in this study and in particular limited the size of 
AVM that could be imaged to a maximum of 3 cm in one conventional plane 
(sagittal, coronal or axial). The availability of high performance gradient sets on 
clinical scanners now allows speed-up to an extent where the fundamental signal-to- 
noise ratio limit becomes imminent.
4.4.1 Interobserver variability
All three MR sequences showed good interobserver agreement with regard to 
size, nidal definition, and numbers of feeding arteries and draining veins (range k 
0.53 to 1.00). Anatomical classification was only fair on pre-contrast TOF 
sequences as in up to four cases this was not assessable by the observers (k 0.3). 
This was partly a reflection of the fact that only small AVMs were studied. 
However there was moderate agreement on CEMRA and very good agreement on 
post contrast TOF sequences (k 0.53 and 0.83 respectively). The origin of arterial 
feeders showed only fair agreement between observers on pre-contrast TOF and 
CEMRA sequences, again partly compounded by the fact that the AVM nidus could 
not be visualised in up to four individuals (k 0.36 and 0.40 respectively). However, 
there was good agreement on post-contrast TOF sequences (k 0.69). There was 
universally only poor to fair agreement on the pattern of venous drainage (range K 
0.17 to 0.39).
Identification of abnormal arterial and venous anatomy showed generally 
good or very good agreement on pre-contrast TOF and CEMRA sequences. There
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were very low kappa values for post-contrast TOF sequences and the identification 
of focal varices and venous occlusion on CEMRA images. In all of these situations, 
looking at the raw data (Appendix 3), there was agreement in 50 -  90% of cases and 
the low kappa values reflect a poor spread of data amongst the cells of the tables.
Decisions regarding management of individual patients showed poor 
interobserver variability on pre-contrast TOF sequences although there was 
agreement in 50% of cases (range K 0.31 to 0.32). Some of these options, however, 
were not assessable as the AVM was too poorly visualised. Interobserver variability 
was moderate or good on CEMRA and post-contrast TOF sequences (range K 0.43 to 
0.74), although only seven of the AVMs could be assessed on CEMRA, whilst 
decisions could be made about all patients on the basis of the post-contrast TOF 
sequences.
4.4.2 Comparison of imaging techniques
Post contrast TOF sequences were by far the best at demonstrating the size, 
nidal definition, anatomical classification and identification of numbers of feeding 
arteries and draining veins and their origin / destination (range K 0.45 to 0.81). 
CEMRA sequences were the next best at identifying the above features, only 
showing no agreement with arterial supply. The main difficulty associated with the 
CEMRA sequences was the limited volume acquisition possible allowing reasonable 
spatial resolution. This meant that landmarks, in particular the Circle of Willis, 
were often not included in the scanned volume. As a result, in four individuals, the 
origin of feeding arteries could not be identified (k 0.00). Pre-contrast TOF 
sequences were the worst at identifying several factors, in particular nidal definition 
(which is often a subjective issue anyway as demonstrated on CTA previously 
(section 3.4.1)) (k 0.18), origin of feeding arteries (k 0.19) and venous drainage (k - 
0.02) and the number of draining veins (k 0.12). In up to nine cases this was 
because vessels, in particular slow-flowing veins, were not visualised.
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The kappa values when comparing visualisation of abnormal arterial and 
venous anatomy were low (range k -0.43 to 0.19), suggesting poor agreement 
between DSA and all MR sequences, except in the identification of diffuse varices 
on CEMRA and post-contrast TOF (k 0.39 and 0.52 respectively). However 
inspection of the post-contrast TOF raw data showed agreement in 60 -  100%. 
There was poor agreement of only 40 -  50% in identifying focal varices and venous 
stenosis when compared with DSA. Again kappa values were low because of few 
cells and poor spread across the tables in Appendix 3. CEMRA in general showed 
poorer agreement with DSA than post-contrast TOF sequences, whilst pre-contrast 
TOF showed still poorer agreement. However, even these two sequences were able 
to demonstrate at least 50% of all abnormal arterial and venous anatomy.
There was generally poor agreement of all MR sequences with DSA when 
assessing management options.
4.5 Conclusion
MRA was able to demonstrate salient angioarchitectural features of AVMs 
but was not able to provide an accurate enough assessment with regard to treatment 
options to replace DSA as an initial diagnostic procedure on which future 
management is planned.
Of the three sequences used here, post-contrast 3D TOF provided the most 
accurate data although was worst at predicting appropriate management on the basis 
of MRA alone (Figures 4.1a -  d). Interobserver variability of post contrast 3D TOF 
sequences showed good kappa values, allowing for the limitations of the kappa 
statistic, suggesting that the assessment was reproducible. CEMRA was the next 
most accurate of sequences, followed finally by pre-contrast TOF sequences. This 
confirmed that the use of gadolinium-based contrast agents was able to improve 
signal-to-noise ratio and visualisation of slow and turbulent flow, particularly for 
nidus definition (Figures 4.2a and b) and draining veins (Figures 4.3a - d).
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Figure 4.1: a) DSA, b) CEMRA and c) pre- d) and post-contrast 3D TOF images
of a small parietal AVM
improved demonstration of slow flow is seen on the contrasted images, particularly in the superior 
sagittal sinus
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a) Pre- and b) post-contrast 3D TOF images of an AVM only 
visualised well post-contrast because of slow flow in the draining 
veins (white arrow)
Figure 4.3: Visualisation of a draining vein 
a DSA arterial phase
b DSA venous phase
c Pre-contrast 3D TOF
d Post-contrast 3D TOF
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In this selected group of small AVMs, it allowed visualisation of the AVM 
itself in several cases where it could not be seen at all on pre-contrast images.
As with CTA images, temporal resolution of CEMRA was not good enough 
to allow a 3D representation of separate arterial and venous phases of the AVM 
without an unacceptable deterioration in spatial resolution. This clearly remains a 
major disadvantage over DSA. Since the completion of this study, a new technique 
of MRA DSA for the assessment of AVMs has emerged. 2D MR acquisitions with 
a temporal resolution of one image sec'1 can now be achieved, allowing separation 
of arterial and venous phases.
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Chapter 5
VOLUMETRIC ANALYSIS OF AVM NIDUS USING MRI
5.1 Introduction
Accurate nidus measurement is important for predicting surgical outcome 
and assessing suitability for radiosurgery. It is an important component of the 
Spetzler grade of the lesion, which influences the mortality and morbidity associated 
with surgical treatment of AVMs (Spetzler and Martin, 1986; Heros, 1993). The 
results of stereotactic radiosurgery are also dependent upon the size and more 
importantly, the volume of AVM, being treated (Lunsford, 1991; Gallina, 1998). 
With increasing volume, the obliteration rate decreases with an associated increase 
in morbidity and side effects. Successful radiosurgical treatment requires accurate 
assessment of the AVM volume, precise delivery of radiation dose to the often 
irregular AVM margin and 3D imaging of the AVM nidus. Although biplane 
angiography is adequate to define the AVM shape in the vast majority of patients, 
MRI provides additional 3D anatomical information (Lunsford, 1991). Treatment 
of AVMs by radiosurgery currently involves stereotactic localisation of the AVM by 
DSA. MRI is used primarily to assess the precise location of the nidus and whether 
it involves eloquent areas of brain and hence the associated risks of stereotactic 
radiosurgery and possible side effects. However, some units are increasingly using 
stereotactic localisation from MRI, thus reducing the need for invasive DSA 
(Petereit, 1993; Kondziolka, 1994; Pollock, 1996c).
A commonly used measure of AVM size is the largest linear dimension, as in 
the Spetzler grading (Spetzler and Martin, 1986). Alternatively, an ellipsoid 
approximation is generated from three orthogonal measurements taken from 
conventional DSA. In a study by Noorbehesht et al. (Noorbehesht, 1987), AVM
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size was determined from DSA, CT and MR by taking the largest orthogonal 
measurement from all three investigations. The size of the malformation measured 
on MR was found, in general, to be smaller than the size determined from 
angiographic films. This discrepancy increased as the size of the AVM increased. 
They concluded that MR by virtue of its ability to discriminate between draining 
veins and AVM nidus, and its ability to do this in three planes, provided a more 
accurate estimate of AVM size than that calculated from DSA.
This study was performed in order to examine the differences in AVM nidal 
volumes generated from three MR sequences (3D fast spin-echo (FSE) and pre- and 
post-contrast 3D TOF) and to compare these with the more commonly used ellipsoid 
approximation of the AVM nidal volume from DSA.
5.2 Methods
5.2.1 Patients
Patients were recruited from those seen by the neurovascular surgery or 
interventional neuroradiology services at The National Hospital for Neurology and 
Neurosurgery between January and October 1999. All patients were known to have 
AVM and had undergone recent catheter angiography confirming its presence, 
anatomy and size. Patients with the usual contra-indications to MRI scanning were 
excluded.
5.2.2 Imaging
Scanning was performed on a 1.5T Signa® scanner (General Electric 
Medical Systems, Milwaukee, USA) at the Multiple Sclerosis NMR Research 
Group, Institute of Neurology. All patients underwent 3D TOF pre- and post­
gadolinium contrast and 3D FSE.
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5.2.2.1 3D TOF sequences
A 3D TOF sequence (TR 30msec, TE 6.9msec, flip angle 30°, 0.9mm slice 
thickness, 21cm field of view, 512x128 matrix) was acquired in the axial plane, 
before and after administration of 15ml O.lmM Gd-DOTA (Dotarem®, Guerbet 
Laboratories, Aulnay-sur-Bois, France), irrespective of body weight. The scan 
sequence took 7:10 min.
5.2.22 FSE sequences
T2-weighted 3D FSE images (TR 3000msec, TE 84msec, 1.5mm slice 
thickness, 25cm field of view and 256x192 matrix) were acquired in the coronal 
plane. The sequence took 3:21 min.
5.2.3 Post processing
All three sequences were post-processed on a Sun® Ultra 5 workstation (Sun 
Microsystems, Berkley, USA) running Advantage Windows®, version 3.1, software 
(General Electric Medical Systems, Milwaukee, USA). The volumetric data sets 
were reformatted to produce contiguous slices of 1.5mm thickness in the sagittal, 
coronal or axial planes. Sagittal slices were defined as parallel to and coronal slices 
perpendicular to the interhemispheric fissure of the brain, whilst axial slices were 
defined as parallel to the line joining the anterior and posterior commisures of the 
corpus callosum. The choice of the reformatting plane depended upon the shape of 
the AVM and was perpendicular to the shortest axis of the nidus. This approach 
minimises errors due to partial volume effects in the end slices of the AVM, since 
the lesion has the smallest cross-sectional area in the reformatted plane.
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5.2.4 Image analysis
52.4.1 MRI
The AVM nidus volume was estimated using Cavalieri’s principle (McNulty,
2000):
Volume = Z  Ai. Az
where Az is the reformatted slice thickness and A is the area of nidus defined on 
each slice.
The boundaries of the nidus were defined independently by three 
neuroradiologists on the Sun® Ultra 5 workstation (Sun Microsystems, Berkley, 
USA) by drawing a freehand trace around the nidus on each reformatted slice. Hard 
copy films of the manual tracings were produced for future review. The area 
measurement of each ROI was multiplied by the slice thickness (1.5mm). The 
subvolumes derived by this method were summed for all slices giving the total AVM 
nidus volume in mm3. The order of sequences on which the nidus was defined was 
randomised in order to minimise bias and no two sequences from the same patient 
were analysed consecutively.
5.2.42 DSA
Three orthogonal measurements of the AVM nidus were taken on the AP and 
lateral DSA projections by the same three observers (Figure 5.1). The AVM nidus 
volume was estimated using approximation to an ellipsoid, where:
where x, y and z are the maximum dimensions of the AVM nidus in three orthogonal 
planes.
Volume
122
Figure 5.1: DSA of AVM showing three orthogonal measurements of nidus for
use in ellipsoid approximation of nidal volume (white arrows)
a
b AP view
Lateral view
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5.2.5 Statistical analysis
Data were collated using Microsoft® Excel 98 and statistical analysis was 
performed using Stata™ 4.0 (Stata Corporation, Texas, USA) as described in section 
3.2.5.
5.3 Results
5.3.1 Patient baseline characteristics
Ten patients with AVMs were recruited to the study (Table 5.1). Three were 
male, seven female with a median age of 36 years (interquartile range of 22 -  46 
years). Four patients had small AVMs, five medium sized and one, a large AVM. 
There was a median time of 31 days (interquartile range 1 - 6 9  days) between MRI 
and DSA in these patients. Five patients had presented with seizures and five with 
intracranial haemorrhage. Five individuals had undergone previous partial 
embolisation of their AVM, whilst one individual had previously been treated with 
stereotactic radiosurgery.
5.3.2 AVM nidus volumes
5.3.2.1 Intersequence variability
Comparison of the mean nidal volume of all observers for each patient and 
imaging method can be used to assess any systematic differences between sequences 
(Table 5.2). On inspection of this table, it appears that nidal volumes calculated 
from post-contrast TOF sequences are consistently larger than those calculated from 
DSA and both pre-contrast TOF and 3D FSE sequences.
To assess intersequence variability between DSA and MR more closely, the 
average nidal volume calculations of all three observers for DSA and MR sequences 
were compared. The average DSA volume for each patient was compared directly 
with the average volume for each MR sequence (Figure 5.2).
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Table 5.1: Demographic data of all patients undergoing MR volumetric studies
Patient
Number
Gender Age Presentation
Site
AVM
Anatomy Size
Time
interval*
Prior treatment Planned treatment
1 F 22 SAH Left callosal Callosal Small 79 None Embolisation
2 F 21 SAH Right basal ganglia Deep Small 35 None Stereotactic DXT
3 M 18 IVH Left callosal Callosal Small 28 None Embolisation
4 F 47 SAH Left occipital Cortical Large 40 Embolisation Embolisation
5 F 27 Seizures Right parietal Cortical Small 1 Embolisation Embolisation
6 M 36 Seizures Left parietal Cortico-
ventricular
Medium 1 Embolisation Conservative
7 M 43 Seizures Left temporal Cortical Medium 69 Embolisation Embolisation
8 F 46 Seizures Left fronto-parietal Cortico-
ventricular
Medium 365 None Conservative
9 F 36 SAH Left callosal Callosal Medium 1 Stereotactic DXT Embolisation
10 F 62 Seizures
ICH
Left occipital Cortico-
ventricular
Medium 2 None Embolisation
* time interval in days between MR studies and DS A
Table 5.2: Mean nidal volume for all investigations
Sequence
Patient DSA 3DFSE Pre-contrast TOF Post-contrast TOF
1 1.37 0.84 1.28 3.79
2 0.59 0.89 1.02 1.16
3 4.27 3.59 3.10 3.81
4 23.04 20.85 21.17 27.97
5 1.78 1.98 1.59 1.97
6 29.21 49.37 48.19 64.90
7 10.25 7.06 8.83 11.76
8 23.88 16.21 23.08 24.71
9 22.88 16.99 21.84 30.44
10 34.78 26.21 27.27 37.11
Figure 5.2: Graph showing average DSA volumes against volumes by all three
MR sequences, together with the line of identity.
”Eo,
DC2
>.n
0)
E3O
>
75
'E
50
a>ai
£ ♦  3DFSE
§1
< ■ Pre-contrast TOF
▲ Post-contrast TOF
 Line of identity
20 30 40 50 60 700 10
Average nidal volume by DSA (cm3)
126
To assess the data further, the method described by Bland and Altman (Bland 
and Altman, 1986) for assessing agreement between two methods of clinical 
measurement was used. Initially the nidus volume by DSA and each MR sequence 
was averaged and compared with the difference between these two volumes. It can 
be seen that the differences between average nidal volume by DSA and MR 
increases with increasing nidal volumes (Figure 5.3).
Figure 5.3: Graph showing the average nidus volume by DSA and MR against
the difference in nidus volume by the same two techniques
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These differences did not have a Normal distribution (Shapiro-Francia W’ 
test for Normal distribution for differences between DSA and MR sequence were 
p=0.00 for 3D FSE and pre- and post-contrast). For further statistical analysis, the 
original data was transformed using a logarithmic transformation. The log- 
transformed data is displayed in a similar way in Figure 5.4 where, although there 
were still differences across the values, the scatter was more evenly spread with 
increasing average nidal volume by DSA.
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Figure 5.4: Graph showing the average log nidus volume by DSA and MR
against the difference in log nidus volume by the same two techniques
0.5 
0.4 
0.3 
0.2 
0.1 
0
-1 Joo
- 0.1
- 0.2 
- 0 . 3
-0.4 4-
-0.5
-0.50 0.00 .50
♦  3D FSE 
■ Pre-contrast TOF 
▲ Post-contrast TOF
i.tto T i ¥
Average log nidus volume by DSA and MR sequence
)0
Using the log-transformed data, limits of agreement can be calculated:
mean difference ± 2 standard deviation
between which 95% of measurements would be expected to lie. These limits of 
agreement are shown in Table 5.3 and graphically in Figure 5.5.
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Figure 5.5: Limits of agreement for 3D FSE, pre-contrast and post-contrast TOF
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Table 5.3: Limits of agreement for all three MR sequences
Sequence Mean
Difference
Standard
Deviation
Limits of 
agreement
Antilogs of limits of 
agreement
3D FSE 0.09 0.20 0.48 to -0.30 3.03 to 0.50
Pre-contrast TOF 0.00 0.11 0.21 to -0.21 1.62 to 0.62
Post-contrast TOF -0.11 0.14 0.16 to -0.39 1.45 to 0.41
These limits of agreement are based upon log-transformed data and therefore 
need to be related to the original scale of measurement. The antilog of these limits 
is a dimensionless ratio. That is, in 95% of cases, the nidus volume by 3D FSE will 
be between 3.03 and 0.50 times the volume by DSA, the nidus volume by pre­
contrast TOF will be between 1.62 and 0.62 times the volume by DSA and the nidus 
volume by post-contrast TOF will be 1.45 and 0.41 times the volume by DSA.
To compare the results obtained by DSA and each of the three MR 
sequences, the paired t test was used in the case of 3D FSE and the non-parametric 
equivalent of the paired t test, the Wilcoxon matched pairs signed rank sum test, was 
used in the cases of pre- and post-contrast TOF. This was performed on the 
transformed data because there were larger differences seen for larger AVM volumes 
as shown in Figure 5.3. The non-parametric equivalent was used in the cases of pre- 
and post-contrast TOF because the differences in transformed data were not 
Normally distributed (Shapiro-Francia W’ test for Normal distribution of differences 
in transformed data were p = 0.27, p = 0.04 and p = 0.03 for 3D FSE and pre- and 
post-contrast TOF respectively).
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Null hypothesis: Volume d s a  = Volume 30 f s e  
t=  1.46 with 9 degrees of freedom
p = 0.18
Null hypothesis: Volume d s a  = Volume pre-contrast t o p  
Sum of Positive Ranks = 34 
Sum of Negative Ranks = 21 
z statistic = 0.66 
p = 0.51
Null hypothesis: Volume d s a  = Volume post-contrast t o p  
Sum of Positive Ranks = 2 
Sum of Negative Ranks = 53 
z statistic = -2.60
p<0.01
For both 3D FSE and pre-contrast TOF, the null hypothesis cannot be 
rejected suggesting that the volumes calculated from DSA do not differ significantly 
from those calculated from these MR sequences. In the case of the post-contrast 
TOF sequence however, the null hypothesis is rejected suggesting that the volumes 
calculated from post-contrast TOF sequences differ significantly from those 
calculated from DSA. Examination of the raw data suggests that those calculated 
from post-contrast TOF sequences are greater than those calculated from DSA.
5 .3 2 2  Inter observer variability
Comparison of the mean nidal volume of the ten patients for each observer 
across the imaging methods can be used to assess any systematic differences 
between observers (Table 5.4).
131
Table 5.4: Mean volumes for each observer
Observer
Patient 1 2 3
1 3.82 0.50 1.14
2 2.11 0.20 0.43
3 6.09 1.46 3.53
4 28.42 17.57 23.78
5 2.28 1.50 1.72
6 58.85 42.47 42.43
7 9.31 8.71 10.41
8 23.98 19.92 22.02
9 31.21 13.62 24.28
10 34.06 28.46 31.51
On inspection of this table, it appears that, observer 1 generally tended to 
overestimate nidus volumes compared with observers 2 and 3 and that, on occasions 
observer 2 tended to underestimate the nidus volumes when compared with 
observers 1 and 3.
The reproducibility of different observer measurements is relevant to the 
study of method comparison because the variability between two methods of 
measurement potentially limits the amount of agreement which is possible. If one 
method has poor repeatability, the agreement between the two methods is bound to 
be poor also. When the established method is the more variable one, even a new 
method that is perfect will not agree with it. If both methods have poor 
repeatability, the problem is compounded.
Two way analysis of variance (ANOVA) and its non-parametric equivalent, 
Friedman’s two way ANOVA, allow a more accurate assessment of interobserver
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variability or repeatability of volumes calculated from each type of investigation. 
The DSA residuals do not have a Normal distribution and hence Friedman’s two way 
ANOVA was used (Shapiro-Francia W* test for Normal distribution of residuals was
p<0.01).
Null hypothesis: Differences in volume d s a  = 0 
H  statistic = 3.8 
Degrees of freedom = 2
0.2 > p > 0.1
The null hypothesis cannot be rejected suggesting that there is no significant 
interobserver variability in the nidal volumes calculated from DSA.
Shapiro-Francia W’ test for Normal distribution of residuals gave p = 0.28, p 
= 0.90 and p = 0.77 for 3D FSE and pre- and post-contrast TOF respectively. For 
all the MR sequences, two way ANOVA was therefore used to assess interobserver 
variability (Tables 5.5 - 7).
Table 5.5: Results of two way ANOVA for 3D FSE
Source of Variation Degrees of 
freedom
Sums of 
Squares
Mean
squares
F  statistic p value
Patients 9 6316.29 701.81 38.43 <0.01
Radiologists 2 164.53 82.26 4.50 0.03
Residual 18 328.71 18.26
Total 29 6809.52
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Table 5.6: Results of two way ANOVA for pre-contrast 3D TOF
Source of Variation Degrees of 
freedom
Sums of 
Squares
Mean
squares
F  statistic p value
Patients 9 6419.61 713.29 26.15 <0.01
Radiologists 2 257.13 128.57 4.71 0.02
Residual 18 490.92 27.27
Total 29 7167.66
Table 5.7: Results of two way ANOVA for post-contrast 3D TOF
Source of Variation Degrees of Sums of Mean F  statistic p value
freedom Squares squares
Patients 9 11310.19 1256.69 41.90 <0.01
Radiologists 2 571.25 285.63 9.52 <0.01
Residual 18 539.94 30.00
Total 29 12421.38
When comparing the nidal volumes calculated by the three observers from 
3D FSE and pre- and post-contrast TOF sequences using Friedman’s two way 
ANOVA, the null hypothesis was rejected (p = 0.03, 0.02 and < 0.01 for 3D FSE, 
pre and post contrast TOF sequences respectively). This suggested that there was 
significant interobserver variability in the nidal volumes calculated from all three 
MR sequences.
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5.4 Discussion
The basis of AVM grading according to size is currently the measurement of 
the largest diameter of the nidus on 2D projectional DSA images. A simple line 
measurement from a projected image is, however, inadequate to describe a complex 
three-dimensional shape. This can be improved by using three orthogonal 
measurements of the AVM nidus from DSA, from which a volume calculation can 
be derived based on an ellipsoid approximation.
5.4.1 Intersequence variability
Although the results of the Wilcoxon matched pairs test comparing mean 
results obtained from DSA and MR suggest that those obtained from DSA and 3D 
FSE and pre-contrast TOF sequences were not significantly different, there was a 
wide variability and standard deviation as shown by the limits of agreement between 
which 95% of future values calculated would be expected to lie. The nidus volume 
by 3D FSE could be between 3.03 and 0.50 times the volume by DSA, and that by 
pre contrast TOF between 1.62 and 0.62 times the volume by DSA. This variation 
is clearly unacceptable in clinical practice. Post-contrast TOF appears to give 
significantly higher values than DSA (Wilcoxon matched pairs test, p < 0.01) (or the 
other MR methods). Areas of slow and complex flow and small calibre vessels are 
not well visualised on the pre-contrast TOF and do not produce reliable flow voids 
on the 3D FSE sequence. These vessels, and in particular, draining veins are much 
better visualised on the contrast-enhanced 3D TOF, which explains the higher 
volume measurements on this sequence (Figures 5.6a - c). Enhancing draining 
veins can also interfere with a clear delineation of the nidus on the reformatted 
images of the contrast-enhanced 3D TOF and lead to an overestimation of the nidus 
size. Although draining veins frequently overlie the nidus on projectional images of 
DSA, these can be isolated by choosing an earlier time frame, which shows only the 
arterial phase, from which to measure nidal size. In a small number of cases there 
was enhancement of abnormal parenchyma with gadolinium around the nidus which
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was falsely included in the nidus volume measurement, thus contributing to 
overestimation of the nidus size (Figures 5.7a - c).
This study has a small sample size, where there are limited observers, some 
of whom have had limited experience. The three observers had a varying degree of 
experience of neuroradiology and endovascular intervention. One of the observers 
was a consultant neuroradiologist with a major interest in vascular intervention, one 
was a specialist registrar in neuroradiology nearing the end of his training period and 
the third was a fellow just beginning his specialist training in neuroradiology. Much 
of the intersequence variability may be improved by repeating this study with a 
larger sample size and with a larger number of better trained observers.
5.4.2 Interobserver variability
There is significant variation between the volumes measured by the three 
observers on MR, although the two way ANOVA test does not indicate where the 
differences lie. Examination of the raw data suggests observer 1, who was the least 
experienced, generally tended to overestimate nidus volumes compared with 
observers 2 and 3 and that, on occasions observer 2 tended to underestimate the 
nidus volumes when compared with observers 1 and 3 (Figures 5.8a - c). This 
suggests that there is poor repeatability of nidal volumes calculated from MR. In 
contrast there is minimal difference and therefore good repeatability in those values 
obtained from DSA. This was also seen by Al-Shahi et al. (Al-Shahi, 2001) 
recently. This may be due to a difference in experience with MRI between 
observers and to the learning curve in applying the new method of nidus 
measurement. The presumed ‘gold standard’ of DSA has been used as a measure of 
nidal size and volume for many years; the use of MR in this way has not. There are 
often decisions to be made as to whether a draining vein or arterial supply should be 
included in the nidal volume and at what point these vessels do not make up part of 
the nidus (Figures 5.9a and b). In many AVMs, draining veins make up a relatively 
large associated volume and therefore difficulties or differences in opinion in this
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regard will potentially result in a large interobserver variability. This was a 
difficulty that was particularly highlighted by the observers in this study. With 
experience, these decisions are likely to be become more routine and consistent 
amongst observers. In addition, appropriate DSA images can be used to define 
nidal volumes. Nidal views are often visualised best on the earlier frames of a DSA 
run, prior to the veins filling, during the arterial phase. This allows the nidus to be 
more easily appreciated without overlying veins. This temporal resolution is not a 
luxury afforded by MR currently.
Calculation of nidal volume from DSA requires one main decision -  that is, 
which is the largest nidal diameter demonstrated. From this the other two 
orthogonal planes are obvious, although further decisions have to be made about 
where the nidal dimensions are maximal within that plane. Ultimately, six decisions 
are made regarding the size of the AVM nidus, from which a volume is generated. 
When generating volumes from MR, a large number of images have to be viewed, 
each of them requiring a decision on nidal boundaries. This means that they are 
vulnerable to many more subjective decisions and opinions. This may be 
compounded by performing high resolution slices. By reducing the number of 
slices imaged, fewer decisions would have to be made by each observer and the 
interobserver variability might thus be reduced. Eleven slices across the AVM were 
imaged in this study, based on previous volumetric work with MR, in this case 
measuring hippocampal volumes in epilepsy patients (Cook, 1992). Any increase in 
the number of slices does not increase the accuracy of the volume calculated 
(McNulty, 2000).
Again, this study has a small sample size and observers with varying 
experience. By increasing the numbers of patients examined and including only 
neuroradiologists with a dedicated interest and expertise in cerebral AVMs, the 
interobserver variability is likely to improve.
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Figure 5.6: Observer 3 freehand traces demonstrating intersequence variability on
a) T2 FSE, b) pre-contrast and c) post-contrast 3D TOF images
a
Total volume 22.8 ml
b
Total volume 19.0 ml
c
Total volume 33.5 ml
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Figure 5.7: The problem with enhancing gliotic tissue
a T2 FSE
Pre-contrast 3D TOF
Post-contrast 3D TOF
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Figure 5.8: Freehand traces of observers 1 to 3 (a-c) demonstrating interobserver
variability on post-contrast 3D TOF images
*
.
T :  t6,5«r»e.ir> 150.11. id 72,00
’“ 1: K.5021 m *  153.94, *d 57.08
Observer 1
Total volume 44.5 ml
b
Observer 2
Total volume 17.9 ml
c
Observer 3
Total volume 28.9 ml
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Figure 5.9: The difficulty with draining veins
a Observer 1 -  total volume 74.8 ml
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b Observer 2 -  total volume 54.9 ml
Differences in observer opinion about the point at which a draining vein has left the AVM nidus will 
result in significant differences in nidal volumes
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5.5 Conclusion
There is currently no definitive and accurate technique for measuring AVM 
nidus volumes. The ‘standard’ measurement of AVM size by a linear distance on 
DSA images appears inadequate. With biplane DSA it is possible to calculate an 
ellipsoid volume based on orthogonal projections, which offers some improvement 
in accuracy. Although these are used as a standard measurement, the accuracy of 
these dimensions cannot be confirmed. MR images show considerable potential in 
this regard and are likely to be most accurate due to their cross-sectional nature, but 
are not easy to interpret due to the varied appearances of flowing blood on different 
sequences and therefore firm conclusions cannot be drawn about the absolute size of 
AVMs from any of the three MR sequences. This may be further complicated by 
enhancement of abnormal brain tissue with the administration of gadolinium. In 
addition, much of the current inaccuracies of measuring nidal volumes may be 
observer related and could become more consistent with greater experience in the 
new techniques.
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PART 3 
PERFUSION IMAGING
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Chapter 6
PERFUSION IMAGING USING MRI
6.1 Introduction
Cerebral AVMs can affect the haemodynamics of the brain to a variable 
degree and in a variety of ways. The two main mechanisms are arterial ‘steal’ and 
venous hypertension. The relative importance of these mechanisms is subject to 
ongoing debate. Until recently there has been no readily accessible technique for 
quantifying cerebral perfusion. Perfusion imaging with MRI is theoretically suited 
to assess regional haemodynamic disturbances at a microvascular or tissue level. It 
is being increasingly used in acute cerebral ischaemia and to assess perfusion in 
organs such as the liver and kidneys (Kashitani, 1995; Kuo, 1995; Uematsu, 1998; 
Vallee, 2000).
6.1.1 Kety method for measuring cerebral blood flow
According to the Fick principle, the blood flow of any organ can be measured 
by determining the amount of a given substance (Qx) removed from the bloodstream 
by the organ per unit time and dividing that value by the difference between the 
concentration of the substance in arterial blood and the concentration in the venous 
blood from the organ ([Ax] -  [Vx]).
Cerebral Blood Flow = CBF = ----- — -----
[Ax]-[Vx]
With the exception of a few cerebral disorders, rCBF is generally coupled or 
related to metabolism. Tracers are therefore trapped primarily by neurones in 
relationship to local CBF. This observation is the basis for cerebral perfusion
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imaging, most indirect methods using Kety’s application of the Fick principle to 
calculate CBF. The ideal brain perfusion tracer: is able to cross the intact blood 
brain barrier freely; undergoes complete first pass extraction from the blood into the 
brain; has a proportional distribution to CBF; has a long retention within the brain 
without redistribution and metabolism; is widely available for clinical use; and in the 
case of nuclear medicine techniques, gives a low radiation dose to patients.
6.1.2 Clinical methods of measuring cerebral blood flow
6.1.2.1 Xenon CT
Xenon is highly lipid soluble and freely crosses the blood brain barrier. 
Because stable xenon gas is radiodense, its concentration in the brain can be 
determined directly by the CT scanner, and the measurement of venous 
concentration is unnecessary. The concentration of xenon in the brain is related to 
its arterial concentration (which itself is time dependent), the CBF and the duration 
of exposure to xenon (because the equilibration of xenon between blood and brain is 
not instantaneous). These factors determine the total amount of xenon presented to 
the brain. Uptake is also determined by the affinity of the brain for xenon, which is 
measured by the brain-blood partition coefficient, X. This reflects the relative 
solubility of xenon gas in the brain and blood or, more simply, the xenon 
concentration in the brain and blood in equilibrium.
Two baseline scans are obtained at two to eight different levels of the brain 
before xenon inhalation. Six enhanced scans per level are then obtained during a 
4.5 minute xenon inhalation. The pairs of baseline scans are averaged and then 
subtracted from each of the enhancement images. End-tidal xenon concentration is 
measured by a thermoconductivity analyser. The image that results is a CBF map 
which uses a fixed colour scale with associated numeric flow values that can be 
extracted by placing ROIs of any shape or size on this CBF map. When larger
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regions are measured, both grey and white matter are usually included in the ROI, 
and the flow measurement will reflect the average of these two compartments.
The main advantages of stable Xe/CT is that it noninvasively provides rapid 
access to high-resolution, quantitative, local CBF information coupled to CT 
anatomy. Xenon-based CBF methodologies are rapidly repeatable and therefore 
capable of defining brain regions with compromised cerebrovascular reserve by 
examining the CBF response to a vasodilatory challenge. The disadvantages are the 
radiation dose of the CT scan, the pharmacological effects of xenon gas, and the 
limitations of the study. Xenon is a potent anaesthetic agent at high concentrations. 
Patients need to be co-operative as alteration of the patient’s sensorium by xenon gas 
can contribute to movement artefact. Limiting the inhaled concentration of xenon 
can reduce the potential side-effects but still allow adequate signal-to-noise. The 
other concern is the degree of flow activation that occurs with xenon inhalation and 
its effects on the accuracy of the measurements. This is thought to be minimal 
because the significant xenon-induced flow activation is delayed for about 2 
minutes.
6.1.2.2 Cerebral blood flow 133Xenon
Intra-arterial injection of 133Xenon (133Xe), a radioactive isotope, into the 
internal carotid artery with extracranial monitoring of the clearance curve using 
highly collimated scintillation detectors can be used to measure CBF. The clearance 
curves obtained from the washout of 133Xe can be analysed by one of several 
methods of curve analysis to calculate the value of CBF: the stochastic method or 
CBF ‘height over area’ method; the initial slope index; and the two-compartmental 
analysis. The latter gives both grey and white CBF values and provides the values 
of the relative weights for the two tissue compartments.
This method suffers from poor resolution when compared with tomographic 
methods secondary to scatter, tissue overlap and blood flow in extracranial soft 
tissue. Information is therefore limited to the superficial cortex.
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6.1.2.3 Nuclear Medicine
Conventional gamma cameras acquire planar images of the brain, imaging 
the presence of radiopharmaceuticals emitting either single photons (SPECT) or 
positrons (PET). To generate tomographic images, the gamma camera obtains a 
series of images of the brain from a number of different angles as it is rotated about 
the brain. Typically 60 to 120 planar images of the brain are acquired over a 360° 
rotation of the gamma camera.
The primary advantage of SPECT and PET is that of any tomographic 
technique, the ability to view activity in a region of the body without the 
confounding effects of superposition of activity from overlying or adjacent regions. 
The resolution of the final tomographic images depend on a number of factors, the 
primary ones being the intrinsic resolution of the gamma camera and the resolution 
of the gamma camera collimator. In clinical studies, an additional factor, patient 
movement, may often be the limiting factor in determining overall image resolution. 
Conventional gamma cameras have intrinsic resolutions of approximately 2.5 -  4 
mm. The collimator, however, has considerably poorer resolution. A standard 
high-resolution collimator gives a resolution of 8 to 10mm in air at a distance of 
10cm.
133Xe is the original radiotracer flow marker for the measurement of rCBF in 
the brain using SPECT. This agent can be administered by intraarterial, intravenous 
or inhalation routes. It is an inert gas that does not undergo any chemical 
transformation in the brain. It allows the assessment of absolute quantitative data, 
however the spatial resoultion when using 133Xe is less than with other agents. In 
addition, the rapid transit of 133Xe (with the resultant short half-life in the brain) 
requires the use of high-sensitivity detector devices that are capable of acquiring 
rapidly changing image data in short time frames. Newer gamma-emitting 
radiopharmaceuticals used in SPECT to measure CBF include 123I-IMP (I-d, I-N- 
isopropyl-p-iodoamphetamine hydrochloride); 99mTc-HMPAO
(Hexamethylpropyleneamine oxime); and 99mTc-ECD (ethyl cysteinate dimer).
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SPECT relative CBV (rCBV) measurements require a compound that will stay 
within the vascular compartment during acquisition. 99mTc-labelled red blood cells 
are the most readily prepared, although 99mTc-labelled albumin and U1ln or 113In- 
labelled transferrin have also been used.
Data from SPECT are at best semi-quantitative and often expressed as a ratio 
of the abnormal area to similar normal brain. An obvious limitation to the widely 
used left:right ratio is the assumption that one side is normal.
PET utilises positron-emitting isotopes, bound to compounds of biological 
interest. Positron-emitting isotopes depend on a cyclotron for production and their 
half-life is short. Each decaying positron results in the release of two photons in 
diametric opposition; these activate two coincidental detectors. Multiple pairs of 
detectors and computer processing techniques enable quantitative determination of 
local radioactivity (and density of the labelled compound) for each voxel within the 
imaged field.
The most widely employed PET technique is the oxygen-15 steady-state 
technique which uses tracer doses of the 150-labelled gases carbon dioxide, oxygen 
and carbon monoxide to obtain quantitative tomographic maps of CBF, CBV, the 
cerebral metabolic rate of oxygen (CMRO2), the cerebral oxygen extraction fraction 
(OEF) and mean transit time (MTT). Other non steady-state techniques also mostly 
employ 150 , notably as labelled water, to measure CBF. To estimate the cerebral 
glucose utilisation, the most widely used technique employs the D-glucose analogue 
18F-fluoro-2-deoxy-D-glucose (18FDG). However PET has not gained routine 
clinical usage because of its complexity and limited availability.
6.1.3 MR perfusion
There are two methods of assessing brain perfusion using MR, contrast bolus 
tracking (CBT) and arterial spin tagging. In this study, CBT was used as it is more 
widely available clinically and offers the possibility of measuring rCBV and MTT,
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as well as rCBF. CBT was evaluated to see whether it could be used to demonstrate 
the effects of intracranial AVMs on cerebral haemodynamics.
A rapid injection of high-concentration contrast agent is given, and the MRI 
signal observed as the bolus passes through the brain. This method exploits the 
magnetic susceptibility (T2*) effect of the first pass of an intravascular contrast 
medium which causes a loss of signal intensity in the tissues that are perfused. This 
loss of signal intensity is proportional to the amount of contrast medium present in 
the voxel and is therefore proportional to tissue perfusion. Ischaemic or non­
perfused regions remain relatively hyperintense. This has been demonstrated in 
animal models with experimentally induced MCA ischaemia (Moseley, 1990; 
Kucharczyk, 1993). Kucharczyk et al. (Kucharczyk, 1993) found that within 10 sec 
of injection of the contrast bolus there was 45% - 95% dose-dependent signal 
intensity decrease below baseline in normally perfused brain. They also found that 
contrast agent transit times were sufficiently different in occluded and reperfused 
cerebral tissue to allow distinction on perfusion sensitive images (Kucharczyk, 
1993). These changes were seen within minutes of the ischaemic insult and 
correlated well spatially with hyperintense lesions seen on diffusion-weighted 
images, whilst initially T2-weighted images remained normal.
6.1.3.1 Determination o f regional cerebral blood flow
The concentration of the contrast agent (measured by changes in T2 or T2*) 
in a ROI can be expressed as (Figure 6.1) (Calamante, 1999):
t
at) = -§-.CBF.[Ca(0® 91(0]"  CBF. z)dr
H f H r  o
where Si(t) is the residue function (the fraction of contrast agent in ROI at time t 
following an ideal instantaneous bolus injected at r=0); Ca(t) is the arterial input 
function (AIF) (the concentration of contrast entering the ROI at time t)\ 0  indicates
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the convolution operation; p  the density of brain tissue; and Hf a haematocrit factor 
that accounts for the difference in haematocrits between capillaries and large vessels 
since only the plasma is accessible to tracer. The convolution operation accounts 
for the fact that, for a non-ideal bolus, part of the spread in the concentration-time 
curve is due to a finite length of the actual bolus. It is generally believed that 
deconvolution of the above curve provides an accurate measurement of CBF.
Figure 6.1: Tracer kinetics
Artery
C.(t)
Organ
Microvasculature
Ch(t)
Ct(t)
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t
The time dependence o f the tracer concentration entering the brain is described by 
the arterial input, Ca(t). The tracer is then distributed through the microcirculation 
where the tracer concentration in the post arterial blood is given by Cb(t) and the net 
concentration in the whole tissue is given by C,(t).
6.1.3.2 Determination of regional cerebral blood volume
In addition to the measurement of CBF, tracer methods can also be used to 
determine the vascular distribution of the agent. For an intravascular tracer, this 
volume is the tissue blood plasma volume. The rCBV can be determined from the 
bolus tracking study by integrating the tissue concentration-time curve and 
normalising the data to the integrated AIF (Calamante, 1999):
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rC BV  = — t-Si----------
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o
The integral in the numerator reflects the total amount of tracer that passes through 
the voxel, while the denominator gives the total amount of tracer in the blood which 
enters the brain, thus the ratio gives the fraction of blood in the brain or region of 
brain.
6.1.3.3 Determination o f mean transit time
The third physiological parameter, MTT, is the average time required for any 
given particle of tracer to pass through the tissue given an ideal bolus injection. 
MTT of the bolus can then be determined from the ratio of the blood volume and 
blood flow maps as:
C BV  
M T T  =
rCBF
6.2 Methods
6.2.1 Patients
Patients were recruited from those seen by the neurovascular surgery or 
interventional neuroradiology services at The National Hospital for Neurology and 
Neurosurgery between January and October 1999. All patients were known to have 
AVMs and had undergone recent catheter angiography confirming its presence. 
Patients were excluded with the usual contra-indications to MRI scanning.
6.2.2 Imaging
All patients underwent a series of T2* weighted gradient-echo EPI images 
(TR 1200 msec, TE 44 msec, 0.75 NEX, flip angle 90°, matrix size 128 x 128). One
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hundred volumes each of 5 contiguous slices (slice thickness 5mm) were acquired 
over 2 min. At 15 sec into the acquisition, a 15ml hand bolus of O.lmM Gd-DOTA 
(Dotarem®, Guerbet Laboratories, Aulnay-sur-Bois, France) was given over 3 - 5  
sec.
6.2.3 Post processing
Images were transferred to the Sun® Ultra 5 workstation (Sun Microsystems, 
Berkley, USA) running Advantage Windows®, version 3.1, software (General 
Electric Medical Systems, Milwaukee, USA). Using proprietary software 
(Functool®, General Electric Medical Systems, Milwaukee, USA), ROIs were 
placed over an artery (most commonly the MCA or distal branch of the MCA) and 
vein (most commonly the SSS) distant to the AVM. Time-signal intensity curves 
were generated from these ROIs (Figure 6.2). Following determination of baseline 
image numbers, pre- and post- contrast bolus passage, and threshold values, 
Functool® was used to create colour maps of CBF, CBV, MTT and time to 
minimum contrast concentration (TTM) for each of the five slices. Deconvolution 
of the arterial time-intensity curve was used to correct for differences in bolus shape.
One shortcoming of Functool® is the inclusion of zero-level pixels in 
‘uncomputable’ regions of the colour maps which interfere with the quantification of 
haemodynamic parameters in the ROI. To overcome this problem, maps were 
transferred to an independent workstation for further analysis, using Analyze® 
AVW 3.0 (Mayo Foundation, Minnesota, USA), which allows exclusion of zero 
value pixels. ROIs were defined for nidus and perinidus by freehand trace. The 
perinidus region was defined as the area immediately adjacent to the AVM nidus but 
excluding any large draining veins. This region was divided into three ‘onionskin’ 
regions with increasing distance from the nidus using the automated division of 
regions tool of Analyze® AVW 3.0 (Mayo Foundation, Minnesota, USA). A 
corresponding region to the nidal ROI was defined in the contralateral hemisphere as 
the ‘contralateral nidus equivalent region’. Ipsilateral and contralateral white and
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Figure 6.2: A sample arterial time-signal intensity curve
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Figure 6.3: Regions of interest defined for each slice for each patient
37 nidus, 38-40 perinidal onionskin rings, 41 contralateral nidus equivalent,
42 ipsilateral white matter, 43 ipsilateral grey matter, 44  contralateral white matter, 
45 contralateral grey matter
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grey matter regions were defined using the thresholding tool in an area distant to the 
AVM nidus, in most cases in the frontal lobes. These ROIs were generated on all 
five slices using the baseline T2* images and saved as ‘object maps’ (Figure 6.3).
These object maps were superimposed on all four colour maps: CBF, CBV, 
MTT and TTM. Size (in mm ), number of voxels, mean and standard deviation 
voxel values were generated for each region on every slice for all four colour maps. 
Only those voxels with values greater than zero were included.
6.2.4 Statistical analysis
Data were collated using Microsoft® Excel 98 and statistical analysis was 
performed using Stata™ 4.0 (Stata corporation, Texas, USA) as described in section 
3.2.5.
6.3 Results
6.3.1 Patient baseline characteristics
Fifteen patients with AVMs were recruited to the study (Table 6.1). Six 
were male, nine female with a median age of 36 years (interquartile range of 25 -  43 
years). Six patients had originally presented with seizures, six with intracranial 
haemorrhage, two with a progressive neurological deficit and one with headaches 
and a homonymous hemianopia. Five individuals had undergone previous partial 
embolisation of their AVM, whilst one individual had previously been treated with 
stereotactic radiosurgery. The remaining nine individuals had had no previous 
treatment.
6.3.2 Haemodynamic parameters
The values from all five slices for each of the haemodynamic parameters 
were averaged. Only those values with a standard deviation of greater than zero
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Table 6.1: Demographic data of all patients undergoing MR perfusion studies
Patient
Number
Gender Age Presentation
Site
AVM
Anatomy Size
Prior treatment Planned treatment
1 M 49 SAH Right temporo-parietal Cortico-ventricular Large Embolisation Embolisation
2 F 22 SAH Left callosal Callosal Small None Embolisation
3 F 21 SAH Right basal ganglia Deep Small None Stereotactic DXT
4 M 18 IVH Left callosal Callosal Small None Embolisation
5 F 47 SAH Left occipital Cortical Large Embolisation Embolisation
6 F 27 Seizures Right parietal Cortical Small Embolisation Embolisation
7 F 36 SAH Left callosal Callosal Medium Stereotactic DXT Embolisation
8
i
F 62 Seizures
ICH
Left occipital Cortico-ventricular Medium None Embolisation
Table 6.1 (continued) Demographic data of all patients undergoing MR perfusion studies
Patient
Number
Gender Age Presentation
Site
AVM
Anatomy Size
Prior treatment Planned treatment
9 M 36 Seizures Left parietal Cortico-ventricular Medium Embolisation Conservative
10 M 43 Seizures Left temporal Cortical Medium Embolisation Embolisation
11 F 46 Seizures Left fronto-parietal Cortico-ventricular Medium None Conservative
12 M 41 Progressive
hemiparesis
Right fronto-parietal Cortico-ventricular Large None Embolisation
13 F 25 Progressive
hemiparesis
Left thalamic Deep Large None Embolisation
14 M 38 Hemianopia
Headaches
Right
holo-hemispheric
Cortico-ventricular Large None Conservative
15 F 37 Seizures Left fronto-parietal Cortico-ventricular Large None Embolisation
ON
were included. Those values with a standard deviation of zero were assumed to lie 
outside the range that this technique could meaningfully post-process. The results 
for CBF, CBV, MTT and TTM across the nidus, perinidal regions and normal 
parenchyma are shown in Figures 6.4 -  7 respectively.
The scale of the y axis has been adjusted to demonstrate the data as clearly as 
possible, which has meant exclusion of several data points (there is a single data 
point missing in Figure 6.4 for patient 8 as the standard deviation for the average 
nidus CBF was zero). All data are shown in Appendix 4. The ipsilateral white and 
grey matter were compared with the corresponding contralateral regions and the 
white matter and grey matter were compared with each other both ipsilaterally and 
contralaterally. The values for nidus were compared with those from the 
contralateral nidus equivalent ROI. The perinidal onion skin regions were 
compared for within subject differences, to see if there was a trend of values across 
the regions with increasing or decreasing distance from the nidus.
All differences were tested to see if they represented a Normal distribution 
using the Shapiro-Francia W* test for Normal distribution. If the values did not 
represent a Normal distribution, they were log transformed. In those parameters 
where the data, either as raw data or log transformed data, represented a Normal 
distribution, a paired t test was performed to assess the differences between 
parameters. In those which did not represent a Normal distribution, a Wilcoxon 
signed rank test was performed to assess the significance of differences (Table 6.2).
Trend was assessed across the three perinidal ‘onionskin’ rings and 
‘normal’ parenchyma (contralateral nidus equivalent ROI). Initially, the residuals 
were generated. These were not Normally distributed in all parameters (Shapiro- 
Francia W’ test for Normal distribution for CBF was p < 0.02 and for CBV, MTT 
and TTM was p < 0.00). Trend was therefore assessed using the non-parametric 
equivalent of a two way ANOVA, a Friedman’s two way ANOVA (Table 6.2).
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Figure 6.4: Cerebral blood flow in all 15 patients
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Figure 6.5: Cerebral blood volume in all 15 patients
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Figure 6.6: Mean transit time in all 15 patients
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Figure 6.7: Time to minimum signal intensity in all 15 patients
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Table 6.2: Results of haemodynamic parameter comparisons
CBF CBV MTT TTM
Ipsilateral white versus p<0.01 p<0.01 p = 0.78 p = 0.20*
grey matter
Contralateral white versus p <0.01 p<0.01 p = 0.08| p = 0.64
grey matter 
Ipsilateral versus p = 0.91t p = 0.83 p = 0.24 p = 0.57
contralateral white matter 
Ipsilateral versus p = 0.46t p = 0.96 p = 0.31t p = 0.20*
contralateral grey matter 
Nidus versus contralateral p = 0.01 p<0.01* p<0.01 p<0.01
nidus
Trend across perinidus p = 0.06 p < 0.01 p > 0.20 p<0.01
* t test performed on log transformed data
t  Wilcoxon signed rank test
6.3.2.1 White and grey matter
Both ipsilateral and contralateral measurements showed that there was a 
significant difference between CBF and CBV between white and grey matter. 
Examination of the raw data revealed the values for CBF and CBV for grey matter 
were higher than those for white matter. Previous studies have shown this to be the 
case with average white matter CBF of 17 - 49 ml 100ml'1 min'1 and that of grey 
matter 43 - 90 ml 100ml'1 min'1 (Leenders, 1990; Schreiber, 1998; Vonken, 1999). 
CBV values are more difficult to obtain, but those calculated from dynamic 
susceptibility MRI and PET again show significantly higher values for grey matter 
compared with white matter. CBV in white matter is normally 2.1 -  4.7 ml lOOg*1 
and that of grey matter 3.8 -  7.8 ml lOOg'1 (Leenders, 1990; Vonken, 1999).
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However, white and grey matter do not appear to have significantly different MTT 
and TTM values. Values from PET studies suggest there are no significant 
differences in MTT values between grey and white matter with values of 4.6 -  9.2 
sec in white matter and 4.6 -  8.2 sec in grey matter, whilst those of time to arterial 
bolus peak values, similar to TTM, were 1.5 -  4.5 sec and 1.0 -  3.8 sec for white and 
grey matter respectively (Vonken, 1999). Although there was no statistically 
significant difference in TTM between white and grey matter, in 19 out of 30 
measurements TTM was higher in white matter than grey. This suggests that the 
technique was able to demonstrate appropriate differences in CBF, CBV, MTT and 
TTM between areas of normal brain, albeit semi-quantitatively.
When ipsilateral and contralateral values for white and grey matter were 
compared, there were no significant differences.
63.2.2 Nidus versus contralateral nidus equivalent
All haemodynamic parameters showed a significant difference between the 
nidal ROI and the corresponding contralateral region.
6.3.23 Perinidal region
There appeared to be no significant difference across the perinidal regions 
when examining MTT. However there was a significant difference across the four 
ROIs for CBV and TTM. The differences in CBF almost reached significance. 
Examination of the raw data showed that there was a gradual decrease in CBF and 
CBV with increasing distance from the nidus, with a gradual increase in TTM with 
increasing distance from the nidus.
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6.4 Discussion
6.4.1 Limitations of Contrast Bolus Tracking MRI
The maps generated using this technique can be misleading in some 
circumstances, with important clinical implications. Although deconvolution of the 
concentration-time course could in theory provide accurate quantification, there are 
several assumptions in the tracer kinetic model used in the quantification of 
perfusion, and many of these assumptions may be invalid in some situations, 
particularly ischaemia (Calamante, 2002).
One of the main assumptions is about AIF. The calculation of CBF requires 
knowledge of the AIF, which in practice is estimated from a major artery (for 
example, MCA or ICA) with the assumption that this represents the exact input to 
the tissue. Any delays and dispersion of the bolus that are introduced during its 
passage from the site of AIF estimation to the tissue of interest will therefore 
introduce an error in quantification of CBF, and this error could well vary from one 
region to another. In addition to these difficulties, absolute CBF quantification 
requires an absolute measurement of the AIF. The accuracy of this may be
compromised as a result of partial volume effects. These are not uncommon in the 
relatively low spatial resolution images used in CBT.
Secondly, the tissue characteristics can influence the proportionality 
constants involved in the quantification of CBF in two ways. The concentration of 
contrast agent (in both the tissue and AIF) is assumed to be linearly proportional to 
the change in relaxation time T2 or T2*. This proportionality constant has been 
shown to be tissue dependent and is therefore likely to vary with pathology. In 
addition, to obtain absolute CBF, values for the density of tissue, and a uniform 
value for the capillary haematocrit are usually assumed. Although the density of 
tissue may not be expected to vary substantially during the acute stages of ischaemia, 
that is not necessarily true for the haematocrit levels in the tissue.
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Instead of assuming values for the proportionality constants, an alternative 
approach for measuring absolute CBF involve cross calibration with other 
techniques. Thus an empirical scaling to absolute units can be obtained. However 
similar to the problems of fixing values for the proportionality constants, this scaling 
constant should be used with caution because it is likely to vary with pathology.
Quantification of CBV is generally believed to provide a robust measure. 
However, since CBV is proportional to the area under the peak, its measurement can 
be insensitive to bolus delay and dispersion. In addition, any changes in the 
proportionality constants as mentioned before (for example, haematocrit levels) or 
errors in the quantification of the area under the AIF (for example, partial volume 
effects) will also introduce error in the quantification of absolute CBV.
Figure 6.8: Schematic demonstration of haemodynamic parameters from the
signal intensity -  time curve
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With appropriate knowledge of the AIF and careful analysis, it is therefore 
possible to generate high-resolution parametric maps of CBF, CBV and MTT from 
the time course of the MRI signal changes by applying kinetic analysis. However in 
the typical clinical setting, MRI-based maps of tracer kinetics are qualitative in
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nature because arterial input in not well characterised and the relaxivity is unknown. 
Relative measurements in the same subject are thought to be reasonably reliable and 
have therefore been used to analyse the data in this study, with no absolute 
quantification of the units used. Absolute quantification of MTT is less subject to 
model assumptions and therefore more robust.
6.4.2 White and grey matter
Grey matter was shown to have significantly higher CBF and CBV compared 
with white matter using this technique. This is supported by previous studies. The 
AVMs did not, however, appear to have a generalised effect on haemodynamics 
throughout the ipsilateral hemisphere as demonstrated by the lack of difference in 
white and grey matter values for ipsilateral and contralateral sides. This may be due 
to the relatively small series, in which four lesions were small and four were medium 
sized. These may have not been of a sufficient size to cause such effects. In 
addition, some of the AVMs were fed by supplied both anterior and posterior 
circulations and therefore sampling frontal white and grey matter (as was done in the 
majority of cases) may not have been a representative sample of what might be 
regarded as ‘normal’ white and grey matter within the supplying vascular territory.
6.4.3 Nidus
CBV and CBF were increased in the AVM nidus compared with a 
corresponding contralateral region, whilst MTT and TTM were decreased. Previous 
PET and SPECT studies have also shown this to be the case (Takeuchi, 1987; Fink, 
1992; Prohovnik, 1993). This is consistent with an increase in vascular density and 
arteriovenous shunting which are known key features of cerebral AVMs. However, 
the CBT technique is only semi-quantitative and reproducibility studies have not 
been performed.
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6.4.4 Perinidus
The gradual decrease in CBF and CBV and increase in TTM seen with 
increasing distance from the nidus could all be explained by the presence of draining 
veins within the innermost of these ‘onionskin’ rings as they exit the AVM nidus. 
Most radiologists do not regard draining veins as part of the nidus and therefore, 
where possible, they have been excluded from the nidus ROI. In practice, using this 
technique, this is extremely difficult to do and the freehand trace is too crude a tool. 
This effect becomes less apparent with increasing distance from the nidus, with 
CBF, CBV and TTM approaching more normal parenchymal values.
In addition, macroscopic susceptibility effects interfere with the assessment 
of cerebral microcirculation in the immediate vicinity of the AVM as the total 
amount of gadolinium within the nidus is very high. This creates a ‘blooming’ 
effect beyond the limits of the intranidal vessels. If this was wholly responsible for 
the progressive changes in CBF, CBV and TTM values across the perinidal region, 
then MTT should also be affected when it is clearly also decreased in the nidus 
compared with the contralateral nidus equivalent ROI. It may be that there is a less 
obvious increase in true MTT values across the perinidus than the other three 
parameters.
In the case of cerebral AVMs, CBT may have methodological limitations in 
distinguishing and separating out the often conflicting effects of ‘steal’ against 
draining veins and the ‘blooming’ effect beyond the limits of the nidus of high 
concentrations of gadolinium. The ‘blooming’ effect may be reduced by using a 
spin-echo EPI sequence instead of a gradient-echo EPI sequence, as the 
susceptibility effect from large vessels is less pronounced with the former.
Closer examination of both Figures 6.4 -  7 and the colour maps (Figure 6.9), 
suggest that Patient 12, who had a large AVM and presented with a progressive 
hemiparesis, may not follow this pattern. There was some evidence of a low CBF in 
the innermost regions of the perinidus adjacent to the AVM nidus, with an increasing 
trend across the perinidus. This was accompanied by a higher MTT in the
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Figure 6.9:
a
a) Mean transit time colour map for patient 12 with b) corresponding 
EPI image
the areas of increased MTT (corresponding to the yellow, green and red regions on 
the colour map seen anterior and posterior to the central black region within the 
right hemisphere (this black region demonstrates uncomputable pixels 
corresponding to the AVM nidus)) can be seen to extend beyond the nidal region 
seen on the EPI image (area of signal intensity loss)
1 6 8
innermost regions of the perinidus, with a decreasing trend towards normal 
parenchymal values. There appeared to be little change in the CBV and TTM 
values across the perinidus. The data from the innermost perinidal ‘onionskin’ ring 
may have been contaminated by draining veins exiting from the nidus and these 
effects were more obviously seen if the innermost ‘onionskin’ ring was ignored. 
Low CBF and prolongation of MTT in the innermost perinidal regions could be 
related to a decreased arterial feeding pressure or increased venous pressure.
Most studies demonstrate a reduction in pressure within AVM feeding 
vessels, the fall in pressure being proportional to the number and length of feeding 
arteries (Nomes and Grip, 1980; Handa, 1993; Kader and Young, 1996). This may 
in part be related to AVM size since FAP is also inversely proportional to AVM size 
(Nomes and Grip, 1980; Spetzler, 1992). The pressure within draining veins, 
however, is increased compared with normal cerebral veins (Nomes and Grip, 1980; 
Young, 1994). Transnidal pressure drop or net CPP gradient is therefore inversely 
correlated with AVM size, suggesting that relative arterial hypotension or venous 
hypertension may be a compounding factor in large AVMs and may be a cause of 
the demonstrated haemodynamic effects seen in Patient 12 (Young, 1994). Sugita et 
al. (Sugita, 1993) reported on a single case demonstrating improvement in CBF, on 
the basis of SPECT, and clinical symptoms associated with the treatment of a large 
AVM. Venous hypertension was implicated as the cause of this patient’s 
neurological symptoms on the basis of angiographic cortical vein reflux.
6.5 Conclusion
CBT was able to demonstrate appropriate relative differences in 
haemodynamic parameters when compared with previous studies. The evaluation 
of the haemodynamic effects of AVMs was complicated by the draining veins that 
are commonly extremely large and lie in the perinidal region as they exit the AVM 
nidus. This meant that the effects of the AVM on haemodynamic parameters,
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particularly in the innermost region of the perinidus, were over-shadowed by the 
intravascular contrast bolus flowing through the draining veins. In addition, high 
concentrations of intravascular contrast caused a ‘blooming’ effect beyond the limits 
of both the nidus and large feeding or draining vessels, which again contaminated 
the results derived from the perinidal regions. In small or medium-sized AVMs, 
which are unlikely to have a far-reaching effect on cerebral haemodynamics, any 
subtle changes may well be lost.
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Chapter 7
D IG IT A L  S U B T R A C T IO N  A N G IO G R A P H Y
7.1 In tro d u c tio n
The natural history of cerebral AVMs is not fully understood and structural 
analysis of the AVM angioarchitecture alone does not provide sufficient 
haemodynamic information. A small number of studies have examined the 
influence of FAP and DVP and have suggested that raised arterial or venous 
pressures within an AVM may be associated with an increased risk of haemorrhage 
(Kader, 1994; Young, 1994; Duong, 1998). These pressures were measured 
invasively, either by superselective arterial catheterisation requiring sophisticated 
calibration methods or intra-operatively by in situ cannulation which is more 
invasive but allows measurement of venous pressures. Measuring blood flow 
velocities at various points may provide valuable information about the resistance, 
pressure gradients and shunting within an AVM. By correlating these results with 
patients’ presentation and symptoms, this may help to identify features such as high 
flow fistulae and intranidal aneurysms that carry a risk of haemorrhage and help to 
target treatment. Velocities could be correlated with presentation, quantification of 
the haemodynamic effects of partial or complete treatment by embolisation or 
radiosurgery may be possible or disease progression assessed.
Conventional angiographic techniques to measure flow require the 
measurement of the time difference between the passage of a bolus of contrast 
material between two sites, a known distance apart along the vessel. Diagnostic 
intra-arterial angiography is normally performed using a rate of 2 -  4 images sec'1 in 
the arterial phase, or in the case of AVMs at 6 images sec'1. Acquisition of up to 30 
images sec'1 however produces a large number of time-resolved images of the
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contrast medium bolus as it passes through the vasculature. A variety of post­
processing techniques can then be used in order to derive haemodynamic parameters.
Time-density curves can be created for several sites along a blood vessel. 
Blood velocity is then calculated from the plots by determining the transport time for 
the passage of a bolus of contrast between sites (bolus transport time) (Silverman 
and Rosen, 1977; Forbes, 1984). Distinct points on the curve, such as the peak or 
the leading edge, are usually identified. The transport time is taken as the time 
difference between the two identical points on the curve at the two sites under study. 
The blood flow is then calculated as the product of the average cross-sectional area 
of the vessel and the distance between the two sites, divided by the transport time. 
This method has been used to determine MTT, peak density time (time to peak 
opacification) (PDT) and time to half peak opacification (Tl/2) of cerebral 
aneurysms (Tenjin, 1998). Cerebral AVMs have a more complex angioarchitecture 
and are therefore even more challenging.
Alternatively, Swanson et al. (Swanson, 1986) suggested a technique for 
determining the velocity by tracking the position of a fixed length of vessel which 
contains the same mass of contrast material in time sequences of radiographic 
images. The integrated radiographic density of all pixels along a defined length of 
artery is determined on the first angiographic image. The integrated radiographic 
densities of the identical length of vessel in the next frame are then similarly 
calculated. These integrated radiographic densities are then shifted relative to each 
other. For each shift the density in the first frame is subtracted from that in the 
second frame. The shift for which the absolute difference in integrated radiographic 
density was a minimum was then determined. The length between this point and the 
original starting point provides a measurement of the distance moved by the blood 
during a known time period (tracking of bolus mass).
A final method was that proposed by Seifalian et al. (Seifalian, 1989) using 
density-distance curves rather than time-density curves. This technique matches the 
amplitude of the plot of contrast medium concentration (density) versus distance in
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adjacent images in a time sequence of radiographic images (matching of contrast 
concentration profiles). Adjacent concentration-distance profiles in the parametric 
image of iodine concentration versus distance are shifted along a vessel axis until a 
match occurs. A match is defined as the point where the sum of squares of the 
difference between the two profiles is a minimum. The distance of translation per 
time frame is equal to the bolus velocity. This allows the pulsatile velocity 
waveform throughout the complete cardiac cycle to be computed.
The aim of this study was to assess whether bolus transport time could be 
used to evaluate the haemodynamic effects of the AVM on feeding artery velocity 
and flow values.
7 .2  P h a n to m  s tu d ie s
7.2.1 Method
A vascular phantom was designed and built to validate measurements of 
velocity and blood flow using RFRDSA (Figure 7.1). This phantom consisted of a 
length of radiolucent tubing (the packaging sheath of a GDC® - 10 (Boston 
Scientific, Cedex, France)), with two radio-opaque markers (fuse wire) at a distance 
of 10cm from each other, secured alongside a radio-opaque ruler. This was 
connected to a power injector (MedRad® mark V power injector, Wolverson Xray, 
Willenhall, UK) and the whole system primed with water. This power injector 
allowed predetermined values for flow rate to be programmed into the machine, but 
at the end of the run reported the actual flow rate of the injection in ml sec'1 or ml 
min'1. The actual flow rate varied from run to run by up to 2% from the nominal 
required flow rate in accordance with the manufacturer's specifications. An air 
bubble of approximately 0.5ml was introduced through a three-way tap situated 
between the power injector and phantom. The injector was primed and injection of 
water triggered after the ‘mask’ had been acquired at the beginning of the
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Figure 7.1s Unsubtracted DSA image of the vascular phantom
Figure 7.2: Subtracted DSA image of vascular phantom demonstrating air bubble
(black arrow)
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angiographic sequence. Angiography was performed on a biplane Toshiba digital 
fluorography system DFP 2000A® (Toshiba, Tochigi-Ken, Japan), using a frontal 
projection only. The angiographic sequence used consisted of an initial ‘mask’ 
sequence (0.8 sec at 7.5 frame sec'1) followed by the true angiographic acquisition.
The six frames of the ‘mask’ acquisition were automatically averaged and 
were then subtracted from the subsequent images, allowing visualisation of only data 
or objects that had changed between images (i.e. the air bubble) (Figure 7.2).
A series of experiments was performed to assess the accuracy of flow 
measurements calculated by RFRDSA, compared with those reported by the power 
injector. Reproducibility of the system and the effects of varying injection rate, 
frame rate, field of view, table height, source-image distance and patient-source 
distance were assessed (Appendix 5).
DSA produces a 2-D projectional image of a vessel. To allow calculation of 
velocities from these images, an accurate measurement of the distance between two
Figure 7.3: Diagram showing arrangement of phantom as the angle from the
horizontal is increased
Image
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ROIs on the vessel is needed. Unless the vessel concerned lies exactly within the 
plane of the DSA image (which is exceedingly unusual), the distance between two 
points is foreshortened. To assess the effect of the angle of the vessel in relation to 
the plane of the DSA image on calculated velocities, a series of experiments was 
performed using a frontal projection, increasing the angle of the phantom from the 
horizontal (Figure 7.3) (Appendix 5).
7.2.1.1 Post processing
Using the ROI function on angiography system, two ROIs of approximately 
10 x 10 pixels were positioned over the path of the air bubble. A time-density curve 
was produced, transferred to Toshiba 230CX® laptop (Toshiba, Tochigi-Ken, Japan) 
and imported into Microsoft® Excel 5.0/95. From this Excel graph, start and end 
frame numbers for the pre- and post-bolus baselines were identified. The pre-bolus 
baseline was defined as that prior to the first dip (created as the air bubble traversed 
the proximal ROI) and the post-bolus baseline as that after the second dip (created at 
the distal ROI) (Figure 7.4).
Inputting these frame numbers, total number of frames taken in the run and 
diameter of the 'vessel' into a home-written fitting programme, flow was calculated. 
Software was developed in-house to read the time-density curves and automatically 
detect the minimum intensity which represented the passing of the air bubble. 
Having found these peaks, the software then fitted the time-density curves to a 
Gaussian function and used fitting parameters to calculate more accurately the time 
between the two points. This value was then used with the acquisition frame rate 
and the diameter of the tubing (or blood vessel) to calculate velocity and flow rates.
In each series of experiments, measured flow was compared with flow 
reported by the pump injector.
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Figure 7.4: Time density curve from DSA showing two dips as the air bubble
passes the proximal and distal ROIs
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7.2.1.2 Statistical analysis
Graphs, with their corresponding regression lines and equations, were 
produced using Microsoft® Excel 98 and statistical analysis was performed using 
Stata™ 4.0 (Stata corporation, Texas, USA), on an Apple Macintosh® iMac 
computer.
7.2.2 Results
7.2.2.1 Terminology
Throughout this chapter, specific terminology has been used. Flow and 
velocity are represented by f and v respectively. If these values had been calibrated 
or adjusted for the model, this was shown by an apostrophe (')• All subscriptions 
refer to the origin of the values. In the phantom, t was the true reported value from 
the pump injector, m was the measured value (calculated from DSA) and p was the
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predicted value. In the patient experiments, TCD represents the values measured by 
TCD, and DSA those calculated from RFRDSA.
1.22.2 Calibration of the model
Flow rates were measured from 10 separate runs for each of three nominal 
flow rates, 1, 5 and 10 ml sec'1. The model can be calibrated by regressing 
measured flow rate on true reported flow rate (Figure 7.5). True flow rate was 
plotted along the x axis as this was the independent variable.
Figure 7.5: Graph showing the relationship between true reported and measured
flow rates from DSA at 30 frames sec'1 
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The regression equation was: 
fm = 1.04ft - 0.21
Residual standard deviation = 0.50 
R2 = 0.98
V ------------- ----------------------------r
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True flow rates can be predicted from measured flow rates by reversing this 
regression equation. This equation is:
f t  =  (fm  +  0 . 2 1 ) /  1 .0 4
This demonstrated the systematic error within the system. In using 
regression analysis, three statistical assumptions were made. Firstly, the values of 
measured flow rate should have a Normal distribution for each value of the predictor 
variable pump reported flow rate; secondly that the variability of measured flow 
rates should be the same for each value of reported flow rate; and thirdly that the 
relationship between the two variables should be linear. If the three above 
assumptions hold then the residuals should have a Normal distribution which they 
did (Shapiro-Francia W’ test for Normal distribution, p = 0.56).
Residual standard deviation indicates the variation not explained by the 
regression line so it is a measure of the ‘goodness-of-fit* of the line in units of 
measurement i.e. ml sec'1 (Altman, 1991). Similarly the high R2 value shows that 
the majority of variability in measured flow rate is explained by variation in the true 
reported flow rate. R values can be reported as a percentage i.e. 98% of the 
variability in measured flow rate is explained by the variation in the true reported 
flow rate. These results suggested that the model for calculating flow rates from 
pump-reported flow rates was accurate at 30 frames sec'1.
7.2.2.3 Reproducibility o f the model
In order to assess the reproducibility or random error of the calibration 
model, this same series of measurements was used. The measured flow rates (fm ) 
were adjusted for the model using the above regression equation. These values 
were plotted against the true reported values, together with their confidence and 
prediction intervals (Figure 7.6).
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Figure 7.6: Graph showing the 95% confidence and prediction intervals for
reported and measured flow rates at 30 frames sec'1
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The true reported flow rates (ft) and adjusted measured flow rates ( f 'm) were 
compared using the paired t test as the differences between flow rates had a Normal 
distribution using the Shapiro-Francia W’ test for Normal distribution (p = 0.55).
Null hypothesis: ft = Adjusted fm = f 'm 
t = 0.00 with 29 degrees of freedom 
p = 0.99
The null hypothesis could not be rejected, suggesting that the reported flow 
rates and adjusted measured flow rate did not differ significantly. In addition, the 
confidence and prediction intervals were narrow, again suggesting that true reported 
and measured flow rates had good reproducibility.
181
7.2.2.4 Angle from the horizontal
Again, the measured flow rates (fm) were adjusted using the regression 
equation from section 1.2.2.2. This equation is:
ft = (fm + 0.21) / 1.04
This adjusted measured flow rate, f ' m, when plotted against angle from the 
horizontal, showed a cosine drop-off (Figure 7.7).
Figure 7.7: Graph showing effect of angle from the horizontal on adjusted
measured flow rate
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To test this model, adjusted measured flow rate was compared with predicted 
flow rate (fp), where:
fp = ft cos 0
= ft cos (sin'1 (height/23.7))
^  Adjusted 
measured  
flow rate 
 C os curve
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The predicted flow rates (fp) and adjusted measured flow rates (f'm) were 
compared using the Wilcoxon matched pairs signed rank sum test as the differences 
between flow rates did not have a Normal distribution, both before and after 
transformation of the data (Shapiro-Francia W* test for Normal distribution, p = 
0.03).
Null hypothesis: fp = f 'm 
Sum of Positive Ranks =120 
Sum of Negative Ranks = 70 
z statistic = 1.01 
p = 0.31
The null hypothesis could not be rejected, suggesting that the predicted flow 
rate and adjusted measured flow rate do not differ significantly.
7.2.2.5 Frame rate, injection rate, field o f view, table height, source-image distance 
and patient-source distance
Varying frame rate, field of view, table height, source-image distance and 
patient-source distance was found to have no effect on the measured flow rates. 
Injection rates up to 10 ml sec'1 at 15 and 30 frames sec*1 showed linear agreement 
between reported flow rate and measured flow rate.
7.2.2.6 Reproducibility and accuracy o f angiography machine
The angiography system automatically reported the source-image distance, 
table height and C-arm height. The accuracy of the reported figures was tested and 
each found to be within 1 cm of the true measurements. This was of particular 
importance in the calculation of magnification of images and hence distances 
travelled by the air bubble, where:
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Magnification = Source-image distance 
Source-patient distance
= __________ Source-image distance__________
Source-image distance -  Patient-image distance
Allowing for the potential 1 cm error reported by the system of these 
measurements, the error in magnification factor was a maximum of 2.6%.
7.2.3 Conclusion
Using this phantom, it was possible to calculate true flow rates from 
measured flow rates at 30 frames sec'1 accurately and reproducibly using the 
calibration equation of:
ft = (fm + 0.21)/1.04
These values have narrow 95% confidence and predictive intervals as seen in 
Figure 7.6. The measured flow rates show a cosine relationship to reported flow 
rates when the ‘vessel’ of interest does not lie in the horizontal plane as expected. 
The error in reported measurements from the angiography system result in a 
maximum of 2.6% error in magnification ratios.
7.3 Patient studies
Having validated the model, a similar technique was used to examine flow 
and velocity rates in patients with AVMs.
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7.3.1 Methods
7.3.1.1 Patients
Patients with known AVMs were recruited from those due to undergo DSA 
as a planned procedure as part of their management, immediately prior to an 
embolisation procedure, between October 1999 and January 2000. Those who were 
pregnant, had a history of allergy to iodine or were aged less than 16 years were 
excluded.
7.3.1.2 Imaging
Prior to the procedure, patients underwent TCD of the intracranial circulation 
to act as a control measurement of velocity within individual vessels. This was 
performed bilaterally immediately prior to the procedure, when the patient was lying 
supine on the angiogram table and under general anaesthesia. The TCD machine 
used was the Pioneer™ Transcranial Doppler System (Nicolet Biomedical, 
Wisconsin, USA).
TCD uses ultrasound to measure blood velocity within the brain. Advantage 
is taken of the relatively thin temporal bone to image the ICA and MCA and the 
technique relies on knowledge of both the depths of these arteries from the temporal 
bone and the velocity and direction of blood flow in these vessels. Using occipital 
and orbital windows, most intracranial vessels can be imaged by an experienced 
operator. Signals can be obtained in about 95% of individuals.
Angiographic studies were performed on a biplane Toshiba digital 
fluorography system DFP 2000A® (Toshiba, Tochigi-Ken, Japan). Femoral 
puncture and insertion of the femoral sheath and angiographic catheter were 
performed in a routine fashion. The catheters used varied according to the nature of 
the planned procedure and therefore prior to insertion, the dead space of the catheter 
was determined. Measurement of the catheter dead space allowed injection of a 
precise 1ml contrast bolus into the patient. After catheterisation of the proximal
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ICA, a routine angiographic run was acquired. Having confirmed the correct 
positioning of the catheter and an adequate angiographic acquisition, RFRDSA was 
performed from this same position. Using a frontal projection, a similar ‘mask’ was 
acquired (0.8 sec at 7.5 frames sec'1) followed by a run up to 8 sec at 30 frames sec'1, 
but acquisition was stopped as soon as the contrast bolus had passed through the 
arterial side of the circulation. A contrast bolus of Omnipaque® 300 (Nycomed 
Amersham, Little Chalfont, UK) was given as a hand bolus immediately after the 
‘mask’ acquisition. A total volume equal to 1ml plus the dead space of the catheter 
was injected, such that the intravascular contrast bolus given was 1ml. All 
RFRDSA angiographic injections were performed on the side of the AVM.
The procedure was completed in a routine fashion. The mean effective 
radiation dose equivalent of a standard four vessel cerebral angiogram was 0.5 -  
0.7mSv. RFRDSA delivered an additional 0.25mSv. Many of these patients 
underwent repeated DSA and embolisation procedures which further increased the 
radiation dose. In this context the additional radiation dose related to RFRDSA was 
considered acceptable.
7.3.1.3 Post processing
Two ROIs of approximately 10 x 10 pixels were this time placed on both the 
ICA and MCA (Figure 7.8). The average diameter of the ICA and MCA and the 
distance between the two ROIs on each vessel were measured. Time-density curves 
were produced, transferred to the Toshiba 230CX® laptop (Toshiba, Tochigi-Ken, 
Japan) and imported into Microsoft® Excel 5.0/95. Software was developed in- 
house to read the time-density curves and automatically detect the maximum 
intensity, representing the leading edge of the contrast bolus. Having found these 
peaks, the software then fitted the time-density curves to a gamma variate function 
and used fitting parameters to calculate more accurately the time between the two 
points. This value was then used with the acquisition frame rate and the diameter of
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Figure 7.8: Magnified example of a DSA image with placement of ROIs for
generation of time-density curve
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the blood vessel to calculate speed and flow rates. Curves were fitted using a 
gamma variate function, which better described an in-vitro bolus than a Gaussian 
function. Velocities and flow rates were calculated as before.
73.1.4 Statistical analysis
Statistical analysis was performed as described in section 7.2.1.2.
7.3.2 Results
7.3.2.1 Patient baseline characteristics
Five patients, three male and two female, underwent RFRDSA (Table 7.1). 
They had a median age of 44 years with an interquartile range of 31 - 46 years. All 
patients underwent RFRDSA as part of a planned embolisation procedure and were 
therefore under general anaesthesia at the time.
Three patients had initially presented with haemorrhage, one with seizures 
and the final patient with a cosmetic deformity with associated visual deterioration. 
Two patients had undergone previous partial embolisations.
7.3.2.2Transcranial Doppler findings
All patients underwent successful TCD measurement of bilateral MCA and 
ICA velocities. Mean, systolic and diastolic velocities are shown in Table 7.2. The 
values shown are the mean values taken from three TCD measurements taken 
immediately before the angiographic procedure, whilst under general anaesthesia, 
with their 95% confidence intervals (CIs).
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Table 7.1: Demographic data of patients undergoing RFRDSA
Patient
Number
Gender Age Presentation
Site
AVM
Anatomy Size
Prior treatment Planned treatment
1 M 44 Seizures Left temporal Cortical Medium Embolisation Embolisation
2 F 45 Cosmetic
Visual deterioration
Right orbital Orbital Medium None Embolisation
3 M 20 ICH Right parietal Cortical Large None Embolisation
4 M 19 ICH
iv h
Right parietal Cortical Small None Embolisation
5 F 48 SAH Left occipital Cortical Large Embolisation Embolisation
oo
VO
Table 7.2: Velocities determined by transcranial doppler of all five patients
undergoing RFRDSA
Patient Laterality Velocity RMCA RICA LMCA LICA
no. of AVM (cm sec'1) (95% Cl) (95% Cl) (95% Cl) (95% Cl)
1 Left Mean 79 55 73 64
(63-96) (40-70) (67-79) (52-75)
Systolic 118 80 104 91
(98-138) (61-99) (99-110) (76-106)
Diastolic 55 39 54 47
(43-66) (28-50) (49-59) (39-55)
2 Right Mean 56 46 62 37
(50-63) (21-71) (52-71) (30-44)
Systolic 82 68 93 56
(75-89) (34-103) (83 -103) (46-67)
Diastolic 39 31 41 24
(35-44) (13-49) (34-48) (18-30)
3 Right Mean 125 114 84 66
(118-131) (107-120) (80-88) (59-72)
Systolic 157 160 115 84
(145 -169) (153- 166) (109-121) (77-90)
Diastolic 96 89 65 48
(86-106) (82-95) (60-69) (41-54)
4 Right Mean 60 45 50 43
(53-68) (38-53) (46-54) (41-45)
Systolic 93 78 84 70
(75-111) (60-95) (78-92) (64 -  76)
Diastolic 41 34 40 30
(36-46) (29-39) (38-42) (25-35)
5 Left Mean 50 44 69 62
(38-49) (38-49) (64-75) (47-77)
Systolic 74 64 97 89
(71-78) (58-70) (90-103) (72-106)
Diastolic 34 30 51 47
(31-37) (26-35) (47-56) (33-61)
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73.2.3 Time-density curves and calculated velocities
Time-density curves were created for the ICA and MCA on the side of 
injection for each patient as shown in Figure 7.9.
Figure 7.9 : Time-density curve of the right ICA injection of patient 2
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In two of the five patients, time-density curves showed a poor bolus injection 
with a double peak as shown in Figure 7.10. In these situations, velocities were not 
calculated by fitting to a gamma curve, but were calculated from the raw data. The 
relevant peaks were identified visually and the number of frames taken for the bolus 
to travel between the two ROIs calculated. This number of frames was divided by 
the frame rate (i.e. 30) giving the time in seconds for the bolus taken to travel the 
distance between the two ROIs. The distance between the two ROIs was then
divided by this figure giving velocity. Flows were calculated similarly, using the
diameter of the relevant vessel to calculate the cross-sectional area.
Calculated velocities and flows are shown in Table 7.3.
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Figure 7.10 : Time-density curve of left MCA injection of patient 5 showing a poor 
bolus injection
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Table 7 .3 : MCA and ICA velocities and flows in all patients calculated from
RFRDSA
Patient Laterality MCA velocity MCA flow ICA velocity ICA flow
no. of AVM (cm sec *) (ml sec1) (cm sec'1) (ml sec'1)
1 Left 30 1.5 22 3
2 Right 31 1 30 3
3 Right 52* 5* 39* 10*
4 Right 18 0.5 22 3
5 Left 28* 2* 23* 2.5*
♦calculated using raw data and without gamma fitting
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7.3.2.4 Comparison ofTranscranial Doppler measurements and measured velocities 
from time-density curves
MCA and ICA velocities calculated from RFRDSA ( v d s a )  were adjusted for 
the model using the regression equation from section 1.2.2.2 (v ' d s a ) .  These values 
were then compared with the mean MCA and ICA velocities measured by TCD 
( v t c d )  as seen in Figure 7.11. Their accompanying regression lines are also shown.
Figure 7.11: Graph showing comparison of MCA and ICA velocities measured by 
TCD with those calculated from RFRDSA and their accompanying 
regression lines
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RFRDSA
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The regression line for MCA velocities has the equation of:
140
v ^ sa = 0.39 vtcd +1.00 
Residual standard deviation = 5.79 
R2 = 0.83
Shapiro-Francia W’ test for Normal distribution of residuals, p = 0.42
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The ICA regression line has the equation of:
v ' d s a  = 0.20 Vt c d  + 13.39 
Residual standard deviation = 5 .1 8  
R2 = 0.60
Shapiro-Francia W’ test for Normal distribution of residuals, p = 0.74
Comparison of the adjusted MCA velocities calculated from RFRDSA 
( v ' d s a )  and those measured on TCD ( v t c d )  using paired t test showed the 
measurements to be significantly different.
Null hypothesis: v ' d s a  =  v t c d  
t = 5.76 with 4 degrees of freedom
p<0.01
Shapiro-Francia W* test for Normal distribution, p = 0.13
Comparison of the adjusted ICA velocities calculated from RFRDSA (v ' d s a )  
and those measured on TCD ( v t c d )  using paired t test also showed the measurements 
to be significantly different.
Null hypothesis: v ' Ds a  =  vtcd 
t = 3.86 with 4 degrees of freedom
p = 0.02
Shapiro-Francia W’ test for Normal distribution, p = 0.42
7.3.3 Discussion
Generally accepted values for MCA and ICA velocities are 55 ± 12 and 39 ± 
9 cm sec1 respectively, whilst the average CBF in young adults is 54 ml lOOg1 
min'1. The average adult brain weighs about 1400g, which means that the total
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cerebral flow is about 756 ml min'1. These values vary with age, generally reducing 
with increasing years. AVMs are often high flow lesions, resulting in considerably 
higher velocities and flows in feeding vessels than normal. Arteries supplying an 
AVM can have a flow ranging from 3 to 550 ml min"1 with an average of 180 ml 
min"1. Total AVM flow ranges from 50 to 900 ml min"1 with an average of 490 ml 
min"1 (Nomes and Grip, 1980). Velocity appears to be related to size of vessel, 
reaching 70cm sec"1 (Nomes and Grip, 1980).
Although the measured velocities and adjusted measured velocities from 
RFRDSA grossly underestimated the true velocity shown on TCD, it consistently 
demonstrated a lower velocity but higher flow in the ICA when compared to the 
MCA. This suggests that there was a systematic error in the RFRDSA 
measurements. This was confirmed by the relatively high R2 values for both 
regression lines comparing MCA and ICA velocities measured using TCD with 
those calculated from RFRDSA (0.82 and 0.60 respectively). However, both 
regression lines did have relatively high residual standard deviations (cm sec"1), 
suggesting that the ‘goodness-of-fit’ of the line could be improved.
7.3.3.1 Sources o f error
Blood velocity within vessels varies depending upon the precise point of the 
cardiac cycle at which measurements are taken. This is seen on TCD, with values 
varying dramatically between diastolic and systolic values (Table 7.2). TCD values 
usually quoted in the literature are systolic values and therefore the highest velocities 
seen within a single cardiac cycle. The RFRDSA values determined may represent 
velocities at any point during the cardiac cycle, including the lowest velocities seen 
at diastole. The ability to calculate instantaneous blood velocity and therefore flow 
measurements at any point in the cardiac cycle, as in the matching of contrast 
concentration profiles technique proposed by Seifalian et al. (Seifalian, 1989), may 
improve accuracy. Mean flow rates can also be determined using the same 
technique (Hoffman, 1991). Systolic, mean and diastolic values could then be
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compared in a much more meaningful way to those obtained from TCD. However 
the RFRDSA values obtained were generally lower than even diastolic TCD 
velocities, so other errors must have been present.
During phantom validation, the air bubble flows and velocities were 
measured through a straight, in-plane ‘vessel’ over a length in the order of 10 cm. 
The distances travelled by the contrast bolus in most patients were very much 
shorter, in the order of 2 -  6 cm. The irregular winding course of the vessel must be 
measured accurately and in it’s entirety to obtain the true distance travelled by the 
contrast medium. This was seldom achieved by a single straight line but was 
closely approximated by summing multiple, short segments that paralleled the axis 
of the curving vessel. In order to calculate the flow rates from velocity figures, an 
accurate measurement of the vessel diameter is required. This is subject to 
considerable greater error because of the smaller size relative to the number of 
pixels. In addition, these vessels were often not completely in-plane, making the 
measured distances travelled by the contrast bolus increasingly inaccurate. As 
shown using the phantom at increasing angles from the horizontal, flow rates 
measured showed a cosine drop-off from the true flow rate values so non-parallel 
vessels will show reduced velocities. Biplanar imaging could improve the accuracy 
in measuring the distance travelled by the contrast bolus by allowing a three- 
dimensional image of the course travelled by the vessel concerned. This would in 
turn improve the accuracy of calculated RFRDSA velocities. This was not possible 
due to hardware and software limitations in the system used. A single injection and 
a single projection only were used in an effort to minimise radiation dose to the 
patient and because time-density curves could be created from only a single plane on 
the angiogram machine used. The frontal projection was chosen because the MCA 
has as near in-plane course as possible on this view. Hawkes et al. (Hawkes, 1994) 
describe a technique that allows the measurement of the three-dimensional path 
length of vascular segments with a minimal error of between 1.3 -  1.6%. This uses 
a rapid frame rate of 25 frames sec'1 in one plane but a standard frame rate of only 2
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frames sec'1 in an orthogonal plane. The use of this technique would limit the 
radiation dose to patients to an acceptable level but would allow a more accurate 
measurement of the distance travelled by the contrast bolus.
There is a trade-off between maximum measurable blood velocity, vessel 
path length and frame rate. To be able to measure velocity using RFRDSA, the 
contrast bolus must be visible on the imaging screen on two consecutive frames. At 
30 frames sec-1 using a magnification factor of 1, the maximum measurable velocity 
is therefore equal to the image diameter divided by the frame period. With an image 
diameter of 25cm, this gives a maximum measurable velocity of 750 cm sec'1. In 
the phantom experiments, using a ‘vessel’ of 2.75mm diameter, this velocity equates 
to a maximum measurable flow of 44 ml sec'1. To avoid pincushion effects, the 
distance measured should be limited to the middle third of the image, giving a 
maximum flow of 15 ml sec'1 or velocity of 250 cm sec'1. Accurate measurement of 
velocities of this magnitude would appear to be adequate for most AVMs. In the 
AVMs studied, the maximum velocity measured by TCD was 160 cm sec'1 (Patient 
3, R ICA).
Seifalian et al. (Seifalian, 1989) compared true mean and measured mean 
velocities calculated from bolus mass tracking and matching contrast concentration 
profiles methods. The first method showed fair agreement between the true and 
measured mean values at low velocities up to 15 cm sec'1 but it underestimated 
higher velocities (up to 35 cm sec'1). This was felt to be due to the fact that a finite 
maximal length of blood vessel is visible within an image at any one particular 
magnification. This limits the maximum velocity, or distance travelled by the bolus, 
which can be measured at a specific frame rate. They suggested that if the window 
were reduced in size to detect higher velocities, then the statistical error in the 
calculated velocities would increase significantly. The second method did not show 
this same underestimate of measured velocity when compared with true velocity at 
higher values. They were able to measure instantaneous velocities of 1 m sec'1 
using only an 80 mm length of vessel at 25 frames sec'1 (Hawkes, 1994). Using this
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method of analysis, a frame-to-frame overlap of only approximately 50% is needed 
to provide adequate data to match distance concentration functions. At extremely 
high velocities however, similar limitations to this technique are seen. Despite 
using the contrast concentration profile method, Seifalian et al. (Seifalian, 1991) 
demonstrated a systematic fall in the measured velocities as the length of ‘vessel’ 
analysed was reduced. When peak flow along a vessel was greater than about half 
of the length of the vessel segment analysed per frame interval, then the tracking 
algorithm failed. Even at velocities of only 30 cm sec'1, the accuracy of the 
measured values decreased as the length of ‘vessel’ analysed was reduced from 200 
to 20mm. The RFRDSA used in this study showed similar limitations which were 
compounded in the clinical situation by considerably shorter lengths of vessels. In 
the best situation of ICA measurements in patient 4 with a vessel length of 75mm 
and an average diameter of 4mm, the maximum measurable velocity were 250 cm 
sec'1 and 31 ml sec'1 respectively. Whilst in the worst situation of MCA 
measurements in patient 4 with a vessel length of 12mm and an average diameter of 
1.7mm, the maximum measurable velocity and flow were 36 cm sec'1 and 1 ml sec*1 
respectively. These values are clearly not adequate to evaluate accurately the 
majority of patients in this study.
In addition to these limitations, there are further inaccuracies due to the 
smearing effect of a finite pulse width of Xray acquisitions. This means that the 
leading edge of the contrast bolus with respect to time and distance travelled is 
difficult to define accurately. This effect increases with higher velocities.
7.3.4 Conclusion
RFRDSA, using the described methods, is currently not able to provide 
accurate absolute flow and velocity values for intracranial vessels. It is likely as a 
result of the above difficulties that the inaccuracies in measuring velocity in this 
manner with RFRDSA will increase to a maximum measurable velocity. There are 
several errors which cause reduction in the measured velocity compared with the
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true velocity. Although the results obtained were extremely inaccurate, they were 
consistent with what is known about the errors involved. Analysis of similar data 
using the matching of contrast concentration profiles as advocated by Seifalian et a l 
(Seifalian, 1989) and Hoffman et al. (Hoffman, 1991) may yield increasingly 
accurate velocity and flow rates. However, it is unlikely that, at 30 frames sec'1, this 
will improve significantly as the frame rate resolution appears to be one of the main 
limiting factors, particularly at high flows and velocities over the short distances and 
with the narrow vessels involved in the cerebral vasculature. With further work, 
determination of relative values comparing different vessels may be of use within 
individual patients and may allow targeting of specific high flow feeders in 
individuals being treated by endovascular methods.
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P A R T  5 
C O N C L U S IO N S
Chapter 8
C O N C L U S IO N S  A N D  F U T U R E  S T U D IE S  
8.1 S t ru c tu ra l  Im a g in g
8.1.1 CT and MR angiography
CTA has enormous potential value in the investigation of AVMs, since it is 
non-invasive and quick to acquire. CTA can be useful in a first level diagnosis, 
excluding or confirming the presence of an AVM in a suggestive clinical context. 
When compared with MRA, CTA has advantages in that calcium is easily visualised, 
bony relationships can be appreciated, there are no flow-related artifacts and it is fast 
and less costly. However, its disadvantages include the post processing time, the 
limited volume that can be acquired (important for large AVMs) and that arterial and 
venous phases are seen together.
At a higher diagnostic level, involving the pre-therapeutic decision-making 
process, CTA cannot yet replace conventional angiography, but could be used in 
conjunction with conventional MR and CT images to obtain a 3D volume-rendered 
display of both the malformation and surrounding normal brain. It could therefore 
be particularly useful in planning surgical approaches as bone and vessels can be 
segmented out separately but viewed together. Precise 3D localisation would be 
helpful for both pre-surgical and pre-radiosurgical evaluation.
3D information about the nidus of AVMs and surrounding structures could 
have a potentially significant impact on evaluation of the effects of treatment. 
Based on true volumetric data allowing 3D reconstructions, CTA may have a future 
role in providing more accurate volume calculations to assess the effects of treatment 
or as a non-invasive alternative for planning of radiosurgery. For treatment with
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radiotherapy, the site of interest must be precisely localised by means of cerebral 
angiography and meticulous attention given to location and shape of nidus. 
Definition of the AVM nidus on CTA may decrease the volume of irradiation. In 
addition, embolisation material is hyperdense on CTA and it may therefore be 
possible to quantify the volume of AVM treated by endovascular means. As an 
outpatient procedure it is ideal for monitoring the response of the lesion to surgery or 
radiotherapy, involving a small radiation dose (less than 1 mSv) compared with DSA 
(3-4 mSv for a typical four vessel cerebral angiogram). Ultimately CTA may be 
able to take the place of conventional follow-up angiography with its associated 
benefits, although further evaluation of CTA in these clinical situations is required 
(Aoki, 1998).
MR techniques are also non-invasive, have a good safety profile and have the 
advantage over CT of not involving ionising radiation.
The use of 3D TOF in the evaluation of AVMs is well established, because it 
has excellent spatial resolution, a high sensitivity and specificity, efficient scan time 
yielding a favourable signal-to-noise ratio, reduced complex flow signal loss and 
clearly visible Tl-weighted anatomy. It is often performed at the same time as 
MRI, necessary because it provides useful information regarding the location and 
topography of the AVM, presence or absence of haemorrhage and associated 
parenchymal changes such as oedema, ischaemia, gliosis, atrophy or mass effect. 
This information is essential for planning the angiographic work-up and correlative 
analysis of the angiographic information. The use of gadolinium-based contrast 
agents is being increasingly used to improve signal-to-noise ratio and to limit the 
effects that slow or turbulent flow have on the visualisation of AVMs, as 
demonstrated in this study (Runge, 1993).
The primary limitation of 3D CEMRA is the k space acquisition speed and 
thus the achievable image resolution during the time limited first pass of contrast 
media. In this study, temporal resolution was not sufficient to allow a 3D 
representation of separate arterial and venous phases of AVM flow, but the use of
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gadolinium meant that AVM angio-architecture was better visualised than on pre­
contrast 3D TOF images.
DSA is currently assumed to be the ‘gold standard* investigation in AVM 
patients. However, there may be considerable interobserver variability in the 
assessment of DSAs which was not addressed in these studies and should be 
investigated. These study designs could be improved further by having a second 
radiologist review the DSA films and a second consensus opinion reached.
Both studies considered a relatively small group of patients which were 
highly selected. In particular, many of the patients investigated had been or were 
due to be treated by endovascular methods. This meant that the kappa statistic had 
its limitations and did not always accurately reflect the degree of agreement between 
images. This could be improved by studying a larger group of patients who are due 
to be treated in a variety of ways.
One of the particular problems encountered in both the CTA and MRA 
studies was the lack of temporal resolution afforded by these imaging techniques. 
CTA currently has heat loading limitations (Brant-Zawadzki and Heiserman, 1997). 
As a result protocols presently in use for CTA require data acquisition times in the 
order of 30-60 sec to provide adequate z-axis coverage. This leads to the inclusion 
of both arterial and venous structures in the data, which can be problematic in 
accurate interpretation of these studies. However the advent of multi-slice CT will 
allow faster CT scans and better temporal resolution when several volumes may be 
acquired during a single contrast injection, the volume acquisitions being timed to 
coincide with arterial or venous phases as in conventional angiography (Rubin, 
1999). Further improvements in MR hardware and software will certainly improve 
the quality of dynamic MRA studies using intravenous contrast injections and will 
allow the study of large AVMs. There will however always be a trade off between 
area coverage, spatial resolution and temporal resolution. It remains to be seen 
whether 2D techniques with a high temporal resolution approaching that of DSA or
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3D techniques just able to resolve arterial and venous phases will be the future of 
MRA use in AVMs. All of these methods will require careful scrutiny.
8.1.2 MR nidal volumes
MRI appears to allow an improvement on the quantification of AVM nidal 
volume over the currently acceptable methods of the largest orthogonal measurement 
or an ellipsoid approximation from DSA. It would be expected that MR images are 
likely to be more accurate than these alternative methods due to their cross-sectional 
nature. Of the three MR sequences analysed, it was the pre-contrast TOF images 
that agreed most closely with those volumes calculated from DSA. However, the 
use of MR in this way may be limited by the large discrepancy in the volumes 
generated from MR and DSA.
In addition, there was a large interobserver variability in volumes generated 
from the MR sequences, but not from DSA. Further experience needs to be gained 
by observers in calculating AVM nidal volumes from MRI. It can be expected that 
with experience the variation in nidal volumes calculated by different observers 
would become more consistent decreasing the interobserver variability. The use of 
only experienced observers in generating AVM nidal volumes from MR may prevent 
this from being a major limitation and may improve interobserver variability 
significantly. At this stage, with few radiosurgical follow-up studies based on MR 
localisation, the need to include certain vascular aspects, such as draining veins or 
feeding arteries, in the irradiated field is unknown.
Although AVM nidal volumes generated from DSA are regarded as the ‘gold 
standard’, it is difficult to know how precise these volumes actually are. Further 
phantom work using DSA and MR may allow a more accurate assessment of the 
limitations of both DSA and MR as techniques to quantify volumes. This may also 
allow the optimum MR sequence for assessing AVM nidal volume to be determined. 
With the advent of 3D DSA, accuracy may be improved still further, although a high
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temporal resolution, which is one of the advantages of 2D DSA, is lost with 3D DSA 
and this may represent a limiting factor.
8 .2  P e rfu s io n  im ag in g
The use of CBT to evaluate the haemodynamic effects of AVMs shows 
potential. Further work is required to evaluate the technique fully, but this study 
showed useful preliminary findings. It appears able to demonstrate relative 
differences in the haemodynamic parameters, CBF, CBV, MTT and TTM. In 
particular, it was able to demonstrate appropriate differences in distant grey and 
white matter as well as those effects seen within the nidus itself. The ‘blooming’ 
effect caused by the high CBV in the nidus is a major drawback in the current study, 
and future work using smaller doses of gadolinium may reduce these effects. 
AVMs have specific problems with their associated large draining veins, which may 
mask haemodynamic effects in the innermost perinidal regions. The post­
processing techniques require further work in order to eliminate some of these 
effects.
Gradient-echo EPI was used in this study as the signal-to-noise ratio is better 
and imaging is faster, however spin-echo EPI could have been used as an alternative. 
The ‘blooming’ effect may be reduced by using a spin-echo EPI sequence instead of 
a gradient-echo EPI sequence, as the susceptibility effect from large vessels is less 
pronounced with the former. Spin-echo EPI tends to remove the effects of larger 
vessels and may therefore be more effective at looking at the effect AVMs have 
haemodynamically at capillary level.
The results of this study do not show any immutable evidence for ‘steal’, 
diaschisis or venous hypertension, but in selected individuals there is a suggestion 
that CBT may be useful in confirming or refuting these diagnoses. Further 
examination with CBT of a selected group of patients with progressive neurological 
symptoms may allow firmer conclusions to be drawn. A combined study using
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CBT and PET studies of CBF, CBV and regional cerebral metabolic rates in these 
patients may also improve our understanding of the haemodynamic effects of 
AVMs.
Currently CBT has the major disadvantage of being only semi-quantitative 
and is a relatively crude tool when used to examine the haemodynamic effects of 
cerebral AVMs. The reproducibility of the technique needs to be evaluated further 
with repeated examinations within one individual. If the technique were 
reproducible, comparison of repeated examinations in one individual would allow an 
assessment of the effects of intervention, such as endovascular embolisation, on 
cerebral haemodynamics. With further refinement of quantification, it would be 
valuable to assess how different nidal features, such as the presence of direct 
intranidal fistulae, influence these haemodynamic parameters.
8 .3  H a e m o d y n a m ic  im ag in g
Further geometric studies are needed to investigate the effect on velocity and 
flow of 2D imaging of oblique vessels not lying in plane. It is possible, with slight 
modifications to the hardware, to have synchronous ECG monitoring which is 
projected on to the RFRDSA images. This would allow some idea of the point in the 
cardiac cycle at which the bolus passes through the intracranial vessels, allowing a 
more meaningful correlation with velocities determined by TCD.
The ability to use higher frame rates would also increase accuracy although 
this is at the expense of increasing radiation dose to patients. The hardware 
described in these experiments is unable to image at higher frame rates and this 
would therefore not possible with the current set-up. In addition the reduction in 
signal-to-noise ratio at the high frame rates may introduce other errors.
The low resistance of the AVM nidus clearly results in increased velocity 
within the feeding vessels as demonstrated by TCD. These values however cannot 
be replicated with RFRDSA using the described methods. Many of the sources of
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error are inherent in the technique. Even with a concerted effort at reducing the 
many inaccuracies present, it is unlikely that this method will ever provide accurate 
absolute flow and velocity values for intracranial vessels in the clinical setting of 
AVMs. It seems that a completely different approach to measuring velocity is 
required.
8 .4  C o n c lu s io n
Much work remains to be done, but currently the temporal resolution 
afforded by these newer structural and haemodynamic imaging techniques is not 
adequate for accurate evaluation of high flow lesions such as AVMs. Improvements 
in hardware such as stronger gradients in MRI and multi-slice CT scanners may 
allow further progress to be made.
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APPENDIX 1
A l.l Statement of originality
This work was carried out between February 1998 and January 2000, during 
an appointment as a Clinical Research Fellow at The National Hospital for 
Neurology and Neurosurgery, London, under the supervision of Dr H. Rolf Jager 
(Reader in Neuroradiology and Consultant Neuroradiologist, Lysholm Radiological 
Department) and Mr Neil Kitchen (Consultant Neurosurgeon, Department of 
Surgical Neurology). All the work described is original and was conducted by 
myself, except where specifically stated below. No parts of this dissertation have 
been submitted for a degree or diploma at any other university.
A1.2 Collaboration and assistance
Chapter 3 -  CT angiography
The CT Angiograms were analysed by Drs Mike Bynevelt and H. Rolf Jager. 
The DSAs were analysed by Dr Wendy Taylor.
Chapter 4 -  MR angiography
The MR Angiograms were analysed by Drs H. Rolf Jager and Phil Rich. 
The DSAs were analysed by Dr Wendy Taylor.
Chapter 5 -  Volumetric analysis of AVM nidus using MRI
The boundaries of the AVM nidus were defined by Drs H. Rolf Jager, Panos 
Nikolopoulos and Adam Waldman. The nidal volumes from MR were calculated 
by Liz Moore.
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Chapter 7 -  Digital Subtraction Angiography
The home-written fitting programme was written by Liz Moore.
A 1.3 Ethical considerations
The protocols for the studies described in Chapters 3, 4, 5, 6 and 7 were 
approved by the National Hospital for Neurology and Neurosurgery Research Ethics 
Committee. The studies were performed with the understanding and written consent 
of each patient.
A 1.4 Publication
Part of the material in Chapters 3 and 4 has been published in the following 
articles:
Editorial: Advances in non invasive imaging of intracranial vascular disease. 
H.RJager and J.P.Grieve.
Annals o f the Royal College o f Surgeons o f England 2000; 82(1): 1-5.
Robust processing of intracranial CT Angiograms for 3D volume rendering. 
E.A.Moore, J.P.Grieve and H.RJager.
European Radiology 2001; 11:137-141.
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APPENDIX 2
Data for Chapter 3 -  CT Angiography 
Interobserver variability for SSD
Nidus size______________________ Nidus definition
Radiologist A
Radiologist B
Radiologist A
Radiologist B
Small Medium Large Good Intermediate Poor
Small 9 Good 5 1 1
Medium 3 2 Intermediate - 2 2
Large 1 5 Poor 2 - 7
Anatomical classification o f AVM
Radiologist B
Radiologist A
Cortical
Cortico-
ventricular
Deep-seated
Cortico-
callosal
Choroid
plexus
Cortical 9 - - - -
Cortico-ventricular 1 5 - - -
Deep-seated - - - - 1
Cortico-callosal - - - 1 1
Choroid plexus 1 - - - -
Arterial supply
Radiologist B
Radiologist A Ant Post Ant and post Ant, post and ext Ant and ext
Ant 9 1 - - -
Post - - - - -
Ant and post 2 1 7 - -
Ant, post and ext - - - - -
Ant and ext - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Presence of venous drainage
Radiologist B
Radiologist A Superficial Deep Superficial and deep
Superficial 7 - 2
Deep - 1 1
Superficial and Deep 1 1 7
Number of arterial feeders Number of veins
Radiologist B Radiologist B
Radiologist A 1 2 3 >3 Radiologist A 1 2 3 >3
1 6 1 - 1 2 4
2 1 - 1 2 3 - 1
3
>3
3
>3
Presence of aneurysm on feeding artery 
Radiologist B
Radiologist A Yes No
Yes
No 20
Presence of Circle of Willis aneurysm 
Radiologist B
Radiologist A 
Yes 
No
Yes
2
No
18
Presence of intranidal aneurysm 
Radiologist B
Radiologist A Yes No
Yes
No 18
Presence of focal varix
Radiologist A 
Y e s ~  
No
Radiologist B
Yes No
10
2
Presence o f diffuse varix
Radiologist B
Radiologist A Yes No
Yes
No 12
Presence of venous stenosis'
Radiologist A 
Yes 
No
Radiologist B 
Yes No^
~  r
19
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Presence of venous occlusion Presence of embolic material
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes - 1 Yes -
No - 19 No 20
Presence of angiogenesis Presence of calcification
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes 2 4 Yes - -
No 4 10 No - 20
Clinical goal of treatment
Radiologist B
Radiologist A
Cure
__
Diminish risk of
Palliate
haemorrhage
Adjunct to 2nd 
treatment
None
Cure - 1 - -
Diminish risk of
2
haemorrhage
Palliate . 1 6 . .
Adjunct to 2nd
treatment
None 2 1
Morphological goal of treatment
Radiologist B
Eliminate high Decrease Obliterate Eliminate No
Radiologist A risk component nidus size nidus specific feeders treatment
Eliminate high
2
risk component 
Decrease nidus
1
size
Obliterate nidus 2 1 7 4 _
Eliminate
1 2
specific feeders 
No treatment - - - - -
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Proposed treatment
Radiologist B
Radiologist A Conservative Medical Embolisation DXT Surgery
Conservative - - 3 - -
Medical - - - - -
Embolisation - - 15 - 1
DXT - - - - -
Surgery - - 1 - -
Interobserver variability for MIP
Nidus size Nidus definition
Radiologist B Radiologist B
Radiologist A Small Medium Large Radiologist A Good Intermediate Poor
Small 9 1 Good —- i r
Medium 4 Intermediate 5 2 4
Large 2 4 Poor 1 6
Anatomical classification ofAVM
Radiologist B
Radiologist A
Cortico-
Cortical
ventricular
Deep-seated
Cortico- Choroid 
callosal plexus
Cortical 7 1 - -
Cortico-ventricular 2 4 - -
Deep-seated 2 1 -
Cortico-callosal 1 - 2
Choroid plexus - - -
Arterial supply
Radiologist B
Radiologist A Ant Post Ant and post Ant, post and ext Ant and ext
Ant 10 - 2 - -
Post - - - - -
Ant and post 1 1 6 - -
Ant, post and ext - - - - -
Ant and ext - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
2 2 6
Pattern of venous drainage
Radiologist A
Radiologist B
Superficial Deep Superficial and deep
Superficial 8 1
Deep - 1
Superficial and Deep - 2 8
Number of arterial feeders Number of veins
Radiologist B Radiologist B
Radiologist A 1 2 3 >3 Radiologist A 1 2  3 >3
1 4 2 1 7 - 1 -
2 2 1 2 1 1 - -
3 1 1 2 3 1 1 - 4
>3 1 - 6 >3 . . . 4
Presence of aneurysm on feeding artery 
Radiologist B
Presence of Circle of Willis aneurysm 
Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes - Yes 2
No 1 19 No 1 17
Presence ofintranidal aneurysm Presence of focal varix
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes 2 Yes 9 3
No 3 15 No 3 5
Presence of diffuse varix Presence of venous stenosis
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes 1 - Yes - 3
No 4 15 No 1 16
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Presence of venous occlusion Presence of embolic material
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes - Yes 6
No 1 19 No 1 13
Presence o f angiogenesis___________  Presence o f calcification
Radiologist B Radiologist B
Radiologist A Yes No Radiologist A Yes No
Yes 4 - Yes 5 2
No 2 14 No 1 12
Clinical goal of treatment
Radiologist B
Radiologist A
Cure
Diminish risk of 
haemorrhage
Palliate
Adjunct to 2 
treatment
None
Cure 8 - 1 - -
Diminish risk of
. 2 2 - _
haemorrhage
Palliate 1 - 5 - -
Adjunct to 2nd
treatment
None _ _ 1 _ _
Morphological goal of treatment
Radiologist B
Eliminate high Decrease Obliterate Eliminate No
Radiologist A risk component nidus size nidus specific feeders treatment
Eliminate high 9
risk component
Decrease nidus
1 1 2
size
Obliterate nidus - 1 8 - -
Eliminate 
specific feeders
- 1 1 2 -
No treatment - - - 1 -
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Proposed treatment
Radiologist B
Radiologist A Conservative Medical Embolisation DXT Surgery
Conservative -
_ _ _
-
Medical - - -
Embolisation - 16 3
DXT - - -
Surgery - - -
Comparison of imaging techniques for all AVMs -  SSD versus DSA
Nidus size Nidus definition
DSA DSA
SSD Small Medium Large SSD Good Intermediate Poor
Small 8 1 - Good 8
Medium - 4 2 Intermediate 3
Large 5 Poor 6 2 1
Anatomical classification ofAVM
DSA
Cortical
SSD
Cortico-
ventricular
Deep-seated
Cortico- Choroid 
callosal plexus
Cortical 8 2 1 -
Cortico-ventricular 5 1 -
Deep-seated - - 1
Cortico-callosal - - 2
Choroid plexus - - -
Arterial supply
DSA
SSD Ant Post Ant and post Ant, post and ext Ant and ext
Ant 9 - 1 - 1
Post - - - 1 -
Ant and post - - 5 3 -
Ant, post and ext - - - - -
Ant and ext - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern of venous drainage
SSD
DSA
Superficial Deep Superficial and deep
Superficial 10 -
Deep 3 -
Superficial and Deep 7
Number of arterial feeders Number of veins
DSA DSA
SSD 1 2 3 >3 SSD 1 2 3 >3
1 6 1 5 -
2 1 1 2 1 4 - 1
3 1 3 1 1
>3 11 >3 . . . 7
Presence of aneurysm on feeding artery Presence of Circle of Willis aneurysm
DSA DSA
SSD Yes No SSD Yes No
Yes - Yes 2 -
No 5 15 No 1 17
Presence of intranidal aneurysm Presence of focal varix
DSA DSA
SSD Yes No SSD Yes No
Yes 1 Yes 10 1
No 3 16 No 3 6
Presence of diffuse varix Presence of venous stenosis
DSA DSA
SSD Yes No SSD Yes No
Yes 2 6 Yes -
No 5 7 No 12 8
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Presence of venous occlusion Presence of embolic material
DSA DSA
SSD Yes No SSD Yes No
Yes 1 1 Yes - -
No 2 16 No 5 15
Presence o f angiogenesis___________  Presence of calcification
DSA DSA
SSD Yes No SSD Yes No
Yes 4 3 Yes -
No 1 12 No 20
Clinical goal of treatment
DSA
SSD
Cure
Diminish risk of 
haemorrhage
Palliate
Adjunct to 2nd 
treatment
None
Cure
Diminish risk of
7 ” “ “
haemorrhage
“ 2 " “ 1
Palliate 1 2 4 - 2
Adjunct to 2nd 
treatment
- - - - -
None _ _ _ _ 1
Morphological goal of treatment
DSA
SSD
Eliminate high 
risk component
Decrease 
nidus size
Obliterate
nidus
Eliminate 
specific feeders
No
treatment
Eliminate high
risk component
2
' '
2
Decrease nidus
size
“ • 1 1 1
Obliterate nidus - - 7 - -
Eliminate
specific feeders
2 ” • 2 1
No treatment - - - - 1
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Proposed treatment
DSA
SSD Conservative Medical Embolisation DXT Surgery
Conservative 1 - - - -
Medical - - - - -
Embolisation 3 2 10 3 1
DXT - - - - -
Surgery - - - - -
Comparison of imaging techniques for ail A VMs -  MIP versus DSA
Nidus size Nidus definition
DSA DSA
MIP Small Medium Large MIP Good Intermediate Poor
Small 8 2 - Good 5
Medium 2 4 Intermediate 7
Large 1 3 Poor 5 2 1
Anatomical classification ofAVM
DSA
MIP
Cortical
Cortico-
ventricular
Deep-seated
Cortico- Choroid 
callosal plexus
Cortical ~~7~ 2 - -
Cortico-ventricular 1 5 - -
Deep-seated - - 1 1
Cortico-callosal - - 1 2
Choroid plexus - - - -
Arterial supply
DSA
MIP Ant Post Ant and post Ant, post and ext Ant and ext
Ant 9 - 1 1
Post - - - -
Ant and post - - 5 4
Ant, post and ext - - - -
Ant and ext - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern of venous drainage
DSA
MIP Superficial Deep Superficial and deep
Superficial 9 - -
Deep - 1 -
Superficial and Deep 1 2 7
Number of arterial feeders Number of veins
DSA DSA
MIP 1 2 3 >3 MIP 1 tT 3 >3
1 6 - 1 5 2 - -
2 1 1 1 2 3 2 - -
3 - 3 3 1 3
>3 - 8 >3 - 6
Presence of aneurysm on feeding artery
DSA
1 Presence of Circle of Willis aneurysm
DSA
MIP Yes No MIP Yes No
Y es - - Yes 2 -
No 5 15 No 1 17
Presence ofintranidal aneurysm Presence of focal varix
DSA DSA
MIP Yes No MIP Yes No
Yes 1 - Yes 9 4
No 3 16 No 4 3
Presence of diffuse varix Presence of venous stenosis
DSA DSA
MIP Yes No MIP Yes No
Yes 4 1 Yes 3 -
No 3 12 No 9 8
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Presence of venous occlusion Presence of embolic material
DSA DSA
MIP Yes No MIP Yes No
Yes 1 - Yes 5 1
No 2 17 No _ 14
Presence of angio gene sis Presence of calcification
DSA DSA
MIP Yes No MIP Yes No
Yes 4 -- Yes 7
No 1 15 No 13
Clinical goal of treatment
DSA
MIP
Cure
Diminish risk o f  
haemorrhage
Palliate
Adjunct to 2nd 
treatment
None
Cure 7 - 1 - -
Diminish risk of 
haemorrhage
- 3 - - 1
Palliate 1 1 3 - 2
Adjunct to 2nd
treatment
None _ - _ - 1
Morphological goal of treatment
DSA
MIP
Eliminate high 
risk component
Decrease 
nidus size
Obliterate
nidus
Eliminate 
specific feeders
No
treatment
Eliminate high
risk component
2 0 0 1
'
Decrease nidus
size
• 1 2 ”
Obliterate nidus - - 7 1 -
Eliminate
specific feeders
2 1 1 1
No treatment - - - - 1
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Proposed treatment
DSA
MIP Conservative Medical Embolisation DXT Surgery
Conservative 1 - - - -
Medical - - - - -
Embolisation 3 2 9 3 1
DXT - - 1 - -
Surgery - - - - -
Comparison of imaging techniques for small A VMs -  SSD versus DSA
Nidus size______________________ Nidus definition
DSA DSA
SSD Small Medium Large SSD Good Intermediate Poor
Small 8 - Good 7 -
Medium - - Intermediate 1 -
Large - - Poor - -
Anatomical classification of AVM
DSA
SSD
Cortical
Cortico-
ventricular
Deep-seated
Cortico-
callosal
Choroid
plexus
Cortical 5 - 1 - -
Cortico-ventricular - - - - -
Deep-seated - - - - -
Cortico-callosal - - - 1 -
Choroid plexus - - - 1 -
Arterial supply
DSA
SSD Ant Post Ant and post Ant, post and ext Ant and ext
Ant 7 1 - -
Post - - - -
Ant and post - - - -
Ant, post and ext - - - -
Ant and ext - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern of venous drainage
SSD
DSA
Superficial Deep Superficial and deep
Superficial 5 -
Deep - 2
Superficial and Deep - 1
Number of arterial feeders
SSD
DSA
1
_  _  _ _
>3
1 6 - -
2 - 1 -
3 - - -
>3 _ _ 1
Presence of aneurysm on feeding artery
DSA
SSD Yes No
Yes - -
No _ 8
Presence of intranidal aneurysm
DSA
SSD Yes No
Yes 1 -
No 7
Presence of diffuse varix
DSA
SSD  Yes No
Yes - 2
No 1 5
Number of veins
SSD
DSA
1 2 3 >3
~~T~
2
3
>3
4 - - - 
1 3
Presence of Circle o f Willis aneurysm
DSA
SSD Yes No
Yes 1 ~
No 7
Presence of focal varix
DSA
SSD Yes No
Yes 2 “
No 2 4
Presence of venous stenosis
DSA
SSD Yes No
Yes
No 4 4
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Presence of venous occlusion Presence of embolic material
DSA DSA
SSD Yes No SSD Yes No
Yes - - Yes - -
No - 8 No 2 6
Presence of an gio gene sis Presence of calcification
DSA DSA
SSD Yes No SSD Yes No
Yes - - Yes -
No - 8 No 8
Clinical goal of treatment
DSA
SSD
Cure
Diminish risk of  
haemorrhage
Palliate
Adjunct to 2nd 
treatment
None
Cure 7 - - - -
Diminish risk o f
haemorrhage
Palliate 1 - - - -
Adjunct to 2nd
treatment
None _ _ -
Morphological goal of treatment
DSA
Eliminate high Decrease Obliterate Eliminate No
SSD risk component nidus size nidus specific feeders treatment
Eliminate high
risk component
Decrease nidus
1
size
Obliterate nidus 7 - -
Eliminate
specific feeders
No treatment - - -
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Proposed treatment
DSA
SSD Conservative Medical Embolisation DXT Surgery
Conservative
Medical
Embolisation
DXT
Surgery
4 5 1
Comparison of imaging techniques for small A VMs -  MIP versus DSA
Nidus size Nidus definition
DSA DSA
MIP Small Medium Large MIP Good Intermediate Poor
Small 8 Good 4 - -
Medium Intermediate 4
Large Poor -
Anatomical classification o f AVM
DSA
Cortico- Cortico- Choroid
Cortical Deep-seated
MIP ventricular callosal plexus
Cortical 5 -
Cortico-ventricular .
Deep-seated -
Cortico-callosal 1 2
Choroid plexus -
Arterial supply
DSA
MIP Ant Post Ant and post Ant, post and ext Ant and ext
Ant 7
_
- -
Post - - - -
Ant and post - - - -
Ant, post and ext - - - -
Ant and ext - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern of venous drainage
MIP
DSA
Superficial Deep Superficial and deep
Superficial 5 -
Deep - 1
Superficial and Deep - 1 1
Number of arterial feeders Number of veins
DSA DSA
MIP 1 2 3 >3 MIP 1 2 3 >3
1 6 1 4 2
2 1 - 1 2 1 1
3 - 3 - -
>3 - >3 - -
Presence of aneurysm on feeding artery
DSA
Presence of Circle of Willis aneurysm
DSA
MIP Yes No MIP Yes No
Yes - Yes 1
No 8 No 7
Presence of intranidal aneurysm Presence of focal varix
DSA DSA
MIP Yes No MIP Yes No
Yes 1 Yes 2 1
No 7 No 2 3
Presence of diffuse varix Presence of venous stenosis
DSA DSA
MIP Yes No MIP Yes No
Yes 1 1 Yes - -
No - 6 No 4 4
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Presence of venous occlusion Presence of embolic material
DSA DSA
MIP Yes No MIP Yes No
Yes - - Yes 2 -
No _ 8 No - 6
Presence of an gio gene sis   Presence of calcification
DSA DSA
MIP Yes No MIP Yes No
Yes - - Yes - 2
No - 8 No - 6
Clinical goal of treatment
DSA
MIP
Cure
Diminish risk of 
haemorrhage
Palliate
Adjunct to 2nd 
treatment
None
Cure 7 - - - -
Diminish risk of
haemorrhage
Palliate 1 - - - -
Adjunct to 2nd
treatment
None _ _ _ _ _
Morphological goal of treatment
DSA
Eliminate high Decrease Obliterate Eliminate No
MIP risk component nidus size nidus specific feeders treatment
Eliminate high
risk component
Decrease nidus
size
Obliterate nidus 7 - -
Eliminate 1
specific feeders
1
No treatment - - -
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Proposed treatment
DSA
MIP Conservative Medical Embolisation DXT Surgery
Conservative - - - - -
Medical - - - - -
Embolisation - - 3 3 1
DXT - - 1 - -
Surgery - - - - -
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APPENDIX 3
Data for Chapter 4 -  MR Angiography 
Interobserver variability for pre contrast TOF sequences
Nidus size
Radiologist B
Radiologist A Small Medium Large Not assessable
Small 5 2 - 1
Medium - 1
Large - -
Not assessable _ 1
Nidus definition
Radiologist B
Radiologist A Good Intermediate Poor Not assessable
Good 1 - -
Intermediate 2 1 1 -
Poor 1 2 1
Not assessable - - 1
Anatomical classification of AVM
Radiologist B
Radiologist A
Cortical
Cortico-
ventricular
Deep-
seated
Cortico-
callosal
Choroid
plexus
Posterior
fossa
Not
assessable
Cortical 3 1 1 - - - 3
Cortico-ventricular - - - - - - -
Deep-seated - - - - - - -
Cortico-callosal - - - - - - -
Choroid plexus - - - - - - -
Posterior fossa - - - - - 1 -
Not assessable - - - - - - 1
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Arterial supply
Radiologist B 
Ant and Ant, post Ant and Not
Radiologist A Ant Post
post and ext Ext assessable
Ant . . . . .  i
Post 2 3 - - - -
Ant and post 1
Ant, post and ext - - - 1
Ant and ext 1
Not assessable . . . . .  i
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
Pattern of venous drainage
Radiologist A
Radiologist B
Superficial Deep Superficial and deep Not assessable
Superficial - - -
Deep - 1 -
Superficial and Deep - - -
Not assessable 3 1 5
Number of arterial feeders _______ Number of  veins
Radiologist B Radiologist B
Radiologist A 1 2 3 >3 Not assess Radiologist A 1 2 3 >3 Not assess
1 2 2 - 1 1 - -
2 - 1 1 - 2 - - -
3 - 1 . 3 - - -
>3 - - 1 >3 - - -
Not assess . - - 2 Not assess 2 - - - 7
Presence o f aneurysm on feeding artery Presence of Circle of Willis aneurysm
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - - Yes - - -
No 1 7  1 No 8 1
Not assess - - 1 Not assess - 1
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Presence ofintranidal aneurysm Presence of focal varix
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes 1 Yes -
No 8 No 3
Not assess 1 Not assess 2 5
Presence of diffuse varix Presence of venous stenosis
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - - Y es -
No 3 - No 3
Not assess 2 5 Not assess ■ to u,
Presence of venous occlusion
Radiologist B
Radiologist A Yes No Not assess
Yes - -
No 3 -
Not assess 2 5
Clinical goal of treatment
Radiologist B
Radiologist A
Cure Diminish risk of 
haemorrhage
Palliate Adjunct to 2nd 
treatment
Not
None
assessable
Cure 3 - ”1  ~ -
Diminish risk o f 1 1
haemorrhage
1
Palliate 1 1 - -
Adjunct to 2nd
treatment
None - - -
Not assessable - 1 1
2 4 4
Morphological goal of treatment
Radiologist B
Radiologist A
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high 
risk component
1 - - 1 - -
Decrease nidus
size
Obliterate nidus - - 3 1 - -
Eliminate 
specific feeders
1 - 1 - - -
No treatment - - - - - -
Not assessable - _ - 1 - 1
Proposed treatment
Radiologist B
Not
Radiologist A Conservative Medical Embolisation DXT Surgery
assessable
Conservative - - - -
Medical - - - -
Embolisation - 6 - -
DXT - 2 - -
Surgery - - - -
Not assessable - 1 - 1
Interobserver variability for CEMRA
Nidus size
Radiologist B
Radiologist A Small Medium Large Not assessable
Small 8
Medium 1
Large -
Not assessable 1
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Nidus definition
Radiologist B
Radiologist A Good Intermediate Poor Not assessable
Good - - - -
Intermediate 3 3 1 -
Poor - 1 1 -
Not assessable - - - 1
Anatomical classification of AVM
Radiologist B
Radiologist A
Cortical
Cortico-
ventricular
Deep- Cortico- Choroid 
seated callosal plexus
Posterior
fossa
Not
assess
Cortical 5 1 - - -
Cortico-ventricular 1 - - - -
Deep-seated - - - - -
Cortico-callosal - - - - -
Choroid plexus - - 1 - -
Posterior fossa - - - 1 -
Not assessable - . - - 1
Arterial supply
Radiologist B
Radiologist A Ant Post
Ant and 
post
Ant, post 
and ext
Ant and 
Ext
Not
assessable
Ant 2 - - - - -
Post - 1 - - 1 -
Ant and post - 1 1 - - -
Ant, post and ext - - - - - -
Ant and ext - - - - - -
Not assessable 2 1 - - - 1
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern of venous drainage
Radiologist B
Radiologist A Superficial Deep Superficial and deep Not assessable
Superficial 4 1 1
Deep 1 - 1
Superficial and Deep 1 - -
Not assessable - - 1
Number of arterial feeders Number of veins
Radiologist B Radiologist B
Radiologist A 1 2 3 >3 Not assess Radiologist A 1 2 3 >3 Not assess
1 3 - - - 1 4 - - - 2
2
'X
- 1 2 - 2 1 2 - -
J
>3 _ >3 .
Not assess 3 - - - 1 Not assess . . . .  i
Presence of aneurysm on feeding artery 
Radiologist B
Presence of intranidal aneurysm 
Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - Yes -
No 9 No 9
Not assess 1 Not assess 1
Presence of Circle of Willis aneurysm Presence of focal varix
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - Yes 2
No 9 No 5 2
Not assess 1 Not assess 1
Presence of diffuse varix Presence of venous stenosis
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes 3 Yes -
No 1 3 2 No 7 2
Not assess 1 Not assess 1
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Presence of venous occlusion
Radiologist B
Radiologist A Yes No Not assess
Yes -
No 1 6 2
Not assess 1
Clinical goal of treatment
Radiologist B
Cure Diminish risk o f Palliate Adjunct to 2nd
None
Not
Radiologist A haemorrhage treatment assessable
Cure 2 - - - - -
Diminish risk of
1
haemorrhage
Palliate - 2 - - -
Adjunct to 2nd
treatment
None 1 - - - -
Not assessable 1 _ . . _ 3
Morphological goal of treatment
Radiologist B
Radiologist A
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high
1
risk component 
Decrease nidus
1
size
Obliterate nidus _ _ 2 _ _ _
Eliminate
1
specific feeders 
No treatment _ _ 1 _ -
Not assessable - - 1 - - 3
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Proposed treatment
Radiologist B
Radiologist A Conservative Medical Embolisation DXT Surgery Not assessable
Conservative ~  - r -
Medical - -
Embolisation 5 -
DXT - -
Surgery - -
Not assessable 1 3
Interobserver variability for post contrast TOF sequences
Nidus size
Radiologist B
Radiologist A Small Medium Large Not assessable
Small 2
Medium 8
Large -
Not assessable -
Nidus definition
Radiologist B
Radiologist A Good Intermediate Poor Not assessable
Good -
Intermediate 1 3 1
Poor 1 1 3
Not assessable -
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Anatomical classification of A VM
Radiologist B
Radiologist A
Cortical
Cortico-
ventricular
Deep-
seated
Cortico-
callosal
Choroid
plexus
Posterior
fossa
Not
assess
Cortical 6 - - - - - -
Cortico-ventricular - 1 - - - - -
Deep-seated - - 1 1 - - -
Cortico-callosal - - - - - - -
Choroid plexus - - - - - - -
Posterior fossa - - - - - 1 -
Not assessable _ _ _ _
Arterial supply
Radiologist B
Radiologist A Ant Post
Ant and 
post
Ant, post 
and ext
Ant and 
Ext
Not
assessable
Ant 4 - - - - -
Post - 4 1 - - -
Ant and post - - - - - -
Ant, post and ext - - 1 - - -
Ant and ext - - - - - -
Not assessable - - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
Pattern o f venous drainage
Radiologist B
Radiologist A Superficial Deep Superficial and deep Not assessable
Superficial 4 1 1
Deep 1 1 1
Superficial and Deep 1 - -
Not assessable - - -
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Number of arterial feeders Number of veins
Radiologist B Radiologist B
Radiologist A 1 2 3 >3 Not assess Radiologist A 1 2 3 >3 Not assess
1 4 - - 1 1 1 4 1 - - 3
2 - 2 1 - 2 1 1 - -
3 - - 1 3 - -
>3 - - - >3 - -
Not assess - - - Not assess - -
Presence of aneurysm on feeding artery Presence of intranidal aneurysm
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - - Yes -
No 1 9 No 1 9
Not assess - - Not assess -
Presence of Circle of Willis aneurysm Presence of focal varix
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes - - Yes 4 -
No 1 9 No 1 5
Not assess - - Not assess -
Presence of diffuse varix Presence of venous stenosis
Radiologist B Radiologist B
Radiologist A Yes No Not assess Radiologist A Yes No Not assess
Yes 2 1 Yes 3
No 1 6 No 7
Not assess - - Not assess -
Presence of venous occlusion
Radiologist B
Radiologist A Yes No Not assess
Yes - 3
No - 7
Not assess - -
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Clinical goal of treat m e n t ___________  ___
Radiologist B
Radiologist A
Cure Diminish risk o f  
haemorrhage
Palliate Adjunct to 2"a 
treatment
None
Not
assessable
Cure 4 - - - - -
Diminish risk o f  
haemorrhage
1 - 1 - - -
Palliate - - 2 - - -
Adjunct to 2nd
treatment
None - - 1 - 1 -
Not assessable _ _ _ _ _
Morphological goal of treatment
Radiologist B
Radiologist A
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high
1 1
risk component
Decrease nidus
size
Obliterate nidus - - 4 - - -
Eliminate 
specific feeders
- - - 2 - -
No treatment - - - 1 1 -
Not assessable - - - - - -
Proposed treatment______________________________
Radiologist B
Radiologist A Conservative Medical Embolisation
Not
DXT Surgery
assessable
Conservative 1 - 1 -
Medical - - - -
Embolisation - - 7 -
DXT - - 1 -
Surgery - - - -
Not assessable - - - -
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Variability for DSA and pre contrast TOF sequences
Nidus size
DSA
Pre contrast Small Medium Large Not assessable
Small 5 3 -
Medium - - 1
Large - - -
Not assessable _ 1 _
Nidus definition
DSA
Pre contrast Good Intermediate Poor Not assessable
Good 1 -
Intermediate 3 1
Poor 2 2
Not assessable 1 -
Anatomical classification of AVM
DSA
Pre contrast TOF
Cortical
Cortico-
ventricular
Deep-
seated
Cortico-
callosal
Choroid
plexus
Posterior
fossa
Not
assess
Cortical 7 - 1 - - - -
Cortico-ventricular - - - - - - -
Deep-seated - - - - - - -
Cortico-callosal - - - - - - -
Choroid plexus - - - - - - -
Posterior fossa - - - - - 1 -
Not assessable 1 - - - - - -
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Arterial supply
DSA
Pre contrast 
TOF
Ant Post
Ant and 
post
Ant, post 
and ext
Ant and 
Ext
Not
assessable
Ant 1 - - - - -
Post 1 3 1 - - -
Ant and post - 1 - - - -
Ant, post and ext - - 1 - - -
Ant and ext 1 - - - - -
Not assessable 1 - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
Pattern of venous drainage
Pre contrast TOF
DSA
Superficial Deep Superficial and deep Not assessable
Superficial - - - -
Deep 1 - - -
Superficial and Deep - - - -
Not assessable 7 2 - -
Number of arterial f e e d e r s   Number of veins
DSA DSA
Pre contrast 1 2 3 >3 Not assess Pre contrast "I" 2 3 >3 Not assess
1 3 1 - - 1 1 - - - -
2 - - - - 2 - - - - -
3 - 2 1 - 3 - - - - -
>3 - - - 1 >3 - - - - -
Not assess 2 - _ - Not assess 8 1 _ _ _
Presence of aneurysm on feeding artery Presence of Circle of Willis aneurysm
Pre contrast
DSA DSA
Yes No Not assess Pre contrast Yes No Not assess
Yes - - Yes -
No 2 7 No 9
Not assess - 1 Not assess 1
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Presence of intranidal aneurysm Presence of focal varix
DSA DSA
Pre contrast Yes No Not assess Pre contrast Yes No Not assess
Yes - 1 - Yes - -
No 3 5 - No - 3
Not assess - 1 _ Not assess 2 5
Presence of diffuse varix___________  Presence of venous stenosis
Pre contrast
DSA
Pre contrast
DSA
Yes No Not assess Yes No Not assess
Yes - - Yes - -
No 1 2 No 2 1
Not assess 2 5 Not assess 1 6
Presence of venous occlusion
DSA
Pre contrast Yes No Not assess
Yes -
No 3
Not assess 7
Clinical goal of treatment
DSA
Pre contrast 
TOF
Cure Diminish risk of 
haemorrhage
Palliate Adjunct to 2nd 
treatment
Not
None
assessable
Cure 2 - - -
Diminish risk o f
1
haemorrhage
Palliate - 1 1 -
Adjunct to 2nd
treatment
None 1 - - -
Not assessable 2 1 1 -
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Morphological goal of treatment
DSA
Pre contrast TOF
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high
1
risk component 
Decrease nidus
1
size
Obliterate nidus _ 2 _
Eliminate specific
1
feeders 
No treatment _ 1 . . _
Not assessable 1 1 2 _ _
Proposed treatment
DSA
Pre contrast
Conservative
TOF
Medical Embolisation DXT Surgery Not assessable
Conservative ~  r -
Medical - -
Embolisation 5 -
DXT - -
Surgery 
Not assessable 2 2
Variability for DSA and CEMRA
Nidus size
DSA
CEMRA Small Medium Large Not assessable
Small 4 4 -
Medium - - 1
Large - - -
Not assessable 1 - -
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Nidus definition
DSA
CEMRA Good Intermediate Poor Not assessable
Good - -
Intermediate 5 2
Poor 1 1
Not assessable 1 -
Anatomical classification ofAVM
DSA
CEMRA
Cortical
Cortico-
ventricular
Deep-
seated
Cortico- Choroid Posterior Not 
callosal plexus fossa assess
Cortical 6 - - -
Cortico-ventricular 1 - - -
Deep-seated - - - -
Cortico-callosal - - - -
Choroid plexus - - 1 -
Posterior fossa - - - 1
Not assessable 1 - - -
Arterial supply
DSA
CEMRA
Ant Post
Ant and 
post
Ant, post Ant and Not 
and ext Ext assessable
Ant 2 - - -
Post - - 2 -
Ant and post - 2 - -
Ant, post and ext - - - .
Ant and ext - - - -
Not assessable 2 2 - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
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Pattern ofyenous drainage
DSA
CEMRA Superficial Deep Superficial and deep Not assessable
Superficial 6 - -
Deep 2 - -
Superficial and Deep 1 - -
Not assessable 1 - -
Number of arterial feeders Number of veins
DSA DSA
CEMRA 1 2 3 >3 Not assess CEMRA 1 2 3 >3 Not assess
1 1 1 1 - 7 6 1 -
2
'X
1 1 - 1 2
'I
2 - -
J
>3 - .
J
>3 - -
Not assess 3 1 - Not assess 1 - -
Presence of aneurysm on feeding artery
DSA
Presence of intranidal aneurysm
DSA
CEMRA Yes No Not assess CEMRA Yes No Not assess
Yes - - Yes - -
No 2 7 No 3 6
Not assess - 1 Not assess - 1
Presence of Circle of Willis aneurysm Presence of focal varix
DSA DSA
CEMRA Yes No Not assess CEMRA Yes No Not assess
Yes - - Yes 1 1
No - 9 No 1 6
Not assess - 1 Not assess - 1
Presence of diffuse varix Presence of venous stenosis
DSA DSA
CEMRA Yes No Not assess CEMRA Yes No Not assess
Yes 2 1 Yes - -
No 1 5 No 2 7
Not assess - 1 Not assess 1 -
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Presence of venous occlusion
DSA
CEMRA Yes No Not assess
Yes - - -
No - 9 -
Not assess - 1 -
Clinical goal o f  treatment
DSA
Cure Diminish risk of Palliate Adjunct to 2 Not
None
CEMRA haemorrhage treatment assessable
Cure 3 1 - - -
Diminish risk of
1 1 - - -
haemorrhage
Palliate - - 2 - -
Adjunct to 2nd
treatment
None - - - - -
Not assessable 2 . _ - -
Morphological goal o f treatment
DSA
CEMRA
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high 
risk component
- 1 1 - - -
Decrease nidus
size
Obliterate nidus 1 - 3 - - -
Eliminate 
specific feeders
- 2 - - - -
No treatment - - - - - -
Not assessable - 1 1 - - -
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Proposed treatment
DSA
CEMRA Conservative Medical Embolisation DXT Surgery Not assessable
Conservative - - - - -
Medical - - - - -
Embolisation - - 4 2 -
DXT - - 2 - -
Surgery - - - - -
Not assessable - - 2 - -
Variability for DSA and post contrast TOF sequences
Nidus size
DSA
Post contrast TOF Small Medium Large Not assessable
Small 5 4 -
Medium - - 1
Large - - -
Not assessable _ . _
Nidus definition
DSA
Post contrast TOF Good Intermediate Poor Not assessable
Good - - -
Intermediate 3 2 -
Poor 4 1 -
Not assessable - - -
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Anatomical classification ofAVM
DSA
Post contrast TOF
Cortical
Cortico-
ventricular
Deep-
seated
Cortico-
callosal
Choroid
plexus
Posterior
fossa
Not
assess
Cortical 6 - - - - - -
Cortico-ventricular 1 - - - - - -
Deep-seated 1 - 1 - - - -
Cortico-callosal - - - - - - -
Choroid plexus - - - - - - -
Posterior fossa - - - - - 1 -
Not assessable - _ _ - _ -
Arterial supply
DSA
Post contrast TOF
Ant Post
Ant and Ant, post 
post and ext
Ant and 
Ext
Not
assessable
Ant 4 - - - -
Post - 4 1 - -
Ant and post - - - - -
Ant, post and ext - - 1 - -
Ant and ext - - - - -
Not assessable - - - - -
Ant -  anterior circulation, Post -  posterior circulation, Ext -  external carotid supply
Pattern o f venous drainage
Post contrast TOF
DSA
Superficial Deep Superficial and deep Not assessable
Superficial 6 - - -
Deep 1 2 - -
Superficial and Deep 1 - - -
Not assessable - - - -
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Number of arterial feeders
DSA
Number of veins
DSA
Post contrast 1 2 3 >3 Not assess Post contrast 1 2 3 >3 Not assess
1 4 2 - 1 7 1 - - -
2 1 1 1 - 2 2 - - - -
3 - - - 1 3 - - -
>3 - - - >3 - - -
Not assess - - - Not assess - - -
Presence of aneurysm on feeding artery Presence of intranidal aneurysm
DSA DSA
Post contrast Yes No Not assess Post contrast Yes No Not assess
Yes - - Yes 1 -
No 2 8 No 3 6 -
Not assess - - Not assess - -
Presence of Circle of Willis aneurysm Presence o f focal varix
DSA DSA
Post contrast Yes No Not assess Post contrast Yes No Not assess
Yes - - Yes 1 3 -
No - 10 No 1 5 -
Not assess - - Not assess - -
Presence of diffuse varix Presence of venous stenosis
DSA DSA
Post contrast Yes No Not assess Post contrast Yes No Not assess
Yes 2 1 Yes 3 -
No 1 6 No 3 4 -
Not assess - - Not assess - -
Presence of venous occlusion
DSA
Post contrast Yes No Not assess
Yes 3 -
No 7 -
Not assess - -
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Clinical goal o[ treatment
DSA
Post contrast TOF
Cure Diminish risk o f  
haemorrhage
Palliate Adjunct to 2nd 
treatment
Not
None
assessable
Cure 3 1 - - -
Diminish risk of 
haemorrhage
1 - 1 - -
Palliate - 1 1 - -
Adjunct to 2nd
treatment
None 2 - - - -
Not assessable _ _ -
Morphological goal o f treatment
DSA
Post contrast TOF
Eliminate 
high risk 
component
Decrease 
nidus size
Obliterate
nidus
Eliminate
specific
feeders
No
treatment
Not
assessable
Eliminate high
i 1
risk component
1
Decrease nidus
size
Obliterate nidus - 1 3 - - -
Eliminate specific
1 1
feeders
1
No treatment - 1 1 - - -
Not assessable _ _ _ _ _
Proposed treatment
DSA
Post contrast TOF Conservative Medical Embolisation DXT Surgery Not assessable
Conservative - - - -
Medical - - - -
Embolisation - 5 2 -
DXT - 1 - -
Surgery - 2 - -
Not assessable - - - -
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APPENDIX 4
Data for Chapter 6 -  MR perfusion
Cerebral blood flow (in arbitrary unit volume lOOg'1 min*1)
Region
Patient
Nidus Perinidus 1 Perinidus 2 Perinidus 3 Normal
parenchyma
1 1290.51 1274.71 1286.51 1295.17 1253.25
2 1293.12 1239.54 1202.51 1128.99 977.69
3 812.44 1052.53 1066.26 1115.82 1006.92
4 1255.17 1165.43 1151.49 1124.98 1165.14
5 1297.31 1201.72 1135.60 1245.48 1156.36
6 1261.29 1234.24 1207.38 1203.27 1237.25
7 1296.29 1256.81 1267.88 1259.66 1223.01
8 - 1287.63 1287.81 1298.65 1277.77
9 1299.44 1233.18 1201.76 1219.47 1152.10
10 1174.15 1272.42 1108.63 967.74 1024.54
11 1297.23 1279.30 1173.60 1206.18 1023.00
12 1288.42 1170.06 1083.48 1170.30 1238.38
13 1271.54 1169.14 1232.94 1273.94 1218.87
14 1273.75 1140.76 1193.63 1151.29 1155.25
15 1297.34 1289.58 1229.93 1258.54 1241.83
- standard deviation for the average nidus CBF was zero therefore presumed to be ‘uncomputable’
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Cerebral blood volume (in arbitrary unit volume)
Region
Patient
Nidus Perinidus 1 Perinidus 2 Perinidus 3 Normal
parenchyma
1 1078.98 932.56 674.34 756.86 390.34
2 395.18 164.78 130.41 94.07 162.69
3 74.33 111.62 101.47 80.57 39.40
4 582.74 408.76 258.26 174.65 279.42
5 950.69 401.75 235.99 292.58 155.25
6 214.48 128.98 143.31 143.36 145.02
7 540.87 180.33 142.21 153.12 146.37
8 2139.01 971.75 958.22 923.52 418.91
9 831.95 286.82 169.34 168.19 142.86
10 296.91 323.56 163.92 102.88 70.03
11 445.50 331.30 171.90 166.93 74.97
12 1826.25 649.65 462.72 559.70 363.23
13 561.56 194.69 192.35 335.24 113.71
14 476.86 244.27 218.69 171.91 231.78
15 801.29 425.24 313.09 305.71 113.45
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Mean transit time (in arbitrary unit time)
Region
Patient
Nidus Perinidus 1 Perinidus 2 Perinidus 3 Normal
parenchyma
1 270.34 240,82 296.77 396.77 375.80
2 275.26 337.82 341.73 334.70 584.41
3 389.83 410.03 312.94 316.80 301.80
4 288.59 401.49 353.46 383.62 449.68
5 244.61 387.02 390.32 306.40 435.52
6 227.25 212.6 220.02 228.25 212.83
7 216.18 226.32 215.54 217.32 229.60
8 222.32 265.55 258.27 270.59 352.88
9 219.81 297.94 305.82 288.46 270.58
10 360.18 318.37 246.37 280.52 311.58
11 220.68 219.61 315.58 281.12 289.60
12 240.14 595.69 739.99 625.97 417.50
13 246.73 301.29 283.49 290.97 245.10
14 250.86 433.32 355.53 435.70 466.11
15 222.65 241.49 312.28 282.21 277.44
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Time to minimum signal intensity (in arbitrary unit time)
Region
Patient
Nidus Perinidus 1 Perinidus 2 Perinidus 3 Normal
parenchyma
1 342.11 350.31 362.71 374.61 374.78
2 345.38 347.30 351.66 352.76 362.45
3 336.90 349.38 341.34 347.89 368.18
4 375.69 379.85 389.277 394.05 394.52
5 370.10 365.57 383.19 380.64 382.82
6 390.78 386.34 387.88 388.43 387.76
7 332.83 328.55 334.46 332.95 343.71
8 338.92 342.54 348.79 350.10 360.65
9 348.34 362.29 370.37 374.03 358.83
10 363.04 378.65 376.24 391.26 389.50
11 353.64 348.59 366.54 369.03 377.33
12 368.02 439.84 440.95 422.11 406.30
13 329.87 343.80 351.75 346.02 344.03
14 361.50 381.48 387.26 395.40 402.06
15 353.64 354.69 362.83 360.80 366.68
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APPENDIX 5
Data for Chapter 7 -  Digital Subtraction Angiography
Variables
No. Frame rate (fr sec'1)
Injection 
rate 
(ml sec'1)
SID
(cm)
PSD
(cm)
FOV
(inches)
Table
Height
(cm)
Angle
from
horizontal
Calibration model
1 30 1.0 100 87 12 87 0
2 30 1.0 100 87 12 87 0
3 30 1.0 100 87 12 87 0
4 30 1.0 100 87 12 87 0
5 30 1.0 100 87 12 87 0
6 30 1.0 100 87 12 87 0
7 30 1.0 100 87 12 87 0
8 30 1.0 100 87 12 87 0
9 30 1.0 100 87 12 87 0
10 30 1.0 100 87 12 87 0
11 30 5.0 100 87 12 87 0
12 30 5.0 100 87 12 87 0
13 30 5.0 100 87 12 87 0
14 30 5.0 100 87 12 87 0
15 30 5.0 100 87 12 87 0
16 30 5.0 100 87 12 87 0
17 30 5.0 100 87 12 87 0
18 30 5.0 100 87 12 87 0
19 30 5.0 100 87 12 87 0
20 30 5.0 100 87 12 87 0
21 30 10.0 100 87 12 87 0
22 30 10.0 100 87 12 87 0
23 30 10.0 100 87 12 87 0
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Variables
No. Frame rate (fr sec'1)
Injection 
rate 
(ml sec'1)
SID
(cm)
PSD
(cm)
FOV
(inches)
Table
Height
(cm)
Angle
from
horizontal
24 30 10.0 100 87 12 87 0
25 30 10.0 100 87 12 87 0
26 30 10.0 100 87 12 87 0
27 30 10.0 100 87 12 87 0
28 30 10.0 100 87 12 87 0
29 30 10.0 100 87 12 87 0
30 30 10.0 100 87 12 87 0
Angle from horizontal
31 30 5 100 87 12 87 0
32 30 5 100 87 12 87 6.78
33 30 5 100 87 12 87 9.72
34 30 5 100 87 12 87 12.18
35 30 5 100 87 12 87 14.66
36 30 5 100 87 12 87 16.67
37 30 5 100 87 12 87 19.22
38 30 5 100 87 12 87 22.32
39 30 5 100 87 12 87 24.69
40 30 5 100 87 12 87 27.38
41 30 5 100 87 12 87 30.7
42 30 5 100 87 12 87 32.4
43 30 5 100 87 12 87 35.31
44 30 5 100 87 12 87 38.95
45 30 5 100 87 12 87 40.84
46 30 5 100 87 12 87 44.46
47 30 5 100 87 12 87 48.32
48 30 5 100 87 12 87 52.49
49 30 5 100 87 12 87 53.69
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Variables
No. Fram e rate (fr sec'1)
Injection 
rate 
(ml sec'1)
SID
(cm)
PSD
(cm)
FOV
(inches)
Table
Height
(cm)
Angle
from
horizontal
Frame rates 
50 6 0.5 100 83 12 117 0
51 6 1.0 100 83 12 117 0
52 6 2.0 100 83 12 117 0
53 6 4.0 100 83 12 117 0
54 6 6.0 100 83 12 117 0
55 7.5 0.5 100 83 12 117 0
56 7.5 1.0 100 83 12 117 0
57 7.5 2.0 100 83 12 117 0
58 7.5 4.0 100 83 12 117 0
59 7.5 6.0 100 83 12 117 0
60 10 0.5 100 83 12 117 0
61 10 1.0 100 83 12 117 0
62 10 2.0 100 83 12 117 0
63 10 4.0 100 83 12 117 0
64 10 6.0 100 83 12 117 0
65 10 8.0 100 83 12 117 0
66 15 0.5 100 83 12 117 0
67 15 1.0 100 83 12 117 0
68 15 2.0 100 83 12 117 0
69 15 4.0 100 83 12 117 0
70 15 6.0 100 83 12 117 0
71 15 8.0 100 83 12 117 0
72 15 10.0 100 83 12 117 0
73 30 0.5 100 83 12 117 0
74 30 1.0 100 83 12 117 0
75 30 2.0 100 83 12 117 0
76 30 4.0 100 83 . .12....... 117 0
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Variables
^  . Injection XT Frame rate J .No. ,e .u rate (frsec ) , , .u (ml sec )
SID
(cm)
PSD
(cm)
FOV
(inches)
Table
Height
(cm)
Angle
from
horizontal
77 30 6.0 100 83 12 117 0
78 30 8.0 100 83 12 117 0
79 30 10.0 100 83 12 117 0
Field of view
80 15 0.5 100 80 12 114 0
81 15 0.5 100 80 9 114 0
82 15 0.5 100 80 7 114 0
83 15 0.5 100 80 5 114 0
Table height
84 15 0.5 100 48 12 82 0
85 15 0.5 100 53 12 87 0
86 15 0.5 100 58 12 92 0
87 15 0.5 100 63 12 97 0
88 15 0.5 100 68 12 102 0
89 15 0.5 100 73 12 107 0
90 15 0.5 100 78 12 112 0
91 15 0.5 100 83 12 117 0
Source-imaee distance fSID)
92 15 0.5 110 68 12 102 0
93 15 0.5 105 68 12 102 0
94 15 0.5 100 68 12 102 0
95 15 0.5 95 68 12 102 0
96 15 0.5 90 68 12 102 0
97 15 0.5 85 68 12 102 0
Patient-source distance (PSD)
98 15 0.5 100 83 12 117 0
99 15 0.5 95 78 12 117 0
100 15 0.5 90 73 12 117 0
101____ 15 . 0 5 .... ... 85 68 12 117..... 0
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